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Abstract 
 
Neurons and glia (astrocytes and oligodendrocytes) are the two major cell types that make 
up the central nervous system (CNS).  They are generated from precursor domains within 
the neuroepithelial germinal zone (ventricular zone, VZ) that surrounds the ventricles of the 
brain and the central canal of the spinal cord (the embryonic neural tube).  In general, 
neurons are generated before glia.  The intra-spinal circuits that control movement and 
locomotion are made up of different neuronal and glial elements that develop separately 
but come together to form interconnected functional units. To understand the logic of 
circuit development and ultimately circuit-driven behaviour, it is necessary to understand 
where and when each type of cell originates.  To identify the products of the most ventral 
progenitor domain in the developing spinal cord, known as (Nkx2.2-expressing p3 domain), I 
made use of Cre-loxP technology.  I generated a transgenic mouse line that expresses an 
inducible form of Cre recombinase (CreERT2) under Nkx2.2 transcriptional control and 
crossed this with a Cre-dependant reporter mouse to visualize p3-derived progeny.  I 
confirmed that the p3 domain generates Sim1-expressing V3 interneurons, serotonergic 
interneurons as well as visceral motor neurons of the hindbrain.  p3 progenitors also produce 
two spatially restricted subtypes of astrocytes, a few oligodendrocytes and ventrally-
positioned ependymal cells.  Unexpectedly, my studies also revealed that pre-ganglionic 
motor neurons of the sympathetic nervous system (SPNs, visceral motor neurons of the 
thoracic spinal cord), as well as a population of dorsally-located Sim1-expressing 
interneurons, are produced from Nkx2.2-expressing precursors.  SPNs have been generally 
believed to originate from the same progenitor pool as HB9-positive somatic motor neurons 
(sMNs), defined by expression of Olig2 (pMN domain, immediately dorsal to p3).  Supporting 
this idea, no spinal sMNs or SPNs are formed in Olig2-null mice.  However, I found that 
Nkx2.2-expressing p3 precursors do not generate any HB9-positive sMNs, implying that sMNs 
and SPNs derive from distinct precursors - the latter from the most ventral part of the pMN 
domain that transiently co-expresses Nkx2.2 and Olig2.  Thus, segregation of SPNs and sMNs 
occurs already in the neuroepithelium before their post-mitotic progenitors migrate away 
from the VZ into the ventral horns.  This is how visceral and somatic MNs are known to 
develop in the brainstem, so my results provide a unifying theme to MN development at 
different levels of the neuraxis. 
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* In the hindbrain, visceral motor neurons (vMN) comprise visceromotor (VMN) and branchiomotor 
(BMN) neurons. 
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Chapter 1  -   Introduction 
 
 
1.1. Vertebrate Central Nervous System Development 
The vertebrate central nervous system (CNS) is a complex, highly organized network of 
billions of neurons and glial cells (the specialized support cells of neurons). Neurons can be 
split into hundreds of subtypes, the exact number of which is still unknown.  It is also not 
known how many subtypes of glial cells – astrocytes and oligodendrocytes – there are.  The 
CNS (brain, spinal cord and retina) is responsible for highly complex tasks as diverse as 
sensory perception, memory, behaviour, motor coordination and homeostasis.  The interplay 
of these multineuronal pathways relies on each distinct class of cells being generated in 
appropriate numbers during development, at the correct time, in an appropriate location 
and forming precise connections within each other. 
Neurons are generally regarded as the electrically active cells of the CNS. They transmit 
signals from one location to another in response to stimuli coming from sensory cells and 
other nerve cells.  Before arriving at the end target, a stimulus can pass through several 
relay neurons where messages can be weakened, strengthened, selected, stored, and 
integrated into the system. The information conveyed by a chain of neurons runs through 
the two semi-independent systems that make up the CNS – the somatic and the autonomic 
systems.  The former allows us to act on the external environment and the latter on the 
body’s internal environment. Often those two systems interact with each other in tasks such 
as swallowing, breathing and heat conservation by interchanging information between 
specialised neurons from each branch of the nervous system. 
It was thought that glial (literally “glue”) cells only gave structural and trophic support to 
the nervous tissue.  However, it is now clear that they fulfil a lot of other functions 
including insulation of axons (myelination), regulation of the blood brain barrier, synapse 
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formation, neurotransmitter uptake, or regulation of water and ion balance.  In the CNS 
glial cells are divided into macroglia (mainly oligodendrocytes, the myelinating cells, and 
astrocytes) and microglia, which are the immune surveillance cells of the CNS. 
Understanding how the CNS develops is not only interesting in itself but can also provide 
insights into more general questions of developmental biology as well as neurodevelopment 
and neurodegenerative diseases. 
 
1.1.1. Neurulation 
An essential early step of the development of the vertebrate CNS is the formation of the 
neural tube, the most primitive form of the CNS and the origin of the PNS, from a group of 
ectodermal cells on the surface of the embryo at the dorsal midline.  The process, referred 
to as neurulation, is triggered by the migration of mesodermal cells to the region 
underneath the neural ectoderm during gastrulation.  Neurulation occurs mainly in three 
spatially and temporally overlapping stages: (1) neural plate stage, (2) neural fold stage, 
and (3) neural tube stage (Gilbert 2000). 
Neural plate stage 
At the end of gastrulation the vertebrate embryo is arranged into three layers: endoderm 
(inner layer), mesoderm (middle layer) and ectoderm (outer layer).  This three layered form 
of the gastrula is attained by the movement of cells from the epiblast through the primitive 
streak and groove, which results first in the formation of the endodermal layer and later the 
mesodermal layer.  During this cell movement, a group of mesodermal cells, called the 
chordamesoderm, keeps contact with the ectoderm and their migration underneath and 
along the node (also referred to as the organizer) and the ectoderm directly causes the start 
of neurulation (Figure 1.1 A).  The existence of an “organizer” – a group of cells that can 
instruct neurulation – was first demonstrated by Spemann and Mangold (Spemann et al. 
1924) who concomitantly showed that cell fate can be determined by signals produced by 
other cells (for an historical review see Sander et al. 2001).  The molecular nature of this 
signal is now partially understood and involves inhibition of bone morphogenic protein (BMP) 
signalling that prevents surface ectodermal cells from acquiring a neural fate.  Among 
ectodermal cells, a tonic level of BMP is produced, particularly BMP-4, which maintains the 
ectoderm in an epidermal-like state.  As chordamesodermal cells migrate underneath the 
ectoderm they produce chordin and noggin, two proteins that inhibit BMP-4 and, in turn, 
allow the process of neurulation to proceed (for review see Munoz-Sanjuan et al. 2002).  It 
now appears that neurulation begins prior the formation of the node and that signalling 
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molecules like fibroblast growth factors (FGFs) have a role in promoting neurulation too 
(Streit et al. 2000; reviewed in Stern 2006).   
The formation of the neural plate is the first distinguishable change seen in neurulation.  In 
response to the inhibition of BMP signalling, a portion of the ectoderm is specified to 
become neural ectoderm and its cells elongate and acquire a columnar appearance.  This 
thickened region of ectoderm forms the neural plate.  The rest of the ectoderm tissue 
becomes the epidermal ectoderm (Figure 1.1 B).  Meanwhile, the chordamesodermal cells 
form the so called notochord, a longitudinal structure that is critically involved in patterning 
the neural tube. 
Neural fold stage 
A complex series of morphogenic movements follows.  The neural plate undergoes apico-
basal thickening, mediolateral narrowing and further rostrocaudal lengthening.  Once this is 
reached the neural plate curls up, anchored to the underlying notochord, and the 
subsequent bending produces an elongated furrow-like shape, the neural fold or groove 
(Figure 1.1 C). 
Neural tube stage 
Closure of the neural tube is a continuation of the bending process described above.  As the 
neural folds elevate and fuse in the midline, the epidermal ectoderm from each fold 
detaches and comes to cover the newly formed neural tube (Figure 1.1 D).  The midline 
cells of the neural plate become the ventral-most cells in the neural tube and are fated to 
give rise to the floor plate at the ventral midline.  The cells at the crest of the folds turn 
into the dorsal-most cells in the neural tube and later form the roof plate or migrate away 
as neural crest cells, which eventually generate the Peripheral Nervous System (PNS) and 
many other cells and structures.  Meanwhile, the cells of the newly formed neural tube are 
destined to form the entire CNS. 
Even as the neural tube forms, it begins to differentiate.  The allocation of cell fate in the 
neural tube depends on signalling systems along the rostrocaudal and dorsoventral axes that 
establish a grid-like set of positional cues.  The position of each cell along these axes is 
thought to influence its fate by defining the identity and concentration of inductive signals 
to which they are exposed.  At the tissue level different functional regions are organised 
thus dividing the neural tube into four regions (see below, section 1.1.2), while at a cellular 
level precursor cells begin to differentiate into various subtypes of neurons and glia 
(discussed in sections 1.2, 1.3 and 1.4). 
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1.1.2. The Neuroepithelium 
The neural tube is initially a monolayer of pseudostratified neural ectodermal cells.  This 
monolayer of cells is called the neuroepithelium and directly lines the fluid-filled central 
canal.  They rapidly proliferate and differentiate into neurons and glia which move laterally 
to form the mantle layer.   
The process of cell diversification from neuroepithelial (NEP) cells is now better understood 
and involves a succession of intermediate progenitor cell types that are restricted to certain 
lineages.  At the beginning of CNS development, neuroepithelial cells are in contact with 
both the inner/apical and the outer/basal surface of the neural tube, known as the 
ventricular and pial surfaces, respectively.  These two surfaces define a region designated 
as ventricular zone (VZ), within which NEP cells undergo so called interkinetic nuclear 
migration during their cell cycle.  Cells going through S-phase form a layer at the apical 
(outerpial) side of the VZ, while mitotic cell bodies line up along the ventricular surface and 
cells in G1 and G2 phases are found in the mid region.  As NEP cells are not synchronized 
and at any one time can be found at any given phase of the cell cycle, the epithelium 
adopts a pseudostratified arrangement.  Before neurogenesis, NEP cells increase in number 
by dividing symmetrically to form two identical progenitors.  It is thought that longer 
periods of symmetrical division occur in regions of the neuroepithelim that later give rise to 
larger CNS regions.  For example, the telecephalon, the forerunner of the forebrain and one 
of the largest structures of the mammalian brain, has been reported to have the longest 
period of continuous symmetrical divisions (Rakic 1995).  As development proceeds, NEP 
cells begin to express “glial” markers such as the astrocyte-specific glutamate transporter 
(GLAST), brain lipid-binding protein (BLBP), while maintaining an apical-basal polarity (for 
review, see Campbell et al. 2002).  They are thus termed radial glia (RG).  They also express 
nestin, vimentin, the RC1 and RC2 epitopes and, in some species (including humans) but not 
in rodents, the astroglial intermediate filament, glial fibrillary acidic protein (GFAP) (for 
review see Kriegstein et al. 2009 and also Malatesta et al. 2007).   
RG cells were long thought to be precursors only of astrocytes (for an historical perspective 
see Rakic 2003 and Kriegstein et al. 2009).  However, recent data showed that RG self-renew 
(Misson et al. 1988; Hartfuss et al. 2001) and generate different cell types throughout 
embryonic development (Gray et al. 1992; Miyata et al. 2001).  A spate of other studies 
contributed to the establishment of RG as the founder cells for most, if not all, lineages in 
CNS.  For instance, Cre/loxP fate mapping experiments based on the expression of the 
human GFAP promoter (which is expressed in rodent RG; Malatesta et al. 2003) or BLBP 
promoter (Anthony et al. 2004), resulted in large numbers of neurons as well as glial being 
labelled.  Furthermore, when FACS-isolated RG cells of a mouse transgenic mouse line that 
Raquel Taveira-Marques Tracing NSCs in the ventral NT Introduction 
 
 21/200 
expresses the green fluorescent protein (GFP) from the human GFAP promoter were 
differentiated in vitro, they could generate clones composed either of neurons or astrocytes 
(Malatesta et al. 2000).  Interestingly, Malatesta et al 2000 also observed that the 
percentage of mixed neuronal/non-neuronal clones was extremely small, suggesting that RG 
are a heterogeneous population committed very early on to a neuronal or glial fate.  This 
partial restriction was also observed in NEP cells (Qian et al. 2000; McCarthy et al. 2001).   
Nevertheless, during development, many neurons and glial cells are not the direct progeny 
of RG, but instead originate from transit amplifying or intermediate progenitor cells (IPCs).  
IPCs are fate-restricted progenitor cells that derive from RG by asymmetric division, 
whereby one neuron/glial progenitor cell and one new RG are produced.  They populate a 
region adjacent to the VZ, now called the embryonic sub-ventricular zone (SVZ), and 
undergo symmetrical divisions to produce two differentiated progeny or else two additional 
IPCs (Noctor et al. 2004; Miyata et al. 2004).  Their existence as functionally distinct 
subtypes of precursors was proven in retrovirally mediated lineage tracing experiments 
(Grove et al. 1993).   
A peculiar property of RG is their transformation into astrocytes around birth.  
Progressively, RG’s morphology changes from bipolar to unipolar as they leave the 
ventricular surface and go off, and retract towards the pial surface.  Eventually they 
become multipolar and adopt an astrocyte morphology.  Both RG and astrocytes express 
RC1, thus supporting a lineage relationship (Misson et al. 1991).  Moreover, when RG cells 
are labelled in newborn ferrets with a fluorescent dye (DiI), the appearance of DiI-labeled 
astrocytes coincides with the disappearance of labeled RG (Voigt 1989).  More recently, the 
translocation of RG and transformation to astrocytes has been directly visualized by using 
retroviral labeling and time-lapse imaging (Noctor et al. 2008). 
Later in development, ependymal cells are also known to derive from late RG cells (Spassky 
et al. 2005) whereas some other RG persist into adult life in some vertebrates and serve as 
multipotent stem cells (Doetsch et al. 1999; Merkle et al. 2004).   
Thus the uniformity of the embryonic neuroepithelium quickly undergoes successive 
restructurings that transform it from a relatively homogeneous proliferative zone into a 
complex layered structure.  The molecular mechanism underpinning neuroepithelial 
specification will be discussed in section 1.2. 
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1.1.3. Rostro-caudal regionalisation of the neural tube 
Signalling along the rostrocaudal axis of the neural tube establishes the main subdivisions of 
the CNS: the forebrain, midbrain, hindbrain and the spinal cord. The rostral or caudal 
character of the neural cells emerges soon after neural induction but before and 
independently of fate restriction along the dorsoventral axis (see section 1.2). Many classes 
of secreted factors have been implicated and all are proposed to function in different 
locations or developmental windows.  In general, these signalling molecules assign cell fate 
by transcriptional control of gene expression.  Many of these factors or “morphogens” 
belong to one of the following signalling factor families: retinoids, fibroblast growth factors 
(FGFs), hedgehogs, and Wnts (for a review see Lumsden et al. 1996). 
The term ‘morphogen’ was first coined by Turing in his reaction-diffusion model of pattern 
formation.  In this model, a diffusible substance is responsible to set a gradient of 
concentrations (a non-homogeneous environment) which determines patterns of gene 
expression on cells exposed to different concentrations (Turing A.M. 1952).  This idea of 
pattern formation by a simple physical process arising from homogeneity was then widely 
used to support the French Flag model which describes space-dependent distribution of 
morphogens to induce positional specification in the embryo (Wolpert 1969; Figure 1.2).  
Morphogens are key regulators of development and they seem to be the trigger for cells to 
acquire a positional value in the embryo, although we know now that additional or 
alternative mechanisms are also crucial for positional information (Kerszberg et al. 2007; 
also see section 1.2.1). 
During neurulation the signals produced from the mesoderm (chordin, follistatin, noggin) 
initiate neural development by imposing an anterior character on the entire neural tube.  
Subsequently, this anterior neural tissue is converted into more caudal regions by exposure 
to posteriorizing signals.  Hence, in the absence of porteriorizing factors the whole neural 
tube develops as forebrain tissue (Lamb et al. 1995).  A posterior character is imposed on 
the anterior neural tissue by the signalling molecules Wnts, FGF and retinoic acid (RA), 
which are produced by the newly generated mesoderm after gastrulation.   
Wnts have a direct and graded effect on anterior neural cells that induce their 
differentiation into progressively more caudal regions: caudal forebrain, midbrain, and 
rostral hindbrain (Kiecker et al. 2001; Nordstrom et al. 2002).  For example, inactivation of 
Wnt8 function leads to the expansion of forebrain markers and abrogates formation of 
posterior regions of the neuraxis (Glinka et al. 1997; Erter et al. 2001).  Conversely, Wnt 
antagonists (e.g. DKK1) are released by anterior neural tissue and are responsible for its 
specification (Hashimoto et al. 2000). 
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FGFs and RA work in synergy for posterior tissue regionalisation (Diez del et al. 2004).  While 
FGF signalling induces continuous generation of new caudal tissue by maintaining a stem cell 
character (Lobjois et al. 2004), RA signalling provided by the adjacent somites is required 
for the induction of neural differentiation by antagonizing FGF activity (Diez del et al. 2002; 
Diez del et al. 2003; Novitch et al. 2003).  Subsequently, the progenitors become responsive 
to D-V patterning molecules such as sonic hedgehog (Shh) and differentiate into neurons and 
glia.  In the developing spinal cord, for example, FGF and RA signalling impose an anterior-
posterior identity on developing motor neurons (MNs) through the regulation of Hox genes.  
Whereas graded FGF signals cause the expression of specific Hox-c proteins at defined 
rostro-caudal levels of the branchial and thoracic spinal cord (Pownall et al. 1996; Liu et al. 
2001; Bel-Vialar et al. 2002; Dasen et al. 2003), RA from the flanking paraxial mesoderm 
induces cervical Hox genes by acting in a paracrine fashion (Sockanathan et al. 1998; 
Novitch et al. 2003; Sockanathan et al. 2003). 
Combinatorial and reiterated actions of the above-mentioned signalling molecules are 
proposed to be integrated locally to pattern further the hindbrain (Hernandez et al. 2004), 
the midbrain-hindbrain boundary (McMahon et al. 1992), the anterior neural ridge (Hebert 
2005) to name a few examples (for reviews see Martinez 2001; Ciani et al. 2005; Mason 
2007). 
Another signalling molecule involved during neural tube regionalisation is Shh.  Loss and gain 
of function experiments have recently been shown that the establishment of the different 
midbrain territories (or arcs) depends on Shh, derived from the underlying notochord (Britto 
et al. 2002), in a concentration- dependent manner (Agarwala et al. 2001; Agarwala et al. 
2002).  Shh also plays a well-defined role in the specification of neuronal cell type in the 
ventral spinal cord (see below, section 1.2). 
 
 
1.2. Spatial patterning along the dorsoventral axis of the SC 
Due to its anatomical simplicity the spinal cord has become a good model for addressing 
problems related to cell diversification in the CNS and has allowed the identification of 
molecular mechanisms that control cell fate in the CNS.  In the following two subsections I 
review spinal cord development; however, as substantial progress has been made in the 
field of spatial patterning and cell specification in the brain, I also highlight the numerous 
similarities between the spinal cord and brain specification, which are extensively reviewed 
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elsewhere (Chandrasekhar 2004; Lupo et al. 2006; Guthrie 2007; Guillemot 2007a; Hebert et 
al. 2008; Sousa et al. 2010). 
Dorsoventral patterning has a prominent role in establishing cell type diversity within each 
of the rostrocaudal subdivisions.  This further level of organisation along the dorsal-ventral 
axis is not surprising and reflects the regionally-restricted distribution of the different types 
of neurons in the spinal cord.  Two functional systems are segregated anatomically in the 
spinal cord: motor circuits, concentrated ventrally, that participate in motor output and 
body movements, and neurons that process and relay sensory input from the body to higher 
order brain centres, largely located in the dorsal half of the spinal cord (Brown 1981). 
 
1.2.1. Extrinsic signals involved in dorsoventral patterning 
There are two local organising centres that initially generate dorsoventral pattern in the 
developing embryonic neural tube: the signal from the notochord underneath the midline 
ventralises the neural tube and, simultaneously, signals from the epidermal ectoderm 
adjacent to the lateral edge of the tube dorsalise the neural tube. 
The main signal from the notochord is the secreted protein Sonic hedgehog (Shh), a 
glycoprotein, discovered in 1993 (Echelard et al. 1993; Krauss et al. 1993), which is 
synthesised by the notochord at the time of floor plate induction, thus causing floor plate 
differentiation. The floor plate itself then begins to produce Shh, setting up a gradient of 
Shh concentration along the dorsoventral axis of the ventral spinal cord over long distances, 
which is interpreted by neighbouring cells in a quantitative fashion thus directing distinct 
cell fates at different concentration thresholds (Roelink et al. 1995; Chiang et al. 1996; 
Briscoe et al. 2000; Wijgerde et al. 2002).  Signals like Shh that act in a concentration-
dependent manner are know as morphogens (Vincent et al. 2001).  Furthermore, the role of 
Shh in ventral spinal cord patterning is both necessary (Chiang et al. 1996; Ericson et al. 
1996) and sufficient (Marti et al. 1995; Roelink et al. 1995), inasmuch as increasing 
concentrations of Shh induces a progressively more ventral character (Ericson et al. 1997a; 
Ericson et al. 1997b).  Two main studies implicate Shh as a morphogen that acts directly to 
specify ventral spinal cord fates: 1) cell-autonomous activation of the Shh signalling cascade 
induces ventral patterning (Hynes et al. 2000) and 2) mutations in components of the Shh 
signalling pathway cause dorsalization of the ventral cord (Briscoe et al. 2001a; Wijgerde et 
al. 2002). 
While Shh patterns the ventral spinal cord, the generation of certain cell populations in the 
dorsal-most region of the ventral neural tube does not depend exclusively on Shh signalling. 
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These cell populations can be induced by a parallel signalling pathway that is mediated by 
retinoids, derived from the paraxial mesoderm and, probably, from neural plate cells too 
(Pierani et al. 1999; Pierani et al. 2001; and see section 1.2.2.).  Moreover, two other 
signalling pathways – Nodal and Fibroblast growth factor (FGF) – have been shown to be 
required for correct ventral neural patterning too.  Whereas Nodal proteins, members of the 
Transforming Growth Factor β (TGF-β) superfamily, play a role in floor plate specification 
and regulation of Shh expression, FGF signals can modulate ventral patterning in the SC, 
specifically generation of MNs , in collaboration with RA and Shh (Novitch et al. 2003 and 
recently reviewed in Lupo et al. 2006). 
Dorsal patterning is less well studied than Shh-mediated ventral patterning.  Although we 
know that BMP signalling is implicated in suppressing neurulation in ectoderm (see section 
1.1.1) it also likely mediates dorsalising activity within the spinal cord.  After neural 
induction ceases, BMP activity starts to induce the dorsal-most cells of the neural tube to 
form the roof plate, which in turn secrete their own BMPs (Liem, Jr. et al. 1995; Liem, Jr. 
et al. 1997; Lee et al. 2000).  Together with BMP antagonists noggin, chordin and follistatin, 
produced in the notochord and the paraxial mesoderm surrounding the ventrolateral neural 
tube, BMP proteins diffuse to create a dorsal to ventral gradient of BMP activity, with higher 
levels of activity existing in the more dorsal regions of the neural tube.  It is then expected 
that this gradient has influence over cell fate decisions.  Supporting this model, increasing 
or decreasing BMP signalling causing the enhancement of dorsal fates or reduced 
specification of dorsal cell types, respectively (Caspary et al. 2003 and references therein). 
While there is not convincing evidence that Shh plays a role in dorsal patterning of the 
spinal cord (Chiang et al. 1996; Wijgerde et al. 2002), it is now known that Shh and BMP 
signalling pathways intersect in a way that BMPs act to limit the ventralizing activity of Shh 
(Liem, Jr. et al. 2000), possibly by sustaining Gli3 expression, a transcription factor along 
the Shh signalling cascade (Meyer et al. 2003; and see below).  Several other key 
observations implicate BMPs in patterning ventral regions of the neural tube.  McMahon and 
collegues reported that mice lacking noggin, a BMP antagonist, have reduced floorplate and 
extensive depletion of ventral neurons in the caudal spinal cord, despite normal level of Shh 
in the floor plate and notochord (McMahon et al. 1998).  Moreover, gain-and-loss of function 
have shown that overexpression of chordin or follistatin, two other BMP antagonist, in chick 
SC leads to the expansion of ventral domains at the expense of dorsal ones reflecting a 
stronger ventralising effect when compared to Shh induction alone (Liem, Jr. et al. 2000; 
Patten et al. 2002).  Conversely, overexpression of constitutively active forms of BMP 
receptors suppresses specification of ventral fates while enhancing dorsal ones (Timmer et 
al. 2002).  These results suggest that both expression of Shh and repression of BMP signalling 
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are required for correct ventral specification.  Futhermore, evidence at the molecular levels 
indicate that Shh and BMP pathways cross-talk (Liem, Jr. et al. 2000) and the components of 
their pathways can be physically associated with each other (Liu et al. 1998).  In contrast, 
conditional deletion of BMP signalling hampers specification of the most dorsal SC 
progenitors without affecting ventral fates.  This result has many possible interpretations, 
but an obvious one would be that another signalling molecule can compensate for the loss of 
BMP – Wnt/β-catenin signalling has been proposed in this context (recent evidence has 
raised increasing interest in this signalling pathway due to its demonstrated role in D-V 
patterning and this is extensively reviewed in Ulloa et al. 2010). 
The diversity of neuronal cell types generated during embryonic development cannot be 
understood by only taking into account the actions of long-range secreted signals.  Signals 
transmitted locally between cells are required to achieve the full repertoire of cell 
subtypes.  Notch signalling is an example.  In a seminal paper, Henrique et al (1995), show 
that, also in vertebrates, nascent neurons can laterally inhibit their neighbours by activating 
Notch signalling pathways in order to preserve a balance between precursors and 
differentiated cells, so that different cell subtypes can be generated in timely fashion and 
in appropriate numbers (Henrique et al. 1995).  Additionally, recent data suggest that Notch 
does not always simply maintain cells in an undifferentiated state, but can also positively 
promote non-neuronal (see section 1.4.2) and neuronal cell fates (carefully reviewed in 
Pierfelice et al. 2011). 
As development proceeds, the neural tube becomes increasingly compartmentalised; the 
position (and therefore the environment) experienced by a cell population at a specific time 
of development determines its fate.  This process can be summarised in the following 
unifying principles of cell patterning: 1) in the early neural tube a signalling grid is set up by 
secreted extracellular signalling molecules (such as Shh, BMPs, Wnt, FGFs among others) 
that spread over variable distances across the neural tissue, thus accounting for the 
regionalisation of the CNS; 2) the combined activities of these signalling molecules are 
spatiotemporally integrated to determine the specific combination of transcription factors, 
typically bHLH and HD transcription factors, that is expressed by cell populations at distinct 
AP and DV locations, thus dividing the neural tube into particular progenitor domains; 3) 
these unique transcription factor expression profiles will then determine which cell type(s) a 
particular domain of the neuroepithelium gives rise to; 4) even subtler aspects of cell 
development, like the timing of differentiation, the rate of proliferation or the targeting of 
axonal connections, are all tighly dependent on the position at which each proginitor cell 
population occupies along the AP and DV axes at a specific time of development (Wolpert 
1969; Jessell 2000; Dessaud et al. 2008). 
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1.2.2. The establishment of ventral progenitor domains 
How do ventral progenitor cells interpret and respond to a graded Shh signal?  The readout 
of the Shh signaling is an intricate one (Chen et al. 2007; Dessaud et al. 2008).  
Concentration gradients of Shh throughout the neural tube depend on the tight regulation of 
Shh secretion, diffusion, retention and degradation by the combined action of multiple 
mechanisms.  Briefly, two transmembrane proteins mediate the intracellular transmission of 
the Shh signal: Patched1 (Ptc1), which is the Shh physical receptor, and Smoothened (Smo), 
which initiates intracellular signalling.  In the absence of Shh ligand, Ptc1 blocks Smo 
activity.  The binding of Shh to Ptc1 releases Smo inhibition, allowing intracellular signal 
transduction.  It has been shown that graded activation of Smo is sufficient to explain the 
graded response of neural cells to Shh (Hynes et al. 2000; Dessaud et al. 2007), and its 
activity is necessary for normal formation of most ventral progenitor domains (Zhang et al. 
2001; Wijgerde et al. 2002).  Ultimately, Smo activity regulates the activity of zinc finger 
transcription factors Gli1-3, which act as repressors (GliR) of transcription of Shh signalling 
target genes in the absence of Shh signal; however, activation of Smo by Shh inhibits the 
proteolytic processing of Gli proteins, converting them into transcriptional activators (GliA) 
(Jacob et al. 2003; Vokes et al. 2007; Vokes et al. 2008).  In other words, Shh signalling 
specifies ventral progenitor domains by removing the repression imposed by GliR activity 
(Litingtung et al. 2000; Wijgerde et al. 2002). 
A three-step model for progenitor specification by Shh in the ventral neural tube has been 
proposed.  1) graded Shh signalling initially establishes five distinct domains of progenitor 
(p) cells, known as p3, pMN, p2, p1 and p0 (ventral to dorsal), by controlling the expression 
of a group of transcription factors at different Shh concentration thresholds.  2) the 
subsequent sharpening and maintenance of domain boundaries depends on cross-regulatory 
interactions between class I and class II proteins (for definition see below).  3) the 
combinatorial activities of class I and class II proteins within each domain determines 
distinct profiles of progenitor gene expression that ultimately specify which neuronal 
subtypes the cells within a specific domain will give rise to (e.g. the pMN domain is 
specified by the combined activity of Nkx6.1/Pax6/Olig2).  In this model, which is based 
mainly on loss-of-function and gain-of-function studies, the Shh-regulated transcription 
factors are divided into two classes:  Class I proteins, which are repressed at distinct 
concentrations of Shh so that their ventral boundaries of expression delineate progenitor 
domains, comprise homeodomain transcription factors Pax6, Pax7, Dbx1, Dbx2 and Irx3.  
Class II proteins, which are activated by Shh signalling so that their dorsal limits of 
expression define progenitor domains, include homeodomain transcription factors Nkx6.1, 
Nkx6.2, Nkx2.2, Nkx2.9 as well as the basic helix-loop-helix (bHLH) protein Olig2 (Novitch et 
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al. 2001) (Jessell 2000 and references therein; see also Figure 1.3, panel A).  Analysis of 
mouse mutants that lack one or more of these TFs of different progenitor proteins has 
reinforced the idea that the activity of individual Class I and Class II proteins is required to 
establish progenitor domains and to direct ventral neuronal fates (Ericson et al. 1997b; 
Mansouri et al. 1998; Briscoe et al. 1999; Sander et al. 2000; Pierani et al. 2001; Vallstedt et 
al. 2001; Zhou et al. 2002; Lek et al. 2010). 
One example of cross-repressive interaction leading to progenitor domain formation is the 
case of Pax6 and Nkx2.2 (depicted in Figure 1.3, panel B).  Low concentrations of Pax6 
repress Nkx2.2 expression, excluding it from the pMN domain and restricting it to the p3 
domain.  In chick, ectopic expression of Pax6 in the normal Nkx2.2 expression domain (p3) 
suppresses Nkx2.2 expression in p3 (Briscoe et al. 2000).  Conversely, ectopic expression of 
Nkx2.2 in more dorsal domains downregulates Pax6 (Briscoe et al. 2000).  Accordingly, in the 
Small eye (Sey) mutant, which lacks Pax6 function, Nkx2.2 is derepressed and expands 
dorsally into the pMN domain (Ericson et al. 1997b); however, expansion of Nkx2.2 does not 
inhibit the expression of Pax6 transcript (Genethliou et al. 2009).  Also unexpected is the 
observation that Pax6 does not expand into the prospective p3 domain of Nkx2.2 null spinal 
cords (Genethliou et al. 2009; Holz et al. 2010), suggesting that a more complex gene 
regulatory network is involved in defining the p3 domain.  Nkx2.9 has also been reported to 
define the p3 domain, since forced expression of Nkx2.9 downregulates cell-autonomously 
Pax6 (Briscoe et al. 2000).  But once again Pax6 expression was reported not to change in 
Nkx2.9 knock-out mice even in the absence of Nkx2.2 (Holz et al. 2010), presumably because 
others factors are required to specify the p3 domain.  These factors remain unknown thus 
far.   
The conventional model of morphogen action proposed to interpret the role of Shh in 
progenitor fate specification, which relies solely on the concentration of Shh perceived by 
cells at specific positions in the Shh gradient (see Figure 1.3, Panel A), has been questioned 
in the light of fresh evidence.  It has recently been shown that in addition to the 
concentration of Shh, the duration of Shh signalling also contributes to the establishment of 
progenitor identity (Dessaud et al. 2008; Ribes et al. 2009).  In an unexpected twist, lineage 
tracing data in mouse indicate that cells from the p3 domain had previously expressed Olig2 
(Dessaud et al. 2007), a transcription factor known to be upregulated only in the pMN 
domain at a specific Shh concentration determined by the positional information hold by 
their progenitor cells.  Histological studies further confirm that Olig2 is first expressed in 
the most ventral neural progenitors and then gradually expands dorsally (Jeong et al. 2005; 
Stamataki et al. 2005). As it does so, ventral progenitors that once expressed Olig2 activate 
Nkx2.2 expression and downregulate Olig2.  In turn, Nkx2.2 expression also expands 
dorsally, repressing Olig2 expression as it goes (Novitch et al. 2001; Jeong et al. 2005; 
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Stamataki et al. 2005; Dessaud et al. 2007).  Eventually, two adjacent but spatially non-
overlapping progenitor domains are formed.  Olig2 and Nkx2.2 genes are also activated 
sequentially when chick spinal cord explants are exposed to a fixed concentration of Shh 
(Dessaud et al. 2007).  This has been explained by proposing that cells are able to integrate 
Shh signalling over time (Dessaud et al. 2008; Ribes et al. 2009; Dessaud et al. 2010).  This, 
however, requires a gradual desensitization of cells to ongoing Shh exposure so as to assure 
an accurate graded readout of Shh signalling over time.  Such a “negative feedback” 
mechanism was found to be mediated by the SHH-dependent upregulation of Ptc1, 
performing its role as a ligand-binding inhibitor of SHH signalling (Chen et al. 1996).  
Concomitantly, a gradient of Gli transcriptional activity emulates the graded Shh signalling 
and those activities together become ultimately integrated to orchestrate patterning of 
ventral neural tube (Stamataki et al. 2005).  This temporal adaptation mechanism prompts 
the suggestion of a dynamic model for progenitor fate specification whereby progenitor 
domains can be specified in a step-wise fashion (Nishi et al. 2009).  Thus, p3 would 
transiently pass through a “pMN-like” state, before Nkx2.2 expression established the 
ultimate p3 domain.  Neverthless, this model presents difficulties since prospective p3 
progenitors cannot take on the full characteristics of their pMN conterparts, as they lack a 
history of Pax6 expression (Jeong et al. 2005; Ribes 2010). 
 
In the developing spinal cord, progenitor cells begin to leave the cell cycle and migrate 
away to form neurons and glia in the mantle layer, or intermediate zone. The 
neuroepithelial layer (also known as the ventricular zone, VZ) remains adjacent to the 
lumen. Neurons send out axons from the intermediate zone towards targets either in the 
brain or in more rostral and caudal spinal cord, generating the cell pool marginal zone. In 
the marginal zone, axons are later covered with myelin-sheaths thus becoming white 
matter. The ventricular and intermediate zones, rich in neuronal cell bodies, later become 
the grey matter. 
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1.3. Establishment of neuronal identity 
1.3.1. Further development: from progenitors to neurons 
Distinct progenitor domains positioned along the dorsal-ventral axis of the spinal cord and 
hindbrain give rise to specific classes of neurons.  Thus, the 5 progenitor domains p3, pMN, 
p2, p1, and p0 generate, respectively, ventral (V)3 interneurons, motor neurons (MN), V2 
interneurons, V1 interneurons and V0 interneurons (Briscoe et al. 2000; see also Figure 1.3 
Panel A, Table 1.1 and Table 1.2).  In the spinal cord, Nkx2.2+ progenitors within the p3 
domain give rise to V3 INs and their generation is dependent on the selective expression on 
Nkx2.2 (Briscoe et al. 1999) , whereas, in the pMN domain, production of somatic motor 
neurons (sMNs) requires combined activity of Nkx6.1, Olig2 and Pax6 (Ericson et al. 1997b; 
Sander et al. 2000; Lu et al. 2002; Zhou et al. 2002).  While its expression spans the three 
most ventral domains (p3, pMN and p2), Nkx6.1 activity is only eminent in the pMN domain, 
where its loss results in a reduction of sMN number and ectopic expression of Nkx6.1 induces 
sMNs (Briscoe et al. 2000; Sander et al. 2000).  In the p3 domain, expression of Nkx2.2 
overrides the activity of Nkx6.1 and leads to the production of V3 INs, whereas in the p2 
domain, the combining activity of Nkx6.1 and Irx3 promotes the generation of V2 INs instead 
of sMNs (Briscoe et al. 2000).  Nevertheless, Nkx6.1 is required for the correct generation of 
the V2 domain, besides MNs, as indicated by the reduction in number of V2 INs and MNs in 
Nkx6.1 mutant mice (Sander et al. 2000).  Nkx6.2-expressing progenitors of the p1 domain 
generate V1 INs and their proper production is dependent on the selective expression of 
Nkx6.2 (Vallstedt et al. 2001).  Finally, p0 progenitors that express Dbx1 give rise to V0 INs, 
which are also dependent on Dbx1 expression for their generation (Pierani et al. 2001). 
 
1.3.1.1. The derepression model 
Through what mechanism do progenitor domain proteins steer production of specific 
neuronal subtypes?  The antagonistic interaction between specific Class I and Class II 
transcription factors raises the possibility of acting as transcriptional repressors.  In fact, 
most Class I and Class II proteins function as transcriptional repressors through the 
recruitment of members of the Groucho/TLE co-repressor complex (Muhr et al. 2001).  
Although not directly binding to DNA, Groucho/TLE proteins are a family of co-repressors 
that are recruited to target gene promoters via direct interaction with sequence-specific 
DNA binding proteins, the transcription factors (Fisher et al. 1998).  The observation that 
Class I and Class II proteins act as transcriptional repressors of cell fates suggest that 
specification of neuronal subtype within a given neuroepithelial domain results from the 
repression of all other possible fates in that domain.  The suggested model comprises two 
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sequential steps of repression: 1) operating at the level of the VZ to establish progenitor 
domains, and 2) acting on neuronal subtype determinants to regulate downstream events in 
neuronal subtype specification such as cell migration, axon projection, morphology and 
neurotransmitter phenotype (Muhr et al. 2001; Briscoe et al. 2001b).  Based on this model, 
the pattern of neuronal generation in the ventral neural tube is set by the spatially 
restricted repression of transcriptional repressors, that is, a “derepression strategy” of 
neuronal specification.   
 
Various experimental results support such a model.  In Olig2 mutants, Irx3 is derepressed 
and expands ventrally into the pMN domain, where it represses MNs leading to ectopic V2 IN 
generation in the pMN domain (Mizuguchi et al. 2001; Novitch et al. 2001; Lu et al. 2002; 
Zhou et al. 2002; see also Figure 1.3 Panel C).  This happens because Irx3 is known to 
promote V2 IN production by suppressing homeodomain protein HB9, a motor neuron 
subtype determinant required to suppress the expression of V2 IN subtype genes in somatic 
MN.  By repressing HB9 activity, Irx3 disrupts the consolidation of MN identity (Arber et al. 
1999; Novitch et al. 2001; Lee et al. 2004).  In wild type mice, Olig2 therefore induces MN 
specification in the pMN domain by repressing a repressor of MN fate.  The loss of Olig2 also 
leads to the dorsal expansion of Nkx2.2 (Briscoe 2011), however at a smaller scale (two-cell 
thick), due to the repressive activity of Pax6 on Nkx2.2 (Briscoe et al. 2000).  This evidence 
supports the idea of a cross-repression interaction between Olig2 and Nkx2.2, Olig2 being a 
weaker repressor than Nkx2.2.   
 
Additional support for a derepression strategy of neuronal fate determination comes from 
studies using Nkx2.2 null mice.  In the spinal cord of Nkx2.2 mutants, the expression of Olig2 
expands ventrally into the p3 domain which no longer is able to produce V3 INs due to the 
loss of Nkx2.2 activity (Briscoe et al. 1999; Holz et al. 2010; also see Figure 1.3 Panel B).  
Moreover, Nkx6.1 expression within the p3 domain allows the bHLH protein Olig2 to be 
expressed (Novitch et al. 2001) which, in turn, is able to promote the expression of 
downstream somatic MN determinants (e.g. Lim3/Lhx3 and MNR2/Hb9) and of the proneural 
bHLH protein Ngn2 (Mizuguchi et al. 2001; Novitch et al. 2001).  Thus, in wild type mice, 
Nkx2.2 induces V3 IN specification in the p3 domain by suppressing MN production via 
repression of Olig2.  The ectopic production of somatic MNs seems, however, restricted to 
the medial motor column (MMC) only (Agalliu et al. 2009) suggesting an early divergence in 
motor neuron subtype identity in the spinal cord.  Such an early divergence in MN subtyte is 
not novel in the developemt of the CNS since it is known that visceral and somatic MNs 
derive from distinct progenitors of the hindbrain (Osumi et al. 1997; Ericson et al. 1997b).   
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In the Small eye (Sey) mouse mutant, which lacks Pax6 function, cross-regulatory inhibition 
of Nkx2.2 by Pax6 is relieved resulting in the dorsal expansion of Nkx2.2 into the pMN 
domain.  There, Nkx2.2 promotes the generation of V3 interneurons at the expense of 
somatic MNs (Ericson et al. 1997b).  However, somatic MNs are recovered later in 
development (Sun et al. 1998), suggesting that suppression of Olig2 by Nkx2.2 might not be 
complete or lasting.  In fact that is the case as Olig2+ scattered cells can be detected within 
the pMN domain of the Sey eye mutants spinal cords (Genethliou et al. 2009).  Albeit at an 
inappropriate time of MN developemnt, the few Olig2-expressing cells are able to produce 
normal numbers of somatic motor neurons, possibly because other factors, apart from Shh, 
might be involved.  Recent studies have linked retinoid signalling and the activator funtions 
of retinoid receptors to several phases of MN specification in the SC (Novitch et al. 2003; 
Sockanathan et al. 2003). 
 
 
 
Table 1.1  -  Characteristics of post-mitotic motor-neurons in the ventral spinal cord.   
(not a likely exhaustive summary but at least a compilation of the most generally accepted facts 
about the different post-mitotic motor neuron populations in the spinal cord) (For clues of the 
undermentioned abbreviations, please look through the beginning of this thesis in the 
Abbreviations page) (below). 
 
 
 
Table 1.2  -  Characteristics of post-mitotic interneuron populations in the ventral spinal 
cord. 
(once again, not a likely exhaustive summary but at least a compilation of the most generally 
accepted facts about the different post-mitotic interneuron populations in the spinal cord; 
adapted from Lewis 2006 and updated based on Goulding 2009) (below). 
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Table 1.1  -  Characteristics of post-mitotic motor-neurons in the ventral spinal cord. 
Progenitor 
domain 
Post-mitotic neuronal 
population 
Neuronal subtype 
determinants 
Final position of cell body Axonal projections Neurotransmitter 
phenotypes 
Functional 
properties 
Key references 
Median Motor Neurons – 
medial subdivision 
Isl1 (Islet1), Isl2 (Islet2), Lhx3 
(Lim3), Lhx4 (Lim4) , Hb9 
(MNR2) 
Located in the ventral horn, medial 
position (lamina IX) at all level of 
the spinal cord 
Axons project ventrally to axial 
muscles that differentiate near the 
vertebral column 
Median Motor Neurons – 
lateral subdivision 
Isl1 (Islet1), Isl2 (Islet2) , Hb9 
(MNR2) 
Located in the ventral horn, lateral 
position (lamina IX) between T1 and 
T12 level of spinal cord 
Axons project ventrally to body wall 
muscles that differentiate within the 
ventral lateral plate mesenchymal 
Lateral Motor Neurons – 
medial subdivision 
Isl1 (Islet1), Isl2 (Islet2) , Hb9 
(MNR2), Hoxc6 (for neurons 
located at branchial levels), 
Hoxc10 (for neurons located 
at lumbar levels), FoxP1 
Located in the lateral horn, medial 
position (lamina IX) between C5 - 
C8, and L1 – L6 level of spinal cord 
Axons project ventrally to limb 
muscles – ventral muscle mass 
Lateral Motor Neurons – 
lateral subdivision 
Isl2 (Islet2), Lhx1 (Lim1), Hb9 
(MNR2), Hoxc6 (for neurons 
located at branchial levels), 
Hoxc10 (for neurons located 
at lumbar levels), FoxP1 
Located in the lateral horn, dorsal to 
lateral MN medial subdivision 
(lamina IX) between C5 - C8, and L1 
– L6 level of spinal cord 
Axons project ventrally to limb 
muscles – dorsal muscle mass 
Choline 
Acetyltransferase 
 
Synapse directly 
onto muscle cells 
Tsuchida et al. 1994; 
Sharma et al. 1998; 
Tanabe et al. 1998; 
Arber et al. 1999; 
Kania et al. 2000; 
Sharma et al. 2000; 
Dasen et al. 2003; 
Kania et al. 2003; 
Dasen et al. 2008; 
Rousso et al. 2008 
Sympathetic 
Preganglionic Neurons 
(also known as pre-
ganglionic motor neurons 
or column of Terni, in 
chick) 
Isl1 (Islet1), nNOS, Hb9 
(MNR2; late appearance), 
Hoxc9, FoxP1, pSmad 
Clustered at two major sites in the 
intermediate grey matter, near the 
lateral white matter 
(intermediolateral nucleous, IML), 
and besides the central canal 
(central autonomic nucleous, CAN) 
Axons project ventrally to visceral 
targets indirectly via relay neurons in 
the sympathetic ganglia, with the 
exception of those axons which 
project ventrally and directly to the 
adrenal gland 
Choline 
Acetyltransferase, (a 
subset of these also 
express NADPH 
Diaphorase)  
Involved in 
homeostatic 
maintenance of 
widespread 
functions of the 
Sympathetic NS 
Cabot 1990; Markham 
et al. 1991; Wetts et 
al. 1994; Arber et al. 
1999; Dasen et al. 
2003; Dasen et al. 
2008; Rousso et al. 
2008 
pMN 
Parasympathetic Motor 
Neurons 
Isl1 (Islet1) (?), nNOS (?), Hb9 
(late) (?) 
Located in the sacral spinal cord Axons project ventrally to visceral 
targets indirectly via relay neurons in 
the parasympathetic ganglia 
Choline 
Acetyltransferase 
Loewy 1990 
p3 Spinal Acessory Neurons Isl1 (Islet1), Phox2b, Tbx20 Located dorso-laterally between C1 
and C4 level of spinal cord 
Axons project dorsally via the spinal 
accessory (XIth cranial) nerve 
Choline 
Acetyltransferase 
Regulate visceral 
functions of the 
Parasympathetic NS 
Loewy 1990; Ericson et 
al. 1997b; Pattyn et al. 
2000; Song et al. 2006 
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Table 1.2  -  Characteristics of post-mitotic interneuron populations in the ventral spinal cord. 
Progenitor 
domain 
Post-mitotic 
neuronal 
population 
Neuronal 
subtype 
determinants 
Final position of cell 
body 
Axonal projections Neuro-
transmitter 
phenotypes 
Functional properties Key references 
V0 ventral Evx1/2 (a subset 
of these also 
express Pax2) 
Glutamate p0 
V0 dorsal Evx1 negative 
but Evx2 positive 
Migrate ventro-medially 
and settle in the ventral 
horn medial to MNs & 
close to FP (lamina VIII). 
Contralateral axons that 
extend rostrally 
(commissural neurons). 
Descend to FP, cross 
midline & extend 1–4 
segments. At least most 
of the cells contact MNs. 
GABA/Glycine 
70% of V0 neurons are inhibitory and 30% are excitatory. V0 
inhibitory commissural neurons are critical in controlling 
left-right alternation during motor activity, like walking or 
swimming. V0 neurons are possibly disynaptic crossed 
commissural INs during adulthood; neurons that give rise to 
C neurons might derive from V0 cells, but they could also 
come from V1 cells and dorsal progenitors. 
Briscoe et al. 2000; Moran-
Rivard et al. 2001; Pierani et al. 
2001; Lanuza et al. 2004; Miles 
et al. 2007 
p1 V1 En1, Pax2, Foxd3 Migrate laterally & settle 
in the ventral horn 
immediately dorsal to MN 
cell bodies in lamina VI, 
VII & ventral lamina IX. 
Ipsilateral ascending 
axons. Axons project 
ventrally & then extend 
rostrally for 1–2 
segments. Renshaw cells 
extend both rostrally & 
caudally. 
GABA/Glycine Renshaw cells all derive from V1 cells—but they are only 10% 
of them. V1 cells also give rise to Ia inhibitory interneurons 
and together with Renshaw cells they comprise only 25% V1-
derived adult population; Ib inhibitory interneurons probably 
also derive from V1 cells. All of these interneurons fine-tune 
motor behaviours 
Ericson et al. 1997b; Saueressig 
et al. 1999; Briscoe et al. 2000; 
Pierani et al. 2001; Goulding et 
al. 2002; Higashijima et al. 
2004; Sapir et al. 2004; Al-
Mosawie et al. 2007 
V2 a Lhx3 (Lim3), 
Chox10, Dll4  
glutamate Excitatory; V2a neurons are ipsilateral components of a 
commissural pathway that controls left-right alternation 
V2 b Gata2/3, medial 
V2b also express 
Tal1 (SCL),, 
Notch1, LMO4 
GABA/Glycine Inhibitory; function not determined yet. 
p2 
V2 c Sox1 
Ventral horn, dorsomedial 
to MN cell bodies but 
ventral to V1 
interneurons; in particular 
Gata2/3+ V2b INs are 
interspersed with V1 
neurons in lamina VII; V1-
derived neurons can also 
be found in lamina IX 
Ipsilateral axons that 
project for greater than 
3–5 segments caudally & 
rostrally? 
? ? 
Ericson et al. 1997b; Sharma et 
al. 1998; Tanabe et al. 1998; 
Saueressig et al. 1999; Briscoe 
et al. 2000; Karunaratne et al. 
2002; Smith et al. 2002; Al-
Mosawie et al. 2007; Del Barrio 
et al. 2007; Lundfald et al. 
2007; Peng et al. 2007; Crone 
et al. 2008; Joshi et al. 2009; 
Panayi et al. 2010 
V3 ventral Sim1 Ventral horn (occupy 
medial laminae VII and 
VIII) 
Excitatory; V3 ventral neurons play an important role in the 
establishment of a stable and balanced locomotor rhythm, 
but are largely dispensable for left-right alternation. 
p3 
V3 dorsal 
(unpublished data) 
Sim1 Dorsal horn 
Mixed 
commissural/ipsilateral 
axons that project for 
greater than 2 segments; 
excitatory INs 
Glutamate 
Excitatory; function not determined yet. 
Ericson et al. 1997b; Briscoe et 
al. 1999; Geiman et al. 2006; 
Zhang et al. 2008 
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1.4. Glia generation 
1.4.1. Neurogenic - to - gliogenic switch 
A fundamental question in developmental biology is how remarkably different cell types 
arise from a seemingly homogeneous germinal zone of the embryonic neural tube during 
development of an organism.  Neurons, astrocytes and oligodendrocytes are all specified 
from the same pool of proliferating progenitor cells which, through dynamic and intricate 
mechanisms, produce various subtypes of neurons and glial cells.  Neurons are produced 
prior to glia, thereby assuring first the establishment of a neuronal circuitry before glial 
numbers and positions are matched to each circuit (Rowitch 2004).  The mechanisms that 
underlie the development of glia, similarly to neurogenesis, require precise interplay 
between regionally-restricted extrinsic signals and cell intrinsic factors; however the 
developmental stages of glia generation unfold differently from those of their neuronal 
counterparts - the main phases of glia proliferation and differentiation seem to occur long 
after the commitment of a relatively small, proliferative precursor pool to the glia lineage 
thereby obscuring the timing of glia specification and hindering its study.  Nevertheless, we 
now know that the neuron-to-glia switch is governed by multiple mechanisms, which involve 
transcription factors, extrinsic signals and modifications of histones and DNA (review in 
Kessaris et al. 2001; Rowitch 2004; Miller et al. 2007; Guillemot 2007b). 
At the transcriptional level, two transcription factors Sox9 and NFIA have been proposed to 
trigger the fate switch of neural progenitors to gliogenesis along the spinal cord by 
promoting gliogenesis (Stolt et al. 2003; Deneen et al. 2006).  Stolt et al (2003) observed 
that, in the mouse, loss of Sox9 led to a reduction in the number of oligodendrocytes and 
astrocytes and a concomitant increase in the numbers of somatic motor neurons and V2 
interneurons whereas Deneen et al (2006) demonstrated that by silencing Nfia gene in the 
chick SC one can prevent the generation of both oligodendrocyte precursors (OLPs) and 
astrocyte precursors (APs) with simultaneous premature differentiation of neuronal lineages.  
These findings also support the concept of a proglial transcription programme (Hosoya et al. 
1995; Jones et al. 1995) - that is, a programme independent of neurogenesis and specifically 
activated during the gliogenic phase.  This runs against the prevailing idea that glial 
differentiation is a “default fate” following downregulation of proneural activity.  Deneen et 
al (2006) went further to realise that NFIA is required for the maintenance of Notch effector 
expression during the gliogenic phase and that it is the Notch effectors that are responsible 
for inhibiting neurogenesis.  Moreover, Delta-Notch signalling has also been shown to 
maintain a subset of progenitors in an undifferentiated state so they could be used as a 
cellular substrate during gliogenesis (Itoh et al. 2003; Park et al. 2003). 
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From the foregoing discussion one can realise that it is more a combinatorial framework of 
transcription factors that it is able to instruct progenitor cells to generate multiple fates at 
a given location and time.  The best studied example to describe such a combinatorial 
transcription factor code is that operating in the pMN domain in the ventral spinal cord, a 
progenitor domain where production of oligodendrocytes is preceded by generation of motor 
neurons (Richardson et al. 1997).  It has been observed in this domain that the onset of 
gliogenesis is led by the downregulation of proneural genes Neurogenin 1 (Ngn1) and 
Neurogenin 2 (Ngn2) (Mizuguchi et al. 2001; Novitch et al. 2001; Zhou et al. 2001), two 
bHLH transcription factors that promote neuronal differentiation (Scardigli et al. 2001; Sun 
et al. 2001b).  But how is the switch from neurogenic to gliogenic phase made knowing that 
Ngns are not sufficient to start gliogenesis all by themselves? A key element in this process 
is the gene Olig2, a bHLH transcription factor that not only was identified in connection with 
OL development (Lu et al. 2000; Takebayashi et al. 2000; Zhou et al. 2000) , but also has 
been implicated in promoting MN fate specification (Mizuguchi et al. 2001; Novitch et al. 
2001).  While having a dual function in MN and OL specification, Olig2 by itself (i. e. at 
ectopic locations) is insufficient to induce the switch from MN to OL specification (Zhou et 
al. 2001).  Instead, Zhou et al (2001) demonstrated that Olig2 is able to induce formation of 
OLPs when it is ectopically coexpressed with either Nkx2.2 (another transcription factor 
involved in OL development [Qi et al. 2001; Sun et al. 2001a]) or with constitutively active 
components of the Notch signalling pathway and with concurrent downregulation of Ngn1 
and Ngn2 (Zhou et al. 2001).  On top of this, domains of Nkx2.2 expression and Olig2 
expression switch from mutually exclusive to overlapping at late stages of embryonic 
development (from ~E12 - onwards) (Zhou et al. 2001; Sun et al. 2001a).  Is this change of 
Nkx2.2 expression responsible for the downregulation of Ngns? This is unlikely to be the case 
as the disappearance of Ngns expression in the pMN domain precedes the dorsal expansion 
of Nk2.2. 
Meanwhile, recent data suggest that Ngn2 downregulation is more a knock-on effect of a 
mechanism that triggers the switch than that mechanism’s trigger.  Li et al (2011) observed 
that phosphorilation of residue Serine 147 (S147) of OLIG2 protein would only happen during 
MN production, but not at or after the onset of gliogenesis (Li et al. 2011).  They further 
realised that S147 dephosphorylation causes OLIG2 to exchange cofactors, preferring to 
dimerise with NGN2 than forming Olig2-Olig2 homodimers.  Being sequestered by OLIG2, 
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NGN2 no longer can play a role in MN production† thus shutting down other MN lineage genes 
such as Hb9, Isl1/2 and Lhx3 (see section 1.3.1 and 1.3.3).  Concurrently, remaining 
undimerised OLIG2 proteins couple with other cofactors to promote OL development (for 
more details see section 1.4.2.3), hence reinforcing the neuron-to-glial switch. 
But the mystery stands, how does the temporal change of Nkx2.2 expression take place and 
how to explain it?  Orentas et al. (1999) already showed that Shh is required during a 
prolonged period of spinal cord development for specifying motor neurons and OLs (Orentas 
et al. 1999). Zhou et al. (2001) has recently suggested that the expansion of Nkx2.2 
expression into the MN domain and the concomitant retraction of Pax6 expression to more 
dorsal levels might be controlled by a marked increase in the level of Shh activity secreted 
by the floor plate (Zhou et al. 2001). The mechanism by which the repression of Olig2 by 
Nkx2.2 in the pMN domain is relieved and the mechanism by which the ability of Olig2 to 
trigger Ngn2 expression is suppressed by coexpression of Nkx2.2 still remain to be 
elucidated. 
 
All in all, mounting evidence focused on pMN domain has highlighted the complex regulatory 
code that mediates the neuron-glial switch.  This involves: downregulation of Ngn2 
expression, ongoing activity of Olig2 and Shh, Notch signalling to assure a reservoir of 
progenitors for the gliogenic phase, and activation of a gliogenic phase-specific 
transcriptional programme.  The mechanism that regulates the interaction of all these 
components is not fully understood yet. 
 
1.4.2. Oligodendrocyte development 
1.4.2.1. The oligodendrocyte lineage and its role in the CNS 
Oligodendrocytes are, literally, cells with a few branches/processes, which wrap themselves 
around developing axons and produce a specialised membrane structure known as the 
myelin sheath. The unique composition of the myelin sheaths (whose richness in lipids and 
low water content allow the electrical insulation of axons) and its unique segmental 
                                              
 
 
† NGN2 has been shown to form heterodimers with Olig2 to control MN differentiation (Lee et al. 
2005). 
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structure (responsible for the salutatory conduction of nerve impulses) assure the adequate 
conduction of nerve impulses. Each oligodendrocyte can myelinate multiple axonal segments 
and the unmyelinated junctions between any two of those segments are called nodes of 
Ranvier.  Oligodendrocytes also allow substantial space saving by allowing reduced axonal 
calibre‡ (Baumann et al. 2001).  Additionally, a population of oligodendrocyte precursor 
cells, OLPs (NG2+ cells), which persists into adulthood, has the capacity to extend processes 
to synapses (Ong et al. 1999; Bergles et al. 2000) and nodes of Ranvier (Butt et al. 1999), as 
well as being able to respond to synaptic inputs from neurons (Lin et al. 2004; Lin et al. 
2005).  Although a matter of speculation at present, OLPs, which have been shown to divide 
and differentiate into mature oligodendrocytes throughout adulthood (Rivers et al. 2008; 
Psachoulia et al. 2009; Kang et al. 2010), are thought to act as a reservoir of new 
myelinating oligodendrocytes upon stimulation by surrounding neurons to meet the 
requirements of neural circuitry.  
In principle, oligodendrocyte development is likely to be a continuous process of 
morphological transitions. In practice, however, we can only see the oligodendrocyte 
development as sequential distinct phenotypic stages, characterized by distinct proliferative 
capacities, migratory abilities, antigenic phenotypes or dramatic changes in morphology 
(summarised in Table 1.3).   
 
 
Table 1.3  -  Developmental stages of cells of the oligodendrocyte lineage. 
Summary of markers identified during the progression from precursor cells to myelinating mature 
oligodendrocytes in rodents.  The timing of appearance of the specific markers varies from 
region to region of the CNS and markers in this table are grossly according to the time of events 
in the spinal cord (data compilation based on Baumann et al. 2001; Woodruff et al. 2001; Miller 
2002; Rowitch 2004) (below).   
                                              
 
 
‡ In invertebrate nervous system, due to the non-existence of myelin sheaths, rapid conduction is 
accompanied by increased axonal calibres (Baumann et al. 2001). 
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Stage of 
Maturation 
Stage-specific 
Markers (*) 
Stage of Development Morphology 
Neuroepithelial 
precursors 
Nkx2.2 (1); Nkx6.1; 
Olig1; Olig2; 
PDGFRα; Sox9 (2); 
Sox10 
 
Oligodendrocytes 
progenitors 
NG2; Nkx2.2 (1); 
Olig1; Olig2; 
PDGFRα; Sox9 (2); 
Sox10  
Late 
progenitors/pro-
oligodendrocytes 
CNPase; DM-20; NG2; 
O4; Olig1; Olig2; 
PDGFRα; Sox9 (2); 
Sox10  
Pre-myelinating 
oligodendrocytes 
CNPase; DM-20; 
GALC; NG2; O4; 
Olig1; Olig2; 
PDGFRα; PLP; Sox9 
(2); Sox10; TCF4 (3) 
 
Myelinating 
Oligodendrocytes 
APC/CC1; CNPase; 
DM-20; GALC; MBP; 
NG2; Nkx2.2 (1); 
Nkx6.2 (4); O4; Olig1; 
Olig2; PDGFRα; PLP; 
Sox9 (2); Sox10;  
TCF4 (3) 
 
 
(*) See clue to undermentioned abbreviations at the beginning of this thesis in the Abbreviations 
page.  (1) Reference: Fu et al. 2002; (2) Reference: Cai et al. 2010; (3) Reference: Fu et al. 2009; (4) 
Reference: Wegner et al. 2005. 
E12.5 
E13.5 
E14.5 
E16.5 
E18.5 
↓ 
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1.4.2.2. Specification of oligodendrocytes and their origins 
Oligodendrogenesis begins in earnest after the neuron to glial fate switch has ceased.  
Oligodendrocyte precursors arise from multiple sources across the ventral-to-dorsal axis of 
the neural tube.  While the earliest evidence supported a ventral origin of OLPs, more 
recently it has become clear that some OLPs also develop from dorsal neuroepithelium 
(Richardson et al. 2006).  The current view is that the ventrally-derived precursors of the 
spinal cord, which develop earlier during development, compete with and suppress their 
dorsal counterparts arising later.  By contrast, in the forebrain the ventral-most lineages are 
replaced by dorsal precursors that populate the same regions later on (Kessaris et al. 2006; 
Richardson et al. 2006 and references therein).   
It is generally accepted that the majority of spinal cord oligodendrocytes are generated 
from a restricted domain in the ventral spinal cord that first give rise to somatic motor 
neurons – the pMN domain.  OLPs, defined by expression of PDGFRα (Pringle et al. 1993; Hall 
et al. 1996) and Sox10 (Kuhlbrodt et al. 1998), are first detected at around E12.5 in the 
mouse spinal cord demarcating roughly the region (pMN) that previously generated MNs 
(Jessell 2000).  Moreover, Shh is both sufficient and necessary for oligodendrocyte 
specification (Poncet et al. 1996; Pringle et al. 1996; Orentas et al. 1999) and together with 
evolutionary arguments linking MNs and OLs (Richardson et al. 2000), it further supports a 
developmental connection between somatic MNs and Ols.  At last, unequivocal evidence 
reinforcing the idea of a lineal relationship between MNs and OLs came from Olig1/2 null 
mice, two basic helix-loop-helix proteins required for the establishment of the pMN domain 
(Lu et al. 2000; Takebayashi et al. 2000; Zhou et al. 2000).  In Olig2 and Olig1/2 mutant mice, 
the expression of p2 domain protein Irx3 expands ventrally to occupy the pMN domain, 
resulting in an ectopic generation of V2 interneurons at the expense of MNs and subsquent 
loss of OLPs, which are replaced by ectopic production of astrocytes (Lu et al. 2002; 
Takebayashi et al. 2002; Zhou et al. 2002).  pMN-derived migratory OLPs disperse laterally 
and dorsally, occasionally over long distances, to occupy the entire developing CNS before 
differentiating into myelin-forming oligodendrocytes (Jessen et al. 2001; Takebayashi et al. 
2002).  But there remains some controversy as to whether other regions of the ventral 
neuroepithelium ever give rise to oligodendrocytes.  For instance, PDGFRα/O4-positive 
precursors have been shown to arise entirely within the Nkx2.2-expressing neuroepithelium 
domain in birds (Xu et al. 2000; Soula et al. 2001), somewhat unexpected as Nkx2.2 gene is 
known to demarcate the p3 domain (Jessell 2000).  It turns out that the domains of 
expression of Olig2, which defines the pMN domain, and of Nkx2.2 in the neuroepithelium 
switch from being mutually exclusive to overlapping (Zhou et al. 2001) during later 
embryogenesis.  This has been further confirmed in mice where different OLPs are 
suggested to be originated from two distinct locations: one population of OLPs coexpresses 
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Olig2 and Nkx2.2, and which emigrates from the zone of overlap between these two factors, 
while the other population expresses Nkx2.2 but not Olig2 and emigrates more ventrally 
possibly aquiring Olig2 expression later on (Fu et al. 2002).  The latter source of OLs has 
been recently confirmed in chick spinal cord by retrovirus experiments (Gotoh et al. 2011).  
It will be of interest to determine wether or not the same finding is extended to rodents. 
Various past studies tentatively put forward the idea of a dorsal source of oligodendrocyte.  
While Spassky and colleagues support a multiple source of OLPs based on their studies with a 
proteolipid protein (Plp)-lacZ reporter line (Spassky et al. 1998; Spassky et al. 2000), Rao 
and his co-workers suggested a dorsal, as well as ventral, source of OLPs based on the fact 
that they were able to isolate OPCs from different parts of the spinal cord neuroepithelium 
and culture them in vitro (Rao et al. 1998; Liu et al. 2003).  Moreover, there were also 
controversial results from chick-quail chimeras that raised the possibility of dorsal OLP 
sources in birds (Cameron-Curry et al. 1995; Pringle et al. 1998; Richardson et al. 2006).  But 
the idea of dorsal-derived OLPs faded away for some time because of convincing data.  
Recently, however, it was shown conclusively that a second and later-derived source of 
oligodendrocytes develops from the dorsal cord of the spinal cord, but these constitute a 
minor population compared to the pMN-derived oligodendrocytes.  These findings were 
concurrently spotted by three laboratories (Cai et al. 2005; Fogarty et al. 2005; Vallstedt et 
al. 2005).  Cai et al. and Vallsted et al. examined Nkx6.1 and Nkx6.2 double mutants (Nkx6 
null) in which Olig2 expression is lost§, thus resulting in the concomitant arrest of both MNs 
and pMN-derived OLs production.  They found that PDGFRα+/Olig2+ expressing cells continue 
to be generated in the dorsal spinal cord of Nkx6 mutants and that they co-express paired 
box gene 7 (Pax7), confirming their dorsal origin.  These dorsal-derived OLPs could also be 
found in wild type spinal cord at around E15, a few days later than ventral ones (E12).  
Fogarty and co-workers confirmed these conclusions by Cre-lox fate-mapping experiments in 
transgenic mice (Fogarty et al. 2005).  They generated a Dbx1- iCre transgenic line whereby 
iCre recombinase was placed under control of the Dbx1 homeobox gene and its expression 
restricted to the neuroepithelial precursor domains p1, p0, dP6 and dP5.  Dbx1-derived 
oligodendrocytes were mainly located in the lateral white matter radially opposite their site 
of origin in the VZ and made up to 3% of the total population of oligodendrocytes in the 
spinal cord.  Further fate-mapping studies using Msx3-iCre transgenic mice, in which iCre 
expression is restricted to the entire dorsal cord, go as far as suggesting that 20% of OLs 
                                              
 
 
§ Olig2 gene is primarily responsible for OLP specification and its expression is under tight control 
of Nkx6 activity (Novitch et al. 2001; Vallstedt et al. 2001). 
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originate in the dorsal spinal cord, hence still representing a minor contribution to the total 
OL population in the SC (Fogarty 2006).  Dorsal-derived OLP specification in vitro is 
dependent on FGF signalling but independent of Shh and it requires downregulation of BMP 
activity (Fogarty et al. 2005; Vallstedt et al. 2005).  Unlikely their pMN-derived counterparts, 
which first appear as a rapidly proliferating group of cells near the VZ, Dbx-domain derived 
OLPs appear to be formed by direct interconversion from radial glial at the time when 
down-regulation of radial markers begins (E15.5) (Fogarty et al. 2005).   
 
1.4.2.3. Further development: from progenitors to mature oligodendrocytes 
After specification, OLPs start to proliferate and migrate widely to populate the entire CNS 
(Miller et al. 1997).  Because they express PDGFRα, OLPs are able to respond to the 
mitogenic and survival factor PDGF (Pringle et al. 1992; Pringle et al. 1993), and PDGF 
depletion limits OLP proliferation in vivo (Calver et al. 1998; Fruttiger et al. 1999; van 
Heyningen et al. 2001).  Interestingly, however, continuous stimulation of OLP proliferation 
by over-expressing PDGF does not yield a proportional increase in the final numbers of 
myelinating oligodendrocytes, consistent with the idea that the final number of 
oligodendrocytes is set by axon-derived survival factors, independently of the number of 
OLPs (Calver et al. 1998). 
OLPs settle along fibre tracts of the future white matter, going through several 
developmental stages, before maturing during late embryonic and early postnatal stages of 
development. When they convert into pre-oligodendrocytes, they still proliferate but no 
longer migrate. Pre-OLs become multiprocessed and change their antigenic profile, losing 
PDGFRα and, in rodents, expressing sulphated glycolipids recognised by the O4 monoclonal 
antibody. Before their final maturation, involving myelin formation, oligodendrocytes go 
through a few more stages of development.  During this development, about 50% of newly 
formed oligodendrocytes rapidly die because of competition among those OLPs for limited 
amounts of axon-derived survival factors (Barres et al. 1992a; Barres et al. 1992b).  The 
presence of unmyelinated axons seems to play a role on OL cell survival rate inasmuch as an 
increasing number of unmyelinated axons directly boosts OL production (Burne et al. 1996).  
Fully differentiated mature OLs, now post-mitotic, express the major myelin components 
such as myelin basic protein (MBP) and proteolipid protein (PLP), which are correlated with 
the late stages of maturation of the oligodendrocyte lineage, and myelin formation.   
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1.4.3. Astrogenesis 
1.4.3.1. Astrocyte definition and classification 
Astrocytes were first visualised over a century ago (Andriezen 1893).  Their name derives 
from the Greek root word “astro”, which means “star”, referring to their star-like 
morphology in Golgi stained samples.  Today, astrocytes are recognized to be a more diverse 
cell population than they appear based on morphology alone (reviewed in Hewett 2009 and 
Zhang et al. 2010).  They carry out multiple roles essential for normal neurological function, 
including maintenance of the blood-brain barrier, trophic support for neurons and 
modulation of synaptic activity (Christopherson et al. 2005).  The most abundant glial 
population in the CNS, astrocytes paradoxically are one of the least understood cell types 
that make up the CNS. 
Astrocytes are broadly divided into two classes – “fibrous” and “protoplasmic” – on the basis 
of their morphology, location and expression of glial filaments.  In general, fibrous 
astrocytes populate the white matter, express high levels of the Glial Fibrillary Acidic 
Protein (GFAP, an intermediate filament protein) (Eng et al. 1971) and are associated with 
neuronal axons at nodes of Ranvier.  Protoplasmic astrocytes are located in grey matter and 
express little or no GFAP (Nolte et al. 2001).  Protoplasmic astrocytes, which are highly 
ramified, are intimately associated with neuronal cell bodies, ensheath synapses and can be 
found in contact with blood vessels.  The CNS also contains other specialized glial cells that 
share many common features with astrocytes.  These include Bergmann glia in the 
cerebellum and Müller cells in the retina. These have small cell bodies surrounded by many, 
branching processes and are closely associated with synapses (Reichenbach et al. 2010).  
Another cell population expressing GFAP are sub-ependymal astrocytes in the subventricular 
zone (SVZ) of the lateral ventricles and the subgranular zone (SGZ) of the dentate gyrus in 
the adult brain.  It is something of a misnomer, however, to consider sub-ependymal 
astrocytes (subsequently renamed type B cells; further discussed in section 1.5) as a sub-
population of astrocytes, as they possess distinct characteristics not present in mature 
astrocytes. 
 
1.4.3.2. Development of astrocytes 
Astrocytes are ubiquitously distributed throughout the CNS. Each astrocyte occupies its own 
microdomain, the extent of which depends on astrocyte-astrocyte interactions (Livet et al. 
2007; Imura et al. 2008).   
Raquel Taveira-Marques Tracing NSCs in the ventral NT Introduction 
 
 44/200 
Astrocytes are produced by neuroepithelial cells via direct differentiation from radial glia 
(Schmechel et al. 1979; Voigt 1989; Goldman 2001).  After neurogenesis is over, radial glia 
cells translocate their cell bodies to the pial surface and differentiate into GFAP expressing 
astrocytes.  Radial glia can also produce intermediate progenitors that expand in number 
before generating astrocytes (as discussed in sections 1.4.2.2. and 1.1.2).  Possibly, fibrous 
astrocytes, which settle along the pial surface, might originate by direct transdifferentiation 
of RG whereas protoplasmic astrocytes, which are scattered in the grey matter, develop 
from proliferative intermediate progenitors.  This is rather speculative, however.  After 
migrating to their final positions astrocytes begin the process of terminal differentiation and 
are generally thought to be quiescent during normal life, becoming “reactive” and 
proliferative after injury (Buffo et al. 2008).   
Recent fate-mapping studies have started to uncover the origins of specific astrocyte 
populations in the spinal cord.  Making use of Cre-loxP technology, Fogarty and colleagues 
showed that both protoplasmic and fibrous astrocytes collectively can come from dP5, dP6, 
p0 and/or p1 progenitor domains (Fogarty et al. 2005; Fogarty 2006).  Dbx-derived 
astrocytes, unlike oligodendrocytes, tend to settle radially opposite their site of origin in 
the VZ, and do not migrate tangentially.  Fittingly, in Msx3-iCre fate-mapping experiments, 
where progenitor domains of the dorsal cord are exclusively marked, astrocytes are found 
occupying almost only dorsal territories (Fogarty 2006).   
 
1.4.3.3. Molecular determinants of astrocytes development 
In spite of stronger appreciation of the functional heterogeneity in astrocytes, it has been 
generally accepted that they develop by a uniform genetic mechanism.  The findings that 
astrocyte generation is induced in the absence of proneural basic (bHLH) function (Nieto et 
al. 2001) or by helix-loop-helix (HLH) proteins that inhibit transcriptional activity of 
neurogenic bHLH transcription factors (Nakashima et al. 2001) have led to the proposal that 
astrocytes develop “by default”, in the absence of signals specifying alternative fates (Ross 
et al. 2003).  However, this view has been recently questioned.  In Drosophila different 
astrocyte-like cells are found to arise from distinct precursors, some of which develop under 
the action of the transcription factor glial cell missing (gmc) while others do not (Awasaki et 
al. 2008; Doherty et al. 2009).  Likewise, work in vertebrates has suggested that, at least in 
the ventral spinal cord, astrocyte sub-type specification operates through region-restricted 
expression of transcription factors in different progenitor domains.   For example, glial sub-
type generation in the pMN and p2 neuroepithelial progenitor domains is regulated by cross-
repressive interactions between the bHLH proteins Olig2 and SCL to produce 
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oligodendrocytes versus astrocytes progenitor cells, respectively (Muroyama et al. 2005).  
Moreover, generation of particular fibrous white matter astrocytes, which are molecularly 
and positionally distinguishable, is dependent on region-specific specification of their 
respective progenitors by homeodomain transcription factors Nkx6.1 and Pax6 (Hochstim et 
al. 2008).  These studies suggest that the origins of some astrocyte subtypes can be mapped 
to progenitors in the neuroepithelium with region-specific molecular phenotypes and open 
additional questions.  It has been shown that interneuron specification at all dorsal-ventral 
levels of the spinal cord is regulated at birth by a segregated transcription code operating in 
distinct neuroepithelial domains; is also astrocyte identity coupled to neuroepithelial 
pattern formation along the neural tube?; Is this segmental division of molecularly specific 
astrocytes linked to their function in the mature CNS, hence mirroring the development of 
functionally different interneurons of the spinal cord?  These and other questions are scope 
for further studies. 
 
 
1.5. The role and origin of ependymal cells in the CNS  
Ependymal cells are cells with motile cilia at the interface between the brain or spinal cord 
parenchyma and the ventricular or lumen cavities, respectively, and collectively they 
comprise the ependymal layer.  In the ependymal layer of both brain and spinal cord resides 
a morphologically heterogeneous population of ependymal cells.  In the brain, most of them 
are multiciliated (containing at least 50 long motile cilia), have large apical surfaces and a 
cuboid phenotype.  However, a novel type of ependymal cells (E2 cells) seem to contain 
only two long cilia (Mirzadeh et al. 2008).  Brain ependymal cells can be stained for S100β, 
CD24, vimentin, Nestin (Lendahl et al. 1990; Frisen et al. 1995; Carlen et al. 2006) and 
FoxJ1 (HFH4; Lim et al. 1997) but they are negative for proliferative markers and do not 
incorporate BrdU in normal conditions.  At the ventricular surface, they lay out in a 
pinwheel pattern with type B cells (the neural stem cells) at the centre surrounded by the 
two types of ependymal cells (Mirzadeh et al. 2008).  On the other hand, ependymal cells of 
the spinal cord express Sox9 (Pompolo et al. 2001), and also vimentin, Nestin and FoxJ1 like 
their brain counterparts.  They possess a lesser number of cilia, one to three, and display 
three different morphological phenotypes: cuboidal ependymal cells, the tanycytes and the 
radial ependymal cells (Meletis et al. 2008).  Cells with intermediate phenotypes can be also 
observed.  The classification of ependymal cells, both in the brain and spinal cord, is based 
purely on morphological criteria (since they show a homogeneous molecular profile) and 
does not have implied functional heterogeneity thus far. 
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Ependymal cells play an essential role in the propulsion of Cerebral-Spinal Fluid (CSF) along 
the ventricular system and their malfunction leads to disturbances of the CSF current and 
ultimately to hydrocephaly (Brody et al. 2000).  Other functions have been attributed to 
them as diverse as filtration of brain molecules or insulation from damaging substances in 
the CSF or even dispersion of neural messengers (Bruni 1998).   
Cells in the ependymal layer of the adult spinal cord have a low level of mitotic activity 
(Johansson et al. 1999); around 20% of ependymal cells are labelled after continuous 
administration of BrdU during one month in the drinking water and they constitute 4-5% of 
all BrdU-labelled cells in a cross-section of an adult spinal cord (Meletis et al. 2008; Barnabe-
Heider et al. 2010).  During normal life, this level of proliferation seems sufficient to 
maintain the ependymal layer, replacing cells that die through normal wear-and-tear.  In 
response to injury, ependymal cells of the adult spinal cord show multi-lineage potential, 
producing scar-forming astrocytes and very few remyelinating oligodendrocytes, as well as 
self-renewing (Barnabe-Heider et al. 2010).  Ependymal cells of the spinal cord do not 
contribute to adult neurogenesis, neither in normal nor injury conditions.   
A contrasting situation is observed in the brain.  Ependymal cells lining the adult lateral 
ventricle wall do not divide, judging by the lack of incorporation of Ki67 and BrdU markers 
in uninjured animals (Spassky et al. 2005; Carlen et al. 2009).  Neither do they generate 
neurons in normal conditions as suggested previously (Johansson et al. 1999).  However, 
ependymal cells in the brain are able to generate neuroblasts and astrocytes in response to 
injury (Carlen et al. 2009).  This process involves ependymal cells regaining radial glial cell 
features (Gregg et al. 2003; Taylor et al. 2005; Zhang et al. 2007) in particular the capacity 
to re-enter the cell cycle through the suppression of canonical Notch signalling.  When 
forced Notch signalling was maintained, ependymal cells failed to produce functional 
neurons and astrocytes (Carlen et al. 2009).  Hence, Notch signalling normally maintains the 
quiescent state of ependymal cells.  However, although they have multi-lineage potential, 
ependymal cells in the brain are depleted by stroke and so do not fulfil the defining criteria 
of a true stem cell, serving instead as a reservoir of primary cells that are used up during 
injury (Carlen et al. 2009).   
A series of recent studies has begun to unveil the origins of the ependymal cells of the spinal 
cord, albeit little advancement has been done on studies on their brain counterparts.  
Spassky and colleagues have shown that ependymal cells originate from RG before birth but 
their committed RG progenitors remain quiescent and only acquire the typical feature of 
ependymal cells after birth (Spassky et al. 2005).  It has also been observed that ependymal 
cells express the ventral transcription factor Nkx6.1, but not dorsal markers such as Pax7, 
strongly suggesting that they are derived from Nkx6.1-expressing neuroepithelium (Fu et al. 
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2003).  Fittingly, Fogarty and co-workers show, by means of Cre-fate mapping techniques, 
that progenitor domains more dorsal than the Nkx6.1-expressing domain do not contribute 
to the ependymal layer of the postnatal spinal cord (Fogarty et al. 2005; Fogarty 2006).  
Moreover, it has been reported that Olig2-positive progenitors in the embryonic spinal cord 
give rise to a subset of ependymal cells of the postnatal spinal cord (Masahira et al. 2006).  
Taken together, the various studies point to ependymal cells as formed from p3, pMN and p2 
domains of the embryonic ventral spinal cord (Richardson et al. 2006).  It is not known, 
however, whether this restricts their regenerative potential to ventral cell types in the 
adult cord after injury. 
It is still unknown how ependymal cells arise from their radial glia progenitors during 
development.  A deeper understanding of the molecular mechanisms underpinning 
ependymal cell specification during embryogenesis and adulthood might aid the 
development of therapeutic approaches where these cells could be modulated in situ to 
produce required progeny in response to injury, as a substitution for cell transplantation. 
 
 
1.6. Fate-mapping with Cre and PAC technologies in mice 
1.6.1. Brief introduction: a historical perspective 
Fate-mapping involves tracking a cell and all of its progeny in order to discover the lineage 
tree of the different cell types that constitute an organism.   
Fate-mapping all cells of an organism constitutes one of the earliest aspirations of 
developmental biologists and, on account of pioneering work of early experimental 
embryologists, we know now, at least in a rudimentary form, the main lineages in 
vertebrates (for a chronology of events see Table 1.4).   
The first fate maps date back to the 1900s and, relied on studies using transparent 
invertebrate organisms combined with Nomarski interference microscopy and video 
recording to follow cell behaviours.  However, only a few organisms are amenable to direct 
observation.  Further improvements on fate-mapping techniques came only some decades 
later with the use of vital dyes and radioactive markers used to mark individual or groups of 
cells (Table 1.1).  While allowing tracing cell behaviours in higher organisms, fate-maps 
relying on vital dyes and radioactivity markers were confused by the tendency of the 
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staining to diffuse and dilute (over cell-division), thus greatly hampering the resolution of 
the method and its use for long term lineage analysis  
In 1969, a milestone was reached with the use of chick-quail chimeras (Table 1.1).  Because 
quail cells can be distinguished from chick cells by their different antigenic profile and 
interphase nuclei, chick-quail grafts provide a natural way of enabling permanent cell 
labelling.  Nevertheless, chick-quail chimeras offer a few challenges, mainly the fact they 
are technically demanding, and they confine lineage studies to bird development.  Also, 
they do not allow individual cell lineages to be followed but only the fates of relatively 
large tissue blocks. 
In the late 1980s, fate-mapping studies were revolutionised with the advent of molecular 
biology, allowing cells to be marked genetically.  Since then powerful techniques have 
evolved enabling permanent labelling by genetically modifying organisms using virus vectors 
or transgenes to drive expression of marker molecules in a targeted way.  And now, thanks 
to the development of new microscopes and markers, investigators can map single cells in 
real time in living organisms and combine lineage analysis with genetic ablation of cells and 
genes. 
 
 
Table 1.4  -  Fate-mapping technologies adopted throughout the years. 
For a detailed timescale of events see Clarke et al. 1999. 
Year Milestone Reference 
1905 Edwin Conklin and co-workers make use of the transparent 
properties of the sea squirt Styela partita to generate a 
remarkable collection of ascidian fate maps. 
Conklin EG 1905 
1978 Uwe Deppe and colleagues used the transparent invertebrate 
organism, Caenorhabditis elegans, combined with Nomarski 
interference microscopy and video recording, to follow the cell 
behaviour of the first 182 cells of the developing worm. 
Deppe et al. 
1978 
1929 Vogt optimised a technique of marking areas of the newt egg 
using vital dyes and followed the fates of different group of cells 
on the surface of the developing embryo during gastrulation. 
Vogt W 1929 
1969 Nicole Le Douarin discovered that quail and chick cells are 
distinguishable for their specific and different interphase 
properties which can be revealed after carrying out a simple DNA 
staining technique. 
Le Douarin 1969 
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Table 1.4 (cont.) 
Year Milestone Reference 
1969-1975 Nicole Le Douarin pioneered the application of chick-quail 
chimaeras for lineage studies. Her studies are outstanding for 
their precision and elegance. She greatly contributed for our 
understanding of neural-crest migration, epithelial-mesenchymal 
interactions and neural-plate formation. 
Le Douarin et 
al. 1969; Le 
Douarin et al. 
1975 
1981 Study describing the tracing of proliferative cells of the 
ventricular zone to the hippocampus of Rhesus monkey 
performed with the radiolabelled dye thymidine. 
Nowakowski et 
al. 1981 
1988 This study reports the use of bright fluorescent dyes in 
combination with radioactive thymidine, injected into single 
cells, to follow cell behaviours. 
McConnell 1988 
1986-1990 These studies report the use of retrovirus for cell lineage 
analysis; while providing with an indelible, heritable, and 
accurate labelling, the retroviral approach has no intrinsic 
marker of clonality and so each clone of cells stain similarly; 
moreover, cells within a population cannot be distinguished using 
this technique.  
Price et al. 
1987; Turner et 
al. 1987; Leber 
et al. 1990 
1996/1997 These works use an intricate but long-term marking strategy of 
single cells and their descendants, which can be visualised after 
LacZ recombination. 
Nicolas et al. 
1996; Mathis et 
al. 1997 
2006 This study makes extensive use of Cre excision-conditional 
transgenesis applied to label cell lineages via permanent 
activation of a reporter gene in combination with cell ablation 
studies. 
Kessaris et al. 
2006 
 
 
1.6.2. Lineage tracing with PAC transgenesis and Cre reporter mice 
Genetic marking of cells in transgenic mice can be achieved typically in two distinct ways: 
1) by targeted insertion of exogenous DNA into a specific locus in the mouse genome - the so 
called “knock-in” approach; and 2) by random insertion transgenesis, where a fragment of 
exogenous DNA is randomly inserted into the genome.  Both techniques have their own pros 
and cons.   
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In the “knock-in” approach the expression of the exogenous DNA is under the control of the 
same regulatory elements as the endogenous gene of interest.  While assuring that the 
exogenous DNA mimics the expression of the endogenous gene, this technique is limited to 
genes that show no phenotypic abnormalities after disruption of one of its alleles (Nutt et 
al. 1999) or to genes that can be combined with the exogenous DNA to produce a functional 
bicistronic construct.  Furthermore, this technique is based on homologous recombination in 
ES cells which makes it time-consuming and costly.   
In the second approach, the making of transgenic mice relies on exogenous DNA being 
placed under the control of specific regulatory element sequences, which are not always 
known for a given gene of interest.  The resulting DNA construct, conventionally not longer 
than 10-20kb, is then inserted into the genome randomly without, one hopes, disrupting any 
essential coding sequences.  This is regarded as a quick-and-easy technique; however, 
expression of exogenous DNA in conventional transgenic mice is often subject to position 
(integration site) effects which can result in misexpression or silencing of the transgene.   
A new approach to mouse transgenesis has recently been developed based on the 
manipulation of P1 bacteriophage-derived or bacterial artificial chromosomes (PACs or 
BACs).  These are circular DNA plasmid vectors that hold large fragments of genomic DNA 
that are likely to contain all the regulatory elements of a gene of interest (Ioannou et al. 
1994).  Moreover, given their large size, PACs/BACs are unlikely to be silenced, i.e. less 
likely to be subject to positional effects, and their use avoids problems of haplo-
insufficiency.  PACs are also simple to manipulate compared with homologous recombination 
in ES cells and recombinant PAC/BAC DNA can be produced in bacteria and easily purified.  
The powerful advantages inherent to PAC/BAC transgenesis streamlines the production of 
transgenic mice and greatly increases our ability to manipulate gene expression in mice. 
Another genetic tool that has revolutionised mouse genetics and the science of fate-
mapping is Cre recombinase.  Cre was isolated from bacteriophage P1 and belongs to the 
integrase family of site-specific recombinases.  In vivo, the function of Cre recombinase is 
to circularize the P1 bacteriophage genome during infection assuring the maintenance of 
the genome in a monomeric state during the phage’s life cycle.  The enzyme efficiently 
catalyzes recombination between two of its consensus 34bp DNA recognition sites, known as 
loxP sites, in any cellular environment and on any kind of DNA.  If two co-linear loxP sites 
are orientated in the same direction then Cre-mediated recombination causes the excision 
of the DNA sequence flanked by the loxP sequences.  If the loxP sites have opposing 
sequence directions then any intervening DNA will be inverted.   
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Due to the unique characteristics of the Cre/LoxP system, numerous genetic engineering 
applications of Cre excision-conditional transgenesis surfaced (Nagy 2000).  For instance, 
Cre-mediated recombination has enabled us to direct mutagenesis in a temporarily 
controlled manner.  For this, a mouse Cre line that expresses Cre in a desired pattern, is 
crossed with another mouse line that carries the gene of interest flanked by loxP sites 
(“floxed”).  When Cre starts to be expressed, it mediates excision of the floxed gene.  
Furthermore, Cre-mediated excision can be applied to label cell lineages via permanent 
activation of a fluorescent or chromogenic reporter gene.  Temporally-controlled fate map 
studies can also be achieved when a ligand binding domain is fused with Cre recombinase 
producing a fusion protein Cre-ERT2 (see Figure 1.4 and Figure 1.5, and also see text-box 
below for more details).  This recombinant inducible-Cre recombinase is only able to 
mediate recombination in the presence of its ligand – the estrogen analogue tamoxifen.  In 
this way tracing cell behaviours both spatially and temporally becomes possible. 
Text-box  -  Cre-ERT2 recombinase 
Cre-ER
T2 is a ligand-dependent chimeric Cre recombinase in which a mutated form of the 
human estrogen receptor (ER) ligand binding domain (LBD) is fused to Cre recombinase (Feil 
et al. 1997; Indra et al. 1999).  In the absence of the ligand, the LBD hinders translocation 
of the enzyme into the nucleus, thus preventing its function.  This is because LBD causes the 
receptor to bind to a cytoplasmic protein complex containing Heat-shock protein 90 (Hsp90) 
when no ligand is present, sequestering the protein in the cytoplasm (Picard 1994).  Once 
available, the ligand binds to the LBD releasing the chimeric protein (Cre-ERT2) from Hsp90 
allowing nuclear translocation.  One problem of these chimeric recombinases is that they 
can be activated by natural ligands that can be present in the host.  In the chosen mutant 
Cre-ER
T2 the mutation is such that Cre-ERT2 can be activated by the synthetic ligands OHT 
(oestrogen 4-hydroxytamoxifen), ICI (ICI 182.780) or tamoxifen (TM), but remains insensitive 
to E2 (17β-oestradiol), which is endogenously present in mice.   
Like Cre recombinase, Cre-ERT2 is a site-specific recombinase that recognises and binds to 
specific sites called IoxP (Nagy 2000).  Two IoxP sites recombine in the presence of Cre, 
allowing the DNA cloned between two such sites to be removed by Cre-mediated 
recombination after TM treatment.  In the example shown in Figure 1.4 the DNA fragment to 
be removed is a “Stop” fragment that blocks the expression of the reporter gene (e.g. the 
lacZ gene, the eGFF gene or YFP gene).  The mechanism by which this process occurs is 
schematically represented in Figure 1.4. 
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Overall, PAC transgenesis in combination with Cre-mediated reporter gene activation 
provides us with the possibility of fate-mapping the mouse at a galloping pace compared to 
previous methods.  I have used the Cre-lox approach in my Thesis work to examine cell fate 
choices in the ventral neural tube.  My studies have provided evidence that motor neurons 
of the autonomic CNS are generated in the ventral-most neuroepithelium domain abutting 
the floor plate.  This contradicts current theories, which place the origin of autonomic 
motor neurons more dorsally than this, in the same progenitor domain (pMN) that generates 
somatic motor neurons. 
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1.7. The aims of the thesis 
The study of cell generation in space and over time is an important aspect of developmental 
neuroscience and a spate of recent studies has brought significant insights to the field.  
Today, the origin of many neurons and glia has been traced back to specific neuroepithelial 
domains.  In the spinal cord, progenitor cells in the most ventral region of the 
neuroepithelium expressing Nkx2.2 have been shown to give rise to V3 interneurons.  
Generation of visceral motor neurons, serotonergic interneurons, and oligodendrocytes have 
also been linked to the equivalent Nkx2.2-expressing neuroepithelial domain in the 
hindbrain.  While much research has been devoted to the brain, little or only weak evidence 
is available on the progeny of Nkx2.2+ domain of the spinal cord, mainly concerning its glial 
progeny.  The purpose of this thesis is to clarify and/or identify the differentiated progeny 
of Nkx2.2+ neuroepithelial progenitor cells in the spinal cord and hindbrain to illuminate 
their lineage and migration patterns.  To do this, Cre/loxP technology and PAC transgenesis 
were used to express an inducible Cre recombinase under Nkx2.2 transcriptional control (see 
Chapter 2).  Chapter 3 describes the generation of an Nkx2.2-CreERT2 mouse line and its 
characterisation.  Chapter 4 reports the results of my fate-mapping studies.  Chapter 5 
summarises the findings of the Thesis and discusses their implications for the field of spatial 
patterning and cell specification in the ventral spinal cord. 
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Figure 1.1  -  Neurulation.  At the start of neurulation it is the ingression of epiblast cells 
that transform the one layered epiblast to the three layered gastrula (A and B).  Signals 
released by the underlying mesoderm trigger the process of neurulation.  The neural plate 
goes through various morphological changes (C) which results ultimately in the formation of 
the neural tube (D).  (adapted from Gilbert 2000 and 
http://thebrain.mcgill.ca/flash/a/a_09/a_09_cr/a_09_cr_dev/a_09_cr_dev.html). 
A B 
C 
D 
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Figure 1.2  -  The The French Flag Model for positional specification in the embryo.  This 
model describes pattern formation in a tissue that is originally homogeneous.  At first, a 
spatial distribution of an exogenous factor (the morphogen) is established in the embryonic 
tissue; for instance, let us consider a morphogen source locating on the left-hand side, and 
a sink (where the morphogen is degraded) on the right.  As the morphogen diffuses, the 
distribution of it eventually creates a differential but stable gradient of concentrations.  
This model assumes that each and every cell is then able to read this morphogen 
concentration and compare it with a given intrinsic threshold concentration spectrum which 
will determine their genetic program of differentiation.  Hence, cells occupying different 
positions in relation to the source of morphogen acquire distinct identities or positional 
values which ultimately lead to pattern formation in the embryonic tissue. (Adapted from 
Wolpert et al. 2006) 
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Figure 1.3  -  Transcription factor dynamics during patterning of ventral spinal cord.  
(see text of sections 1.2.2, 1.3.1 and 3.1 for more details) panel A)  each progenitor (p) 
domain is colored using a grey scale, in which the gradation in colour mimics the decreasing 
Shh concentration along dorsoventral axis, with the maximum concentration at the floor 
plate (black triangle);  panel B and C) pattern indicates weak or practically absent 
expression of Nkx2.9;  panel C) blue stars represent scattered Olig2
+
 cells).  Arrows indicate 
that at the specified age the boundary is moving in that direction.  Note: Despite not being 
schematically shown in this diagram, expression of Nkx2.2 and Nkx2.9 in the floor plate of wild type embryos at or before 
E9.5 has also been referenced (Pabst et al. 2003; Strahle et al. 2004; Jeong et al. 2005; Placzek et al. 2005; Holz et al. 
2010). 
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Figure 1.4  -  Cre-ER
T2
/loxP system.  Cre is a site specific recombinase isolated from P1 
bacteriophage.  It recognises a 34 bp sequence — loxP site.  If 2 loxP sites are present in the 
same fragment of DNA, in the same orientation, Cre catalyses the excision of the DNA 
sequence flanked by the 2 loxP sites.  As exemplified in the figure, upon the presence of 
tamoxifen Cre recombination event allows the transcription of a reporter gene (bright 
green) to occur, which expression would otherwise be silenced by the existence of a spacer 
DNA (such as a poly A sequence) (see text for further details). 
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Figure 1.5  -  Breeding strategy for a site- and time- specific gene targeting of a cell type 
specific gene.  The technique involves the use of two transgenic mice: a reporter mouse, 
containing an inactive reporter gene that is constitutively activated by Cre-mediated 
recombination, and a Cre mouse, in which CreER
T2
 recombinase (an inducible form of Cre 
recombinase only functionally active in the presence of its ligand, tamoxifen) is placed 
under the control of the regulatory elements of a cell type specific gene.  The two mice 
lines are then crossed to generate double-transgenic offspring.  Upon tamoxifen 
administration, expression of the reporter gene is activated only in cells of these offspring 
that express Cre-recombinase.  Thereafter, reporter gene expression permanently stays 
activated since its expression is under transcriptional control of a constitutively active 
promoter in the mouse.  This breeding strategy allows to permanently label progenitor cells 
and all their progeny in a spatio-temporally controlled manner. 
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Chapter 2  -   Materials and Methods  
 
General chemicals and reagents were purchased from Sigma-
Aldrich Co Ltd, unless otherwise stated, and, when 
available, all of them were of a Molecular Biology grade. 
 
2.1. Bacterial strains, growth and 
storage 
All plasmids were maintained in Escherichia coli (E. coil) 
strain XL1-Blue (recA1, endA1, gyrA96, thi-1, hsdR17, 
supE44, relA1, lac [F’ proAB, laclqZ∆M15, Tn10 {TetR}]). 
Bacteria grew at 37°C in Luria Broth (LB; per litre: 10g 
bacto-tryptone, 5g yeast extract, 1Og NaCI) or on LB-agar 
plates containing LB and 15g/l bacto-agar. Whenever an 
ampicilin selection was needed, ampicilin was added to the 
LB or molten LB-agar (after cooling to 55°C) at a final 
concentration of 1OOg/ml (100mg/ml stock in water, 
0.20µm filter-sterilised and stored in aliquots at -20°C). 
Liquid cultures were continually agitated in a rotating 
environmental shaker (InnovaTM 4330 from New Brunswick 
Scientific) at 250rpm.  For long-term storage of bacterial 
strains and clones glycerol was added to overnight (O/N) 
cultures at a final concentration of 15% (v/v), having these 
stocks been stored in 1mI aliquots at -80°C. 
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2.1.1. Preparation of Electrocompetent Bacterial Cells 
The XL1-Blue E. coli bacterial strain was used for electroporating plasmid DNA while the 
EL250 strain was used for electroporating PAC DNA (for method see section 2.6). 
Electrocompetent cells were prepared using the following method Dower et al. 1988. An 
overnight culture of cells was set up in 10ml of SOC medium (with tetracycline selection at 
35 µg/ml in the case of XL1-Blue). 2 x 400ml of SOC were then inoculated with 4 ml of the 
overnight cultures and grown until the OD600 reached 0.6 – 0.8 (3 – 4 hours). 16 x 50ml 
centrifuge tubes were pre-cooled on ice and the cultures then decanted into these and 
cooled for 15 minutes. They were then spun for at 4°C for 15 minutes at 1,500g. In a cold 
room, the supernatants were discarded and the pellets gently resuspended in 25 ml of cold 
ultraclean water. The suspensions were then pooled into 8 x 50ml tubes. These were 
centrifuged again as before, and the pellets once more resuspended in 25ml of ultraclean 
water and then pooled, this time into 4 x 50ml tubes. The tubes were spun a third time and 
the pellets resuspended in 10 ml of ultraclean water and pooled into one 50ml tube. After a 
final spin the pellets were resuspended in 250µl of cold 10% glycerol. These were then 
aliquoted into 1.5ml screw-cap cryo-tubes and snap frozen in liquid nitrogen. They were 
stored at -80°C until required. 
 
 
2.2. Plasmid DNA isolation 
2.2.1. Extraction of DNA with phenol/chloroform 
An equal volume of 1:1 (v/v) phenol/chloroform was added to the samples to be extracted. 
The sample was vortexed and centrifuged at high speed (16,3 x103 g) for 5 min. The upper 
aqueous phase was collected and re-extracted with an equal volume of chloroform, 
centrifuged at high speed (16,3 x103 g) for 5 min and collected as we have above referred. 
 
2.2.2. Precipitation of DNA with ethanol 
2x volumes of 100% ethanol, 0.1x volume of 3M Sodium acetate pH5.3 and 1µl glycogen 
(Sigma) were added to the sample to be precipitated. The mixture was vortexed, incubated 
on dry ice for 15 - 30min and then centrifuged at high speed (16,3 x103 g). The pellet was 
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then washed in 70% ethanol, air dried and resuspended in an appropriate volume of TE 
buffer (5mM Tris, pH 7.5, 0.5mM EDTA, pH 8.0) or water. 
 
2.2.3. Small scale preparation of plasmid DNA by alkaline lysis (mini-
prep) 
This preparation was performed according to Sambrook et al. 2001. 3ml of LB containing the 
appropriate antibiotic was inoculated with a single bacterial colony and was incubated in a 
37°C shaking incubator overnight (ON) (12-18hr). 1.5ml of O/N culture was transferred to a 
Microfuge tube and centrifuged for 1min at high speed (16,3 x103 g) in a microcentrifuge 
(Biofuge pico from Heraeus). 100µl of solution I (50mM glucose, 25mM Tris-HCI pH8.0 and 
10mM EDTA pH8.0) was used to resuspend the pellet, followed by 200µl of solution II (1% 
w/v Sodium Dodecyl Sulphate and 0.2M Sodium Hydroxide). This was gently mixed by 
inversion. 150µl of solution III (3M Potassium acetate and 8.7% v/v Acetic acid) was added, 
gently mixed and left on ice for 10 min. After spinning for 10min at high speed (16,3 x103 g), 
the supernatant was carefully removed, avoiding the floating material, and transferred to 
another tube. The plasmid DNA was precipitated with 2x volume ethanol at -20°C for 10 
min. This was spun down at high speed (16,3 x103 g) for 10min and the pellet was washed in 
70% ethanol, air dried and resuspended in 4Oµl TE buffer pH 7.6. This preparation resulted 
in 1 - 2µg plasmid DNA. 
 
2.2.4. Large scale preparation of plasmid DNA (maxi-prep) 
This method is a scaled-up version of the small scale plasmid isolation method described 
above with several additional plasmid purification steps. The protocol started with a 50ml 
stationary O/N bacterial culture grown in Terrific broth (per litre: solution A [per 900ml: 12g 
bacto-tryptone, 24g bacto-yeast extract, 4ml glycerol, in distilled water] was added to 
solution B [per lOOml: 2.31g KH2PO4, 12.54g K2HPO4, in distilled water] after both were heat 
sterilised and cooled) containing the appropriate antibiotic. The culture was spun down in 
two 50ml Falcon tubes at 3,800g for 10min. The pellet was resuspended in 4ml of solution I 
and was left on ice for 5min. 8ml of solution II was then added, mixed well and left on ice 
for 5min. 6ml of solution III was added to precipitate the chromosomal DNA and the mixture 
was left on ice for 10min. After centrifugation at 3,800g for 15min at 4°C, the supernantant 
was transferred to another tube, through a sheet of autoclaved muslin to avoid floating 
material, and 17ml of isopropanol was added to the filtered supernantant. The plasmid DNA 
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was allowed to precipitate on ice for 15min. This was centrifuged at 3,800g for 15min at 4°C 
and the pellet was resuspended in 2ml TE pH7.5. 2.5ml of 4.4M Lithium Chloride was added 
to precipitate the RNA on ice for one hour. The precipitated RNA was pelleted (3,800g for 
15min at 4°C) and the supernatant was transferred to a clean tube. 9ml of 100% ethanol was 
added to precipitate the plasmid DNA and the solution was left at room temperature for 10 - 
15min. The DNA was spun down for 15min at 4°C, washed in 70% ethanol and air dried. Then 
it was resuspended in 400µl TE and transferred to an Microfuge tube. To remove 
contaminating RNA, 10µl of RNase A (O.5µg/µl) was added and the mixture was incubated 
for 15min at 37°C. 2Oµl of 10% SDS was then added and the mixture was heated to 70°C for 
10 min to destroy the RNase A. One phenol/chloroform extraction and one chloroform 
extraction were performed. The DNA was precipitated with 2x volumes of 100% ethanol, 0,lx 
volume of 3M Sodium acetate pH5.3 at room temperature for 10- 15min. This was spun down 
at high speed (16,3 x103 g) for 10min and the pellet was washed in 70% ethanol, air dried 
and resuspended in 2O0µl TE buffer pH 7.6. This method typically resulted in 0.5- 1mg of 
10Kb plasmid from a 50ml culture. 
 
 
2.3. Analysis of Plasmid DNA 
2.3.1. Restriction enzyme digestion and agarose gel electrophoresis 
Restriction enzymes were supplied by New England Biolabs and Promega. Digestions were 
carried out using the appropriate buffer systems supplied with the enzyme and following the 
enzyme manufacturer’s protocols. Genomic DNA (maximum 25µg) was digested at 37°C 0/N 
in a 5Oµl volume containing 0.2 - 0.4U/µl of the relevant enzyme.  
Conventional electrophoresis was performed in Life Technologies gel apparatus. 
Multipurpose agarose (Bioline) was used for all agarose gel electrophoresis at 0.6-4% (w/v), 
this specific percentage depending on the molecular weight of the DNA of interest. The 
agarose was dissolved in the appropriate volume of 1x TAE (0.04M Tris, 0.001M EDTA) by 
boiling in a microwave oven, cooled below 60°C, and ethidium bromide was added to a final 
concentration of 0.5.µg/ml. The gel was poured into the electrophoresis system and let to 
solidify. Loading buffer was added to the DNA samples (1Ox stock: 50% glycerol (v/v), 1mM 
EDTA pH8, 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol, destilled water 
treated with DEPC) and the gel was loaded. Electrophoresis was carried out in 1x TAE 
buffer. The DNA was visualised in a lightproof cabinet containing an ultraviolet 
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transilluminator at 302nm, a CCD camera and a thermal printer to record the image (Alpha 
Innotech Corporation). Alternatively, in the case of gels containing genomic DNA, no 
ethidium bromide was added to the gel before running it. Instead, the gel was post-stained 
in ethidium bromide diluted in distilled in deionized water for 15 min and then 
photographed. 
 
2.3.2. Southern analysis 
2.3.2.1. Southern Blotting 
The DNA to be analysed was run on an agarose gel as described in section 2.3.1. This was 
then washed for half-hour periods at room temperature in 3 solutions with thorough rinsing 
in destilled water in between: O.5M HCI solution to de-purinate de DNA; denaturing solution 
(0.4M NaOH, 1.5M NaCl) to denature the fragments on the gel; and neutralising solution (1M 
Tris HCI pH 7.5, 1.5M NaCI, 1mM EDTA) to neutralise the denaturing solution.  
Following treatment of the DNA in the gel, an 0/N capillary blot in 10x SSC was set up as 
described in Sambrook et al. 2001. For this, HybondTM-XL membrane (Amershem Pharmacia 
Biotech UK limited) was cut to size and rinsed in 1OX SSC prior to use in the capillary blot.  
Following transfer to the membrane, the DNA was then cross-linked to the membrane by 
irradiating with UV light (UV Strata Linker 1800 from Strata Gene; Auto Cross Link program). 
 
2.3.2.2. Pre-hybridizaton 
Hybridization of HybondTM-XL membrane was carried out according to the manufacturer’s 
instructions. In brief: the membrane was placed on a piece of nylon mesh and rolled up into 
a tight roll in 2X SSC. This was placed in a hybridisation bottle which contained 2X SSC. 2X 
SSC was replaced with 10-20ml of pre-hybridization solution (MIB solution [0.225 M NaCl, 15 
mM NaH2PO4, 1.5 mM EDTA, 10% PEG 8000, 7% SDS] with 0.01% salmon sperm DNA previously 
denaturated at 95°C for 5min followed by 5min on ice).  
Pre-hybridization was carried out for at least 1 hour at 65°C rotating in a hybridisation oven 
(Hybaid). 
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2.3.2.3. Hybridization to a labelled DNA probe 
The DNA fragment to be used as a probe was prepared by purification from an agarose gel 
slice using the electroelution method described in the section 2.4.1. This was radioactively 
labelled using rediprimeTM II random prime labelling kit (from Amersham Pharmacia Biotech 
UK Limited) with RedivueTM alpha-32P dCTP (from Amersham Pharmacia Biotech UK Limited) 
according to the manufacturer’s instructions. In brief: 25ng of DNA was denatured at 95°C 
for 5min in a total volume of 45µl and was quenched on ice. The denatured DNA was added 
to the reaction tube containing the appropriate enzyme DNA polymerase, random primers 
and three nucleotides (dATP, dGTP, and dTTP). To the above mixture was added 5µl of 
alpha-32P dCTP. The labelling reaction was typically incubated at 37°C for 1 hour. 
32P labelled probes were purified away from unincorporated nucleotides by spun- column 
chromatography using Micro BioSpin® P-30 Tris chromatography columns from BioRad 
Laboratories and according to the manufacturer’s instructions. In brief: the probe was 
loaded onto the column and the eluate was collected in an microfuge tube after spinning 
(16,3 x 103 g). The success of the labelling reaction was estimated using a Geiger counter, 
to count the relative amounts of radioactivity in the column and in the microfuge tube. The 
procedure was continued only when the amount of radioactivity in the eppendof tube was 
higher than in the column.  
Before use, the purified 32P labelled probe was denatured at 95°C for 5min and was 
quenched on ice for 5min. This was added to the pre-hybridization solution and incubated at 
65°C 0/N. 
 
2.3.2.4. Washing of membranes 
Following hybridisation, the membranes were washed in two solutions of increasing 
stringency: 1) 2X SSC, 0.1% SDS, at 65°C, with a slow constant rotation, during 10 min; 2)  
0.1X SSC. 0.1% SDS, at 65°C, for as long as needed until no more radioactivity was being 
removed. 
 
2.3.2.5. Developing of membranes 
Excess liquid was blotted off the radioactive membranes, which were then wrapped in 
Saranwrap and exposed to HyperfilmTM MP (from Amersham Pharmacia Biotech UK Limited) 
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in a light-sealed cassette with 2 intensifier screens at -80°C.  Exposure time varied 
according to the intensity of the signal. 
 
2.3.3. DNA sequencing 
DNA sequencing was carried by the Wolfson Institute for Biomedical Research automated 
sequency service using a Beckman Coulter CEQ2000XL Sequencer. The double stranded 
plasmid DNA templates to be sequenced were prepared according to the instructions 
specified by the service. 
 
2.3.4. Quantification of DNA 
The concentration of DNA was assayed by submitting an aliquot of the DNA to agarose gel 
electrophoresis. The brightness of the band was then compared to the ladder (Hyper Ladder 
I from Bioline) to have an estimate of the amount of DNA present. Alternatively, the 
concentration of DNA was determined using NanoDrop 1000 V3.6.0 spectrophotometer. 
 
 
2.4. Cloning techniques 
2.4.1. Isolation of DNA fragments for cloning 
DNA fragments for cloning were usually purified from agarose gels on which they had been 
run following plasmid digests or PCR amplification. Bands were visualised on the agarose gel 
using a UV light and then excised from the gel with a scalpel, taking care to remove as much 
agarose as possible while minimising the time of exposure of the DNA to the UV light. The 
following steps were carried out:  
Dialysis tubing of appropriate size was rinsed with distilled water, sealed at one end using a 
dialysis clip and filled with 1x TAE buffer. The agarose slice containing the DNA band was 
placed in it. Most of the fluid was removed leaving enough to keep the gel in constant 
contact with the buffer. The other end was sealed using another clip avoiding trapping of air 
bubbles. This was subjected to electrophoresis in 1 X TAE for ~30min at 130V. The buffer 
solution from the dialysis tube was recovered. The suspension was taken through one 
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phenol/chloroform and one chloroform extraction and the DNA was precipitated on dry ice 
for 30mim with 2X volume of absolute ethanol, 0.1X of 3M sodium acetate, pH5.3 and µg 
glycogen (Sigma). The resulting solution was spun down and the pellet washed in 70% 
ethanol and air dried. Afterwards, it was dissolved in an appropriate volume of milli Q H20. 
This method resulted in an almost 100% DNA recovery.  Alternatively, and more recently, 
the isolation of DNA fragments was done using the illustraTM GFX PCR DNA and Gel Band 
Purification kit from GE Healthcare (cat. #28-9034-70).  See user manual for details. 
 
2.4.2. Ligation of DNA fragments 
Ligations referred in this research report involved DNA fragments digested with restriction 
enzymes that generated overhanging ends and PCR products. The latter were performed 
using TOPO TA cloning® (from Invitrogen, Cat no. K4600-01) and according to the 
manufacturers instructions. TOPO TA cloning® containing pCR®II-TOPO® uses a topoisomerase 
enzyme to rapidly clone any PCR fragment into its covalently bound vector. The former 
were performed using 1x ligase buffer supplied with the enzyme, assuming a vector:insert 
molar ratio of 1:3 and using the T4 DNA Iigase from Roche. The reaction was allowed to 
proceed overnight at 16°C. 
 
2.4.3. Transformation of electrocompetent cells 
2µl of the ligation reaction was usually used to transform electrocompetent bacterial cells 
(E. coil strain XL1-Blue; stock from the lab, see section 2.1.1). Alternatively, the total 
volume of the ligation reaction was ethanol precipitated and ressuspended in a small volume 
of water (~5µl) and used in the transformation. Electrocompetent cells were thawed on ice 
and 40 µl used immediately for transformation. This was done using Micro Pulser (from Bio-
Rad Laboratories Ltd). The cells were mixed gently with the DNA and transferred to a 
chilled disposable 0.2cm electroporation cuvette (from Bio-Rad Laboratories Ltd). 
Transformation was carried out at 2.5kV. A time constant between 5-6 seconds was 
produced. The pulsed bacteria were added to 500ml of LB at 37°C and decanted into a 
warm 1.5ml microfuge tube.  These were then incubated at 37°C for 30min before plating 
on LB agar plates supplemented with suitable antibiotic, afterwards incubated at 37°C 
incubator 0/N. Whenever possible, blue/white selection was used to distinguish 
recombinant plasmids from non-recombinant ones. This was dependent on the insert ligating 
into the lacZ gene of a cloning vector to cause the gene disruption. Using IPTG (0.1M; 1M 
stock in water, O.2Oµm filter-sterilised and stored in aliquots at -20°C) and X-Gal (8mg/ml; 
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40mg/ml stock in N,N-dimethyl formamide (DMF) and stored in aliquots at - 20°C) as IacZ 
gene substrates we could distinguish the plasmids which contain inserts (white colonies). 
 
 
2.5. Polymerase chain reaction 
PCR was used at various stages of the project to amplify pieces of plasmid DNA (e.g. for 
cloning or for use as probes) or to amplify pieces of PAC DNA (e.g. for cloning).  
The PCR conditions and the cycling programmes are specified in the relevant sections of 
Results. The primers used in PCR reactions are listed in the Table 2.1. The PCR machines 
used were Master Cycler Gradient from Microfuge, Primus 96 plus from MWG-Biotech, 
Multigene from Labnet, and 96 Universal from peQSTAR. 
 
Table 2.1  -  List of primers used for PCR amplification and DNA sequencing.  
The names of the primers, their sequence (in a 5’ to 3’ orientation) and the template from which 
they were designed are shown. 
Name Primer Sequence (5'  3') Template used 
T7 GTA ATA CGA CTC ACT ATA GGG C pNkx2.2 
M13-20 GTA AAA CGA CGG CCA GT -ditto- 
M13-reverse GGA AAC AGC TAT GAC CAT G -ditto- 
MNkx2.2F2 GAA ACT GGC TGA GCC CTG GGT GAC C Nkx2.2 PAC clones 
MNkx2.2R2 CCG AGC CCT GGT GGC AGG AGT TCC -ditto- 
PAC4 5' For1 ACA GTT CTG ACT TTT ACG AC -ditto- 
PAC4 5' Rev1 TTG ACT AGT GGG TAG GCC TG -ditto- 
PAC4 5' For2 TAT TAC ACG CCA TGA TAT GC -ditto- 
PAC4 5' Rev2 TGA GTC GCT CCT CCT GCC AG -ditto- 
PAC4 3' For1 CGA CTC ACT ATA GGG AGA GG -ditto- 
PAC4 3' Rev1 GGC ATG ACT ATT GGC GCG CC -ditto- 
PAC4 3' For2 CGA GCT TGA CAT TGT AGG AC -ditto- 
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(cont.) 
Name Primer Sequence (5'  3') Template used 
PAC4 3' Rev2 CCT TGA GAG CCT TCA ACC CA Nkx2.2 PAC clones 
CreERT2BstAPIF1 GCA TAA ATT GCG GGG TCC GGA ACC ATG TCC AAT TTA 
CTG ACC GTA CAC C 
pCre-ERT2 
CreBamR1 CGT TTT CTT TTC GGA TCC GCC GC -ditto- 
Nkx2.23'NotF1 ATA AGC GGC CGC AAG TAG CGA AAC TTG GCC GCA ACG Nkx2.2 PAC clones          
(ID: 1 and 2) 
Nkx2.2 3' NotF2 ATA AGC GGC CGC CAC CGA GGG CCT CCA ATA CTC CCG   -ditto- 
Nkx2.2 3' NotF3 ATA AGC GGC CGC ACA CTC GCT GGC TGG CCA GCA CC -ditto- 
Nkx2.25'AscF1 TTG GCG CGC CCG GAG CCG GAG CTG ACG GCA CC -ditto- 
Nkx2.25'NcoR1 GCG CCC CAT GGT TCC GGA CCC CGC AAT TTA TGC C Nkx2.2 PAC clones          
(ID: 1 and 2) 
Nkx2.45’PacF1 GGG TTA ATT AAG CCC TAC AAT GGC AGA GGA CGG Nkx2.2 PAC clones          
(ID: 1) 
Nkx2.45’MluR1 TCA CGC GTT AGT CCA GTG CCA GGT TTA CGA C -ditto- 
Nkx2.43’HindF1 TCA AGC TTG CCT GCG ACT CGC AGG ATC CGC C -ditto- 
Nkx2.43’AscR1 TTG GCG CGC CAT GAG CTG CAT CTT GGG TTG GGG -ditto- 
 
 
2.6. PAC techniques 
2.6.1. Screening a mouse PAC library 
Mouse PAC (RPCI21) library (from UK HGMP Resource Centre) was stored at 4°C and no 
special treatment of  the filters was performed prior to screening by the Southern blot 
analysis protocol (section 2.3.2) with the following changes: pre-hybridization was carried 
out for at least 2 hours at 65°C in a rotating  hybridization oven; followed by hybridization 
0/N. After Hybridazation; filters were washed in two solutions of increasing stringency: 1) 
2X SSC, 0.1% SDS, at room temperature, with a slow constant rotation, for 10 min, once; 2) 
0.1X SSC, 0.1% SDS, for 15 min, with a slow constant rotation at 65°C; this process being 
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repeated, with a slow constant rotation, at room temperature, until no more radioactivity 
was being removed from the membrane. 
 
2.6.2. PAC DNA isolation 
Each PAC clone was streaked onto BHI-agar-Kanamycin plates (kanamycin was added to 
molten brain heart infusion (BHI)-agar [per litre: 37g/l BHI (from Sigma), 15g/l bacto-agar 
(from Difco), in deionised water; heat sterilized; stored at room temperature] at a final 
concentration of 12.5µg/ml (10mg/ml stock; from Sigma) in such a way as to obtain single 
colonies. A single colour was re streaked and incubated,  colonies were then incubated at 
32°C incubator 0/N.  
 
2.6.2.1. Small scale PAC DNA isolation (mini-prep) 
This was performed as described in section 2.2.3. with the following changes: 5Oml of BHI 
containing an appropriate amount of kanamycin (12.5µg/ml) was inoculated with a single 
colony and was incubated at 32°C incubator 0/N. Whenever needed the PAC DNA was 
sampled using wide bore pipette tips.  
 
2.6.2.2. Large scale PAC DNA isolation (maxi-prep) 
This was performed according to Low copy PAC purification protocol of the NucleoBond® 
Nucleic Acid Purification kit (from Clontech). The kit uses NucleoBond® AX resin columns — 
anion exchange columns, that allow the purification of PACs as well as other nucleic acid 
species. In brief: the protocol started with a 500ml stationary overnight bacterial culture 
grown in LB broth containing the appropriate amount of kanamycin (12.5µg/ml) at 32°C. 
After centrifuging cells, the pellet was lysed and then centrifuged briefly to clear the 
lysate. The resulting lysate was filtered and allowed to enter the resin of NucleoBond® AX 
resin columns by gravity flow. The column was washed and the PAC DNA was eluted and 
then precipitated with isopropanol. For technical reasons, the next step of centrifugation 
was carried out at 10,000xg for 45min at 4°C (AvantiTM J-20 I centrifuge from Beckman 
Coulter). The pellet was washed with 70% ice-cold ethanol and then centrifuged at 10,000xg 
for 10min at 4°C. The pellet was ressuspended in 15Oµl of milliQ water and stored at 4°C. 
Whenever needed the PAC DNA was sampled using wide bore pipette tips. 
 
Raquel Taveira-Marques Tracing NSCs in the ventral NT Materials and Methods 
 
 70/200 
2.6.3. PAC analysis by pulse field gel electrophoresis 
Pulsed-field gel electrophoresis (PFGE), was performed in a contour-clamped homogeneous 
electric field apparatus (Bio-Rad). PFGE was carried out in 0.5X TBE buffer pH 8.0 (per litre: 
108g Tris base, 55g boric acid, 40ml 0.5M EDTA, in distilled water, at pH 8.0) at 4°C, with 
fluid recirculation. PAC DNA, to which was added loading buffer, was run in 1% agarose gel 
in 0.5X TBE at 5.8V/cm, initial switch 2.1 sec, final switch 1O sec, for 12.5hr. The gel was 
then stained in ethidium bromide diluted in water for 30min. DNA was visualised by UV light 
and its size estimated by comparing to the Pulse markerTM from Sigma.  
 
2.6.4. Homologous recombination in bacteria 
Homologous recombination was performed according to Yang et al. 1997. Electrocompetent 
EL250 bacteria cells [modified DH1OB strain (Gibco) containing defective lambda prophage 
Yu et al. 2000 and arabinose-inducible flpe gene Lee et al. 2001] were transformed with 
PAC DNA by electroporation. This was carried out as described in section 2.4.3, with the 
following changes: 2µl of PAC DNA was used to transform the electrocompetent bacterial 
cells, instead of 2µl of ligation reaction. Transformation was carried out at 1.8kV, instead at 
2.5kV, and 0.1cm electroporation cuvettes were used instead of 0.2cm cuvettes. 
Transformed bacterial cells were allowed to recover in warm LB broth at 32°C for 2hr, then 
plated on LB-agar plates supplemented with suitable antibiotic (kanamycin; 12.5µl/ml) and 
incubated at 32°C, 0/N. 5ml of LB broth containing the appropriate amount of kanamycin 
(12.5µl/ml) was inoculated with a single transformed bacterial colony and was incubated in 
a 32°C shaking incubator O/N. 4ml of the O/N culture was inoculated into 50ml of fresh LB 
broth (without kanamycin) in a 500ml flask and was incubated at 32°C with shaking until 
OD600=0.5-0.8. Induction was performed by transferring 1Oml of the growing culture into 
125ml flask and placing the flask in a water-bath at 42°C. The flask was shaken by hand for 
15min, then immediately placed into ice slurry and shaken by hand to cool down the cells 
quickly, during 5min. A non-induced culture was kept at 32°C and it was also placed into the 
ice slurry and used as a negative control for the recombination - in between this step and 
the transformation step of the process should take no longer than 40min and the culture 
once induced should never rise above 0°C. 1OmI of culture (induced and non-induced 
culture) was transferred to a conical Falcon tube (one for each culture) and it was spun 
down for 8min at 1,1OOg at 4°C in a GS-6KR centrifuge from Beckman Coulter. The pellet 
was ressuspended in 1mI ice cold sterile water and it was then transferred into an 1.5ml 
microfuge tube. This was spun down using maximum speed (16,3 x103 g) for 20sec. The cell 
pellet was washed three times using 1ml ice cold sterile water. Between washes, the pellet 
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was spun down at high speed for 20 sec. After the final wash the cell pellet was 
ressuspended in 1OOµl of ice cold sterile water for use in electroporation. Electroporation 
was performed at 1.8KV. Immediately prior to electroporation, 100-300ng of donor DNA was 
mixed with 5Oµl of the competent cells (from induced and non-induced culture) and the 
mixture was pipetted into an electroporation cuvette (0.1cm). To the pulsed bacteria cells 
were added 500ml of LB at 32°C and these were incubated at 32°C for 1.5hr with shaking 
before plating on appropriate selective agar media (LB agar plates supplemented with 
20µl/ml of ampicilin) and nonselective agar media (LB agar plates supplemented with 
12.5µl/ml of kanamycin). Incubation was carried out in a 32°C incubator 0/N.  
 
2.6.5. Screening for recombinant PACs 
Culture obtained following homologous recombination event was, whenever required, 
titrated prior to screening to obtain an appropriate titre so as to obtain individual isolated 
colonies.  
Two rounds of screens were carried out to isolate single recombinant PAC clones. For this, 
screening was performed by plating onto 15cm round bacterial plates, containing 
appropriate selective media (LB agar plates supplemented with 15µl/mI of chloramphenicol) 
and the recombinant PAC culture. Incubation was carried out in a 32°C incubator 2 x 0/N. 
Colonies were transferred from agar plates onto HybondTM-XL filters as follow: the plates 
were cooled at 4°C for 30 mins to ensure that the top agarose sticks to the bottom agar; the 
HybondTMXL round filters was then placed on the top agarose for 1min; using a sterile 
needle, holes were made on the filters thought to the agar to mark the position of the 
membrane on the plate; the filter was lifted carefully using forceps and was placed on a 
piece of 3MM paper saturated with 10% SDS solution for 3min, with the colonies side up; this 
was followed by a treatment in denaturing solution (0.4N NaOH, 1.5M NaCI) for 2min and 
two rounds of neutralising solution (1.5M NaCI, 1M Tris-HCI, pH7.5) for 3min; the filter was 
transferred briefly on a piece of 3MM paper to remove excess denaturing solution between 
steps. Finally, the filters were washed vigorously in 2xSSC for few minutes at room 
temperature. The DNA was fixed to the membrane by uncrosslinking.  
To search for positive clones, filters were placed in between nylon mesh membranes, to 
ensure an even distribution of the probes on the filters, and washed in 2xSSC for 45 min at 
65°C. This was followed by a pre-hybridisation step (pre-hybridisation solution as described 
in 2.3.2) for again 45min at 65°C. Hybridisation, washing of filters and autoradiography was 
carried out as described in section 2.3.2 of this chapter. Finally positive clones were then 
picked from each screen and were either subjected to another round of screen or were 
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grown to prepare PAC DNA. PAC DNA could then be further analysed by carrying out 
Southern analysis to determine if recombination had occurred in the desired way. 
 
2.6.6. Arabinose inducible “FLIPE” 
The chloramphenicol resistance cassette, flanked by FRT sites, was removed with an 
arabinose inducible flpe gene present in EL250 bacteria. For this 300µl of EL250 bacteria 
cells containing the recombinant PAC was used to inoculate 15ml of fresh LB and grown at 
32°C to O.D.6oo=O.5-0.8 with shaking. Sterile L-arabinose (1% stock) was added to a final 
concentration of 0.2% (w/v) and grown at 32°C for 1 hour. 1mI of this culture was then 
taken to inoculate 1OmI of fresh LB and incubated for 2 hours at 32°C with shaking before 
plating on appropriate selective agar media (LB agar plates supplemented with 2Oµl/ml of 
ampicilin; 1ul, 10µl and 80µl) and nonselective agar media (LB agar plates supplemented 
with 15µl/ml of chloramphenicol; 10µl) using a 1 in 100 dilution. Incubation was carried out 
in a 32°C incubator 0/N. Checking for proper recombination was done by Southern blotting 
using part of the targeting construct as a probe and recombinant PAC DNA prior to 
recombination as a negative control. Removal of the chloramphenicol resistance cassette 
should result in a decrease of about 1.3 kb in fragment size. 
 
2.6.7. Preparing Linear PAC DNA for microinjection 
PAC DNA was extracted from an 0/N culture as described above followed by restriction 
digest with Mlu I enzyme for not less than 4 hours.  Digests were run on PFGE as described 
above, however in this case, 90% of the digested PAC DNA was run in a central wide lane on 
the gel, while two small ‘marker’ lanes on each side of the wide lane were loaded with 5% 
of the digest each.  After the gel was run, the ‘marker’ lanes were cut off and stained in 
dH2O containing 0.5g/ml ethidium bromide for 10min with gentle agitation. A photo was 
taken to the gel with a ruler in order to localise the position of the PAC DNA band and PAC 
Vector band (used as a control) in the unstained gel using the ruler, and excise these bands. 
PAC DNA band was put in the middle on a mini gel tray with PAC vector on the left side. Set 
an asymmetric order to identify the PAC band position in the gel easily. A 4 % L.M.P. agarose 
was poured around the bands in the minitray.  The gel was run at 50 volts for approximately 
9hr in the cold room (at 50 volts the gel runs 1cm in 3 hours). After the gel has run, the PAC 
vector lane was cut off and stained in dH2O containing 0.5µg/ml ethidium bromide for 10min 
with gentle agitation. A photo was taken using a ruler and was checked if the entire DNA 
had run out of the 1% gel. The position of the PAC DNA was localised in the 4% LMP agarose 
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gel using the ruler and 0.5- 0.8 cm block was excised. The block was equilibrated on a 
rotator (in a 15ml Falcon) in 12.5ml of TENPA buffer (1M Tris-HCI pH7.5, 0.5M EDTA pH8, 5M 
NaCl) with 3OµM Spermine and 7OµM Spermidine for at least 1.5 hours. Gel slice was dried 
with a clean tissue by just touching the liquid, transferred to a 1.5 ml microfuge tube, melt 
for 3min at 68oC, centrifuged the tube for 10sec to bring down the molten agarose and 
incubated it for additional 5min at 68oC. The microfuge tube was quickly transferred to a 
42°C water bath and left for 5min. Working in the 42°C bath, 2 units of β-Agarase (NEB, 
stock 1 unit per µl) was added per 1OO µl of molten gel slice. Volume of agarose was 
checked against Microfuge standards. The β-Agarase was mixed using the p20 pipette and 
wide bore tips (scooshed ~4 times slowly). Incubation was carried out at 42°C for 3 hr. In a 
small Petri dish 3 dialysis membranes (Millipore, pore size 0.025µm) were placed floating on 
microinjection buffer (1M Tris-HCI pH7.5, 0.5M EDTA pH8, 5M NaCI) containing fresh 3OµM 
spermine and 10µM spermidine. 50µI of the PAC DNA solution was put on each dialysis 
membrane and left at room temperature for 1hr. The PAC DNA solution was recovered 
carefully from the top of the dialysis membrane and stored at 4°C. DNA concentration and 
integrity was checked by running 1µl, 3µl, and 5µl of the dialysed, purified, PAC DNA on a 
Pulse Field Gel for 12hrs (as above) against a known PAC DNA standard. The appropriate 
dilution was then prepared in micro-injection buffer containing 3OµM spermine and 10µM 
spermidine for injection. 
 
 
2.7. Genomic DNA isolation 
 
2.7.1. Extraction of genomic DNA from mouse tissue (salt/chloroform 
extraction procedure) 
Genomic DNA was extracted from mouse tissues using a modified version of the 
salt/chloroform protocol described by Mullenbach et al. 1989. Mouse tissues were isolated 
and snap frozen in liquid nitrogen where they were stored until required (for DNA 
extraction). In the case of extraction of genomic DNA from already frozen tissue, care was 
taken not to thaw samples when taken from liquid nitrogen tank. Samples were then placed 
in liquid nitrogen until required at the bench. The frozen tissue was homogenized in liquid 
nitrogen using a pestle and mortar and was transferred to a 50 ml Falcon tube by scraping 
the frozen tissue from the mortar with a spatula. The pestle and mortar were previously 
Raquel Taveira-Marques Tracing NSCs in the ventral NT Materials and Methods 
 
 74/200 
cleaned with H20 and then with 70% Ethanol and cooled in liquid nitrogen before being used. 
The frozen tissue was mixed with 3 - 7.5 ml of proteinase K extraction buffer (10mM TrisHcl 
pH 8, 0.1M EDTA pH 8, 0.5% SDS) with proteinase K added at a final concentration of 
0.3mg/mI. The mixture was vortexed and incubated at 55 - 56°C 0/N. The amount of 
extraction buffer used was dependent on the size of the tissue. Typically, for one adult 
mouse kidney, 3 ml of extraction buffer was used.  4 ml of pre-warmed [extraction buffer: 
5M NaCI] (at a ratio of 3:1) was added for each 1ml of proteinase K - treated sample and 
mixed (vortexed). This was followed by one phenol/chloroform extraction and then by one 
chloroform extraction. For that an equal volume of phenol/chloroform was added, vortexed 
and centrifuged at 3,000rpm for 10min. The top aqueous phase was transferred to a clean 
50ml Falcon and an equal volume of chloroform was added, vortexed and centrifuged at 
3,000rpm for 10 min. The top aqueous layer was transferred to a clean 50 ml Falcon tube 
and the genomic DNA was precipitated with an equal volume of isopropanol. The tube was 
inverted up and down 8 times. This was kept on ice for 10 minutes. Sometimes, the DNA was 
visible, in which case it was taken out using a clean pipette tip and transferred to a 
microfuge tube containing 70% ethanol. In cases where the DNA was not visible by eye, the 
mixture was centrifuged at 3,700rpm for 10 minutes in a cold rotor. The pellet was washed 
in 70% ethanol on a rotator at room temperature 0/N. Samples were then centrifuged at 
3,700rpm for 5 min. This was just enough to bring down the DNA without compacting it at 
the bottom of the tube, which would make it more difficult to resuspend. The supernatant 
was poured off and tubes were allowed to dry (up side down) in fumehood for 10min. The 
genomic DNA was resuspended in a suitable volume of TE (500µl - 1ml) and incubated at 
55°C for 30 - 60 min to dissolve it better. Samples were stored at 4°C. 
 
2.7.2. Extraction of genomic DNA from mouse tails or ear clips 
Mouse progenies were genotyped by PCR and Southern blot analysis using DNA extracted 
from tail samples. Tails were taken from 10-30 day old mice which were toe clipped as a 
means of identification. Up to 0.5 cm was taken from the tip of the tail and was lysed in 
500µI of proteinase K lysis buffer (100mM Tris-HCI pH8.5, 5mM EDTA pH8.0, 0.2% SDS, 
200mM NaCI) containing proteinase K at a final concentration of 0.48 mg/mI. This was 
incubated at 55°C 0/N.  
To reduce the coprecipitation of unwanted contaminants (e.g., oligosaccharides) with 
genomic DNA, 200ul of 6M ammonium acetate was added to the samples, vortexed and left 
on ice for 15min.  Tail debris were separated by centrifugation at 13,200rpm for 20min and 
the supernatant was transferred to a clean microfuge tube.  
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The DNA was precipitated by adding equal volume of isopropanol and then centrifuged at 
13,200rpm for 3min at room temperature.  The DNA pellet was washed with 70% ethanol, air 
dried and resuspended in 100 µl /50µl of TE or milliQ water. 
Through the years, tail biopsy and toe clip were replaced by ear clip as a mean of tissue 
biopsy and identification.  In this case, only 250µl of proteinase K lysis buffer containing 
proteinase K at a final concentration of 0.48 mg/mI was used and quantities used in the 
above protocol were adjusted accordingly.  Genomic DNA was resuspended in 50µl of milliQ 
water. 
 
 
2.8. Transgenic mice procedures 
2.8.1. Inducing superovulation 
Superovulated females were used for the production of fertilized eggs since the number of 
female mice maintained for the isolation of eggs is minimized by the use of superovulation.  
Six 3-4-week-old (B6 x CBA)F1 female mice were injected with 5 i.u. follicle-stimulating 
hormone (Folligon, Intervet) between 4 and 5pm (assuming a light period of 6 p.m. to 7 
a.m., twilight for the first and last hours) and with 5 i.u. human chorionic gonadotropin, 
hCG (Chorulon, Intervet) 44-45 hours later. Both hormones were diluted in 0.9% sodium 
chloride (NaCl Injection B.P., Antigen Pharmaceuticals).  After the administration of hCG, 
females were mated with (B6 x CBA)F1 fertile males.  Typically, 4-6 female mated yielding a 
total of 100-200 fertilized eggs.  Mice were purchased from the commercial breeding farm 
Charles River Laboratories (UK). 
 
2.8.2. Pronuclei injection 
The gene transfer method used was the microinjection of DNA directly into the pronuclei of 
fertilized mouse eggs.  The microinjection service was carried out by U. Dennehy and P. 
Iannarelli (Richardson’s laboratory, WIBR).  
Briefly, linear ~1ng of linear PAC DNA in suspension in microinjection buffer (see section 
2.6.7) was injected into the fertilised mouse ova. On average, 18-22 embryos (two-cell 
stage) were reimplanted into the oviducts of a pseudopregnant foster mother. 
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Pseudopregnant mice were prepared by mating 6 weeks - 4 months old (B6 x CBA)F1 females 
in natural oestrus with vasectomised males the day before implantation. 
 
2.8.3. PCR Genotyping 
Genomic DNA was extracted from tissue biopsy and used as template DNA for PCR 
amplification as described above. Primers and PCR conditions for genotyping are listed in 
table 2.2. 
 
Table 2.2  -  List of primers used to genotype the transgenic lines created and also the 
program required in the PCR reaction.  
Reactions were carried out in 0.2ml PCR tubes, each reaction containing 10% of 10X PCR buffer 
(Promega), 6% of 25 mM magnesium chloride (Promega), 1% of DNA polymerisation mix 
(containing 20mM each of dATP, dCTP, dGTP and dTTP, Amersham Biosciences), 0.8% of forward 
and reverse primers at 100 µM/µl (from MWG or TAGN), template DNA (varying concentrations 
depending on the PCR reaction) and 1unit Taq DNA Polymerase (Promega or home-made). 
Reaction mix was filled up to 25µl with water.   
Transgenic Line Forward Primer     
(5’  3’) 
Reverse Primer      
(5’  3’) 
Program Product size 
Nkx2.2-CreERT2    
(heterozygous) 
Nkx2.2 CreER F2 
(ACG CCC ACC GCC 
TAC ATG)  
Nkx2.2 3' R1 (GGG 
CAT ACT AAG CAA 
ATG) 
94˚C for 4min 
 
Cycle (x38): 
94˚C for 30 sec 
57˚C for 45 sec 
72˚C for 28 sec 
 
72˚C for 30 sec 
400 bp 
Nkx2.2-CreERT2    
(homozygous) 
Cre 5’ (TCG ATG 
CAA CGA GTG ATG 
AG) 
Ra-KO-a (CCC TTG 
TGG TCA TGC CAA 
AC) 
Cre 3’ (TTC GGC 
TAT ACG TAA CAG 
GG) 
Ra-KO-b (GCT TTT 
GCC TCC ATT ACA 
CTG G) 
94˚C for 4min 
 
Cycle (x20): 
94˚C for 30 sec 
61˚C for 45 sec 
72˚C for 1 min 
 
72˚C for 10 min 
460 + 420 bp 
[**] 
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(cont.) 
Transgenic Line Forward Primer     
(5’  3’) 
Reverse Primer      
(5’  3’) 
Program Product size 
Nkx2.2-KO / 
Nkx2.2-CreERT2 
interbreeding [*] 
Gen mNkx2.2 F2 
(CCCCAGTCACAGC
CTACATT) 
Gen mNkx2.2 R2 
(AAAACCCCGTCTTT
GTGTTG) 
94˚C for 4min 
 
Cycle (x37): 
94˚C for 30 sec 
62˚C for 45 sec 
72˚C for 1 min 
 
72˚C for 10 min 
300 bp 
[*] – To detect Nkx2.2-KO heterozygous in an Nkx2.2-CreERT2 background, PCR conditions were 
re-designed to amplify part of the endogenous Nkx2.2 first exon which is omitted from the PAC 
DNA in the Nkx2.2-CreERT2 transgenic line.  [**] – 2 pairs of primers were used simultaneously; 
the efficiency of PCR amplification between those two set of primers were such that allowed to 
distinguish an heterozygous from an homozygous sample. 
 
2.8.4. Southern Blot Genotyping 
Southern blotting was carried out on genomic DNA extractions from putative founder mice 
to confirm the presence of the transgene. 20µl of genomic DNA was used in an appropriate 
restriction enzyme digest and the resulting fragments electrophoresed, blotted and analysed 
as described above. 
 
2.8.5. Mouse Breeding 
Mice were maintained on a ~12 hour light-dark cycle (6pm-7am, twilight for first and last 
hours).  Breeding pairs were caged together overnight from 6pm; noon the following day was 
designated embryonic day 0.5 (E0.5); otherwise breeding protocol is described in the 
respective section.   
In pilot trials, we found that ~90% of successful couplings took place between 9:30pm and 
1:30am (63% [19/30] of successful 4-hour-matings compare to 71% [12/17] of effective O/N 
matings).  Nonetheless, we also observed that 34% of couplings could happen between 
6:30pm and 10:30pm (24% [4/17] of successful 4 h mating compare to 71% [12/17] effective 
O/N mating) indicating that there is a considerable chance of conception before 9:30pm.  
For this reason, embryos harvested from an O/N mating were carefully staged (see below). 
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During the optimisation studies for CreERT2 activation by tamoxifen (TM) administration, 
homozygous reporter strains (please, see table 2.3) and Nkx2.2-CreERT2 mice were 
maintained separately and inter-crossed to yield double-heterozygous offspring.   
Subsequent work was performed on mice containing two copies of both Nkx2.2-CreERT2 and 
Rosa26-YFP as a mean to improve the efficiency of TM-induced transgene activation. 
Compound mouse lines were inter-crossed until mutant strains (knock-outs and knock-ins) 
were in a background of double-homozygous Nkx2.2-CreERT2 : Rosa26-YFP. 
The stages of embryos with different genotypes were matched by somite numbers (until 
E11) or using morphological features specific to developmental stages older than E11.5-old 
embryos (e.g. early sign of fingers at E12 or fingers separate distally at E14)Theiler 1972. 
 
Table 2.3  -  Summary of mouse strains used in this Thesis. 
The table includes a brief description of the transgenic/mutant lines used and its source. 
Name Allele type Brief description Reference 
Nkx2.2-CreERT2 Transgenic (PAC) Tamoxifen-inducible form of 
Cre recombinase under 
control of Nkx2.2 promoter 
Taveira-Marques et al. 
2010; Taveira-Marques 
2010 
Olig2-IRES-Cre Targeted knock-in Constitutive Cre recombinase 
targeted in Olig2 ~130bp 
downstream of the initiation 
codon 
IRES-Cre-lox-PGK-Neo-lox 
cassete provided by D.H. 
Rowitch; knock-in mice 
produced by N. Kessaris 
(unpublished) 
Ngn3-Cre Transgenic (BAC) nls-Cre-SV40pA sequences 
under control of Ngn3 
promoter 
Schonhoff et al. 2004 
Dbx1-iCre Transgenic (PAC) Codon-improved Cre 
recombinase under control of 
Dbx1 promoter 
Fogarty et al. 2005 
Nkx2.2 null Targeted knock-
out 
Targeted disruption of the 
entire ORF of Nkx2.2 
Briscoe et al. 1999 
Olig2 null Targeted knock-
out 
Targeted deletion of most of 
the Olig2 coding region 
Lu et al. 2002 
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(cont.) 
Name Allele type Brief description Reference 
Smoflox/flox Targeted 
conditional 
knock-out 
Smoothened conditional allele Long et al. 2001 
Rosa26-LacZ Targeted knock-in lacZ gene under the control of 
the ubiquitous Rosa26 
promoter 
Soriano 1999 
Rosa26-YFP Targeted knock-in YFP under the control of the 
ubiquitous Rosa26 promoter 
Srinivas et al. 2001 
Rosa26-GFP Targeted knock-in EGFP under the control of the 
ubiquitous Rosa26 promoter 
Mao et al. 2001 
Z/EG Transgenic EGFP under the control of the 
pCAGGS promoter 
Novak et al. 2000 
 
All mice used in this thesis were maintained on a C57BL/6/CBA background.  Mouse colonies 
were maintained at the animal facilities of the Wolfson Institute for Biomedical Research, 
University College London.  All animal work was carried out in accordance with United 
Kingdom legislation. 
 
 
2.9. Staining Protocols 
2.9.1. In situ hybridisation analysis 
2.9.1.1. Tissue fixation and preparation 
Tissue required for in situ hybridisation analysis was initially fixed overnight in 4% 
paraformaldehyde (4% PFA, in phosphate buffered saline [PBS] diethylpyrocarbonate-
treated, [DEPC-treated]) or, sometimes, for smaller time periods (over fixation is known to 
reduce probe penetration into the tissue). In the case of postnatal tissue, animals were 
terminally anaesthetised with pentobarbitone (Pentoject) i.p.  Once unconscious, animals 
were perfused with PBS via the left ventricle of the heart at a slow and steady pace until 
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most of the blood was flushed out.  This was immediately followed with 4% PFA to fix the 
tissue.  Following perfusion fixation, the tissue of interest was dissected out and then left in 
4% PFA overnight or less.  Once fixed the tissue was cryoprotected by overnight treatment 
with a 20% w/v sucrose solution in PBS.  This 20% sucrose was made RNase free by DEPC 
treatment (diethyl pyrocarbonate, added to solution at 1/1000th volume and left for at 
least one hour, then autoclaved).  After sucrose treatment, tissues were embedded in OCT™ 
compound (RA Lamb), frozen in isopentane on dry ice and stored at -80°C. 
Embryonic tissue was treated in exactly the same way except that perfusion step was 
omitted.  Embryonic tissue was simply removed from the pregnant mother euthanised by a 
schedule 1 method, and placed in 4% PFA.  All other steps were as those for postnatal 
animals. 
Whole-mount in situ hybridization was performed on E11.5 brainstems from which the 
meninges were removed.  Dissected brainstems were fixed in 4% paraformaldehyde, 0.1% 
Tween in PBS-DEPC-treated for 2 h at room temperature, washed, progressively dehydrated 
in increasing concentrations of alcohol, and then rehydrated before treatment with 
proteinase K at 10ug/ml in 0.1% Tween : PBS-DEPC-treated for 11minutes at room 
temperature.  After rinsing briefly with 0.1% Tween : PBS-DEPC-treated, brainstem were 
further fixed in 4% paraformaldehyde and washed before hybridisation. 
 
2.9.1.2. Generating mRNA probes for in situ hybridisation 
To prepare probes for in situ hybridisation, a plasmid template was required. cDNA 
templates were obtained from collaborators, the IMAGE consortium, or by PCR amplifying 
genes of interest cloned into the TOPO® vector.  The template was linearised at an 
appropriate point using restriction enzyme digestion.  10ug of template was digested with 
100 units of linearising restriction enzyme in a total volume of 100µl.  Unless the linearizing 
restriction enzyme had star activity, digestions were done O/N.  The resulting linear 
fragment was purified using phenol-chloroform extraction and ethanol precipitation or, 
alternatively, reaction was purified using the kit illustra GFX PCR DNA and Gel Band 
Purification kit(GE Healthcare).  Working solutions were made with DEPC-treated water 
(three times autoclaved to remove any traces of DEPC) to ensure that the template 
remained RNase free.  RNA transcription reaction was carried out using 20 units of RNA 
polymerase (T3 or T7, depending on which gave the desired strand synthesis), 800 ng – 1 µg 
template, 5µl of 5x transcription buffer (Promega), 7.5 µl dithiothreitol (DTT, 100 mM), 
2.5µl RNA labelling mixture (DIG labelling, Roche), 1 µl RNasin (RNase inhibitor, Promega), 
DEPC-treated water added up to a total volume of 25 µl.  This mixture was incubated at 
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37°C for 2.5 hours.  The success of the transcription was checked by running 1µl of the 
reaction mixture on a fresh made 1% agarose gel to ensure the presence of a transcript at 
the correct size, quality of probe and to quantify by comparing it to a control (e.g. a tested 
probe of same size).  Finally, the reaction mixture was diluted with 75µl DEPC-treated 
water, aliquoted in 2µl aliquots and stored at -80°C. 
 
Table 2.4  -  List of mRNA probes used for in situ hybridisation.  
Probe Source Amplified fragment Linearise with Transcribe with 
CreERT2 Bill Richardson 
(UK) 
Full cDNA sequence Not I T7 
Hoxb1/Hox2.9 Robb Krumlauf 
(USA) 
NM_008266.4 
(1318bp - 353bp) 
Cla I T7 
Krox20/Egr2 Pascale Gilardi-
Hebenstreit 
(France) 
NM_010118.2  
(1135bp - 1897bp) 
BamH I T3 
Nkx2.2 John Rubenstein 
(USA) 
Full cDNA sequence Not I T7 
Sim1 Katsuhiko Ono 
(Japan) 
NM_011376 
(1480bp – 2108bp) 
Xba I  T7 
 
 
2.9.1.3. Single in situ hybridisation using NBT/BCIP chromogenic detection 
Tissue blocks were sectioned in a Bright OTF5000 cryostat.  Coronal sections were typically 
cut to a width of 15µm.  Sections were collected on SuperFrost® Plus slides (VWR 
International) and dried for at least one hour before used.  Probe aliquots were defrosted, 
and the probe, usually diluted 1/1000, was added to hybridisation buffer containing 50% 
deionized formamide, 10% dextran sulphate (Fluka) , 0.1mg/ml yeast tRNA, 1x Denhardt’s 
solution (Sigma), and 1x salt solution (10x salt stock, 2M NaCl, 50mM EDTA, 100mM Tris-HCl 
pH 7.5, 50mM NaH2PO4.2H2O, 50mM Na2HPO4, DEPC treated).  The diluted probe was 
denatured at 70°C for 5 minutes and then vortexed and pulse centrifuged and immediately 
applied to the slides.  The slides were placed in a hybridisation box, the base of which 
contained 2 sheets of 3MM paper (Whatman) wetted with hybridisation buffer.  After 
application of the probe, each slide was covered with a coverslip (previously baked at 200°C 
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O/N) and the hybridisation box was sealed closed with tape.  Hybridisation was carried out 
at 65°C overnight.  After hybridisation, slides were placed in wash solution (50% formamide, 
1x SSC, 0.1% Tween-20) in a coplin jar for 5 minutes at 66°C to remove the coverslips.  The 
slides were then washed a further two times for 30 minutes each at 65°C.  The slides were 
next washed in room temperature 1x MABT (5x stock, 0.5M maleic acid, 0.75M NaCl, 1M 
NaOH [pH7.5], 0.5% Tween 20) twice for 30 minutes each.  The sections were then blocked 
in blocking solution (8g blocking reagent, Roche cat no 1-096-176, 100ml 5x MABT, 200ml 
distilled water, heated to 65°C to dissolve then 80ml heat treated sheep serum added and 
finally made up to 400ml with distilled water) for at least one hour at room temperature.  
Next, an anti-Digoxigenin alkaline phosphatase conjugated (Roche) antibody was diluted 
1/1500 in blocking solution and applied to the sections in a humidifier chamber overnight at 
4°C.  The sections were then washed 5 times for 20 minutes in 1x MABT, followed by 2 ten 
minute washes in staining buffer (0.1M NaCl, 0.05M MgCl2, 0.1M Tris pH 9.5, 0.1% Tween-
20).  The colour reaction was developed by placing the slides in a solution containing 20ml 
staining buffer, 1ml 1M MgCl2, 87µl NBT (1g 4-nitro blue tetrazolium chloride crystals, plus 
7ml dimethyl formamide and 3ml distilled water), 67µl BCIP (BCIP from Roche, 1g plus 20ml 
dimethyl formamide), and 20ml of a 10% polyvinyl alcohol solution (10% w/v polyvinyl 
alcohol in distilled water with 0.1M NaCl, 0.1M Tris pH 9.5 and 0.1% Tween-20). Reactions 
were incubated in the dark at 37°C and periodically checked for development of a blue 
precipitate on the sections. In cases of less abundant transcripts, reactions were allowed to 
proceed overnight.  Once reactions had proceeded to a suitable point, they were quenched 
with excess PBS. After this, the sections were dehydrated through alcohols before being 
treated with xylene and mounted in DPX mountant (Fluka) under a coverslip. 
 
2.9.1.4. Double fluorescent in situ hybridisation 
Double in situ hybridization on cryostat sections was done with DIG- and fluorescein-labeled 
mRNA probes.  The probes were detected with alkaline phosphatase (AP)- or horseradish 
peroxidase (POD)-conjugated anti-DIG (1:1000) or anti–FITC (1:1000) Fab Fragments (Roche), 
accordingly.  For double-labelling, AP was detected using Fast Red (Roche; one tablet 
dissolved in 2 ml of 0.1M Tris pH8. 0.4M NaCl) and POD was detected with fluorescein 
amplification reagent, as recommended by the manufacturer (Perkin Elmer; 10-min 
incubation in fluorophore tyramide working solution).  After developing the in situ colour 
reagents sections were counterstained with Hoechst 33258 dye (Sigma, 1/1000 dilution, 5 
minutes at RT), washed and coverslipped with mounting medium (Dako Cytomation Ltd).   
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2.9.1.5. Whole-Mount in situ hybridization (Chromogenic detection) 
Brainstems were overnight hybridized with 100-200 ng/ml digoxigenin (DIG)-labelled RNA 
probe in Hyb-mix [50% formamide : 5x SSC pH4.5 : 2% SDS : 2% BBR (Roche)] at 70°C with 
rocking.  Followed by washes with Solution X (50% formamide : 2x SSC pH4.5 : 1% SDS) and 
1x MABT, digoxigenin detection with alkaline phosphatase-conjugated antibody (Roche 
1:2000 diluted in 20% serum/2% BBR/ 1x MABT) was followed by further washes with 1x 
MABT and NBT/BCIP staining (Roche) to reveal signal.  Finally, brainstems were post-fixed in 
4% PFA for 20minutes at RT, incubated overnight at 4 °C in PBS/80% glycerol and flat 
mounted in same medium.  
 
2.9.2. Immunohistochemistry 
2.9.2.1. Tissue fixation and preparation 
Embryos were fixed in 4% (w/v) paraformaldehyde (PFA) in phosphate-buffered saline (PBS) 
at 4°C.  Postnatal animals were perfused with 4% (w/v) PFA through the right ventricle of 
the heart under terminal anaesthesia as above.  Spinal cords and brains were dissected out 
and were immersed in 4% PFA in PBS at 4°C.  Generally, fixation times for 
immunohistochemistry were varied according to the age of the embryo and the epitope in 
question.  Tissue was cryo-protected overnight at 4°C in DEPC-treated 20% sucrose (w/v) in 
PBS, embedded, frozen in isopentane on dry ice and stored at –80°C as described above.   
Coronal cryo-sections (10 to 20 µm) were cut on a cryostat, collected on slide and let to dry 
before proceeding with protocol (designated as “dry sections” in table 2.5).  Alternatively, 
PBS was applied to sections immediately after collecting a ribbon of 3-4 consecutive 
sections onto a slide, in this way avoiding sections to dry (named as “wet sections” in table 
2.5). 
For post-natal (~P10 and above) and adult tissue, 30 µm coronal sections were picked up 
with a damp paint brush and floated in PBS, and treated as floating sections throughout the 
protocol (referred to “floating sections” in table 2.5).  After immunohistochemistry, floating 
sections were transferred onto glass slides and air dried before mounting. 
For immunolabelling on whole brainstems, brainstems were dissected in cold PBS and fixed 
for 2 h at 4 °C in 4% PFA with rocking.  For some antibodies used, the tissue was less 
severely fixed in order to preserve the epitope structure of the antigen of interest.  For cell 
permeabilisation, tissues were dehydrated at room temperature in PBS-EtOH solutions 
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progressively more concentrated in ethanol (e.g. 25%, 50%, 100% [2 times]) for 10min each 
solution, with rocking.  Samples were stored in 100% ethanol at -20 °C for at least several 
months.  Brainstems were rehydrated before incubation with primary antibody.  
 
2.9.2.2. Detection of antigen on tissue sections 
For immunohistochemistry, sections were pre-treated with blocking solution (10% heat-
inactivated serum (v/v), 0.1% Triton X-100 (v/v BDH) in PBS), and then incubated 
sequentially in primary antibody and secondary, all in blocking solution, for overnight at 4°C 
and for 1-2 h at 20–25 °C, respectively.  The primary antibodies used are listed in table 2.5.   
Secondary antibodies used were Alexa Fluor 488–, 568– or 647–conjugated (Invitrogen, 
1:1,000), Cy3- or FITC-conjugated goat or donkey antibody to guinea pig IgG (Chemicon, 
1:500). 
Following antibody treatment, sections were stained with Hoechst (Sigma) and post-fixed 
for 5-20 minutes in 4% PFA.  Sections were mounted under coverslips in mounting medium 
(Dako Cytomation Ltd).  
After incubation with primary, secondary, Hoechst and 4% PFA, sections were washed 
thoroughly (at least 3 times 10 minutes) in PBS containing 0.1% Triton X-100 or PBS (just 
before mounting).   
 
2.9.2.3. Immunohistochemistry of Whole-Mount Mouse Embryos 
Brainstems were washed in PBS, followed by 1 hour incubation at RT in blocking buffer (10% 
heat-inactivated serum, 0.1% Triton X-100 in PBS) with rocking, twice.  The samples were 
then incubated 48 h at 4 °C in a primary antibody solution (primary antibody diluted in the 
blocking solution) with rocking.  Brainstems were subsequently washed for 8 h at 4 °C in 
PBS/0.1% Triton X-100 and incubated with the appropriate Alexa Fluor dye (1:1000; 
Invitrogen) for 48 h at 4 °C with rocking.  Following antibody incubation, samples were 
washed for 24 h at 4 °C in PBS, 0.1% Triton X-100 and counterstained with Hoechst 33342 
(1/1000; Sigma).  Finally, brainstems were incubated overnight at 4 °C in PBS/80% glycerol 
and flat mounted in same medium. 
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Table 2.5  -  List of primary antibodies used in this thesis. 
In this table is shown all the primary antibodies used for immunohistochemistry, from which 
species they were raised in, their working dilutions, sources and required protocol conditions. 
Abbreviations used: BCBC (Beta Cell Biology Consortium), DSHB (Developmental Studies 
Hybridoma Bank), M (Mouse), GP (Guinea-pig). 
Antibody name Raised 
in 
Working 
dilution 
Required protocol conditions Source 
5-HT 
(serotonin) 
Rabbit 1:5000 Any Sigma-Aldrich 
APC (CC-1) M IgG2b 1:200 Standard (i.e. o/n fixed tissue, 
o/n antibody incubation) 
Calbiochem 
ChAt Goat 1:100 Non-sucrosed, non-frozen, o/n 
fixed tissue 
Chemicon 
Cre M IgG1 1:1000 Light fixation (e.g. 1h fixation 
for a E11.5 body) 
Chemicon 
Gata3 M IgG1 1:30 Any Santa Cruz 
GFAP M IgG1 1:400 Any Sigma-Aldrich 
GFAP Rabbit 1:500 Any DakoCytomation 
GFP Rabbit 1:6000 Any AbCam 
GFP Chick 1:1000 Any Aveslab 
Human Olig2 Goat 1:500 Any R&D Systems 
Lim3 Rabbit 1:300 Any Gift from T. 
Jessell 
MNR2 M IgG1 1:5 Light Fixation (e.g. 20min for a 
E10.5 body) 
DSHB 
NeuN M IgG1 1:400 Any Chemicon 
Nkx2.2 Rabbit 1:5000 Any Gift from T. 
Jessell 
Nkx2.2 M IgG2b 1:10 Light Fixation (e.g. 20min for a 
E10.5 body) 
DSHB 
Nkx6.1 M IgG1 1:500 Light fixation (e.g. 45min for a 
E12.5 body) 
BCBC 
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(cont.) 
Antibody name Raised 
in 
Working 
dilution 
Required protocol conditions Source 
nNOS Rabbit 1:500 Any Zymed Lab. 
nNOS Sheep 1:2000 Any Gift from P. 
Emson 
Pax6 Rabbit 1:2000 Any Chemicon 
PDGFRα Rat 1:500 Light fixation (e.g. 45min for 
P10 spinal cord) 
BD Biosciences 
Phox2b Rabbit 1:2000 2h fixation at RT Gift from J.-F. 
Brunet 
Rat Isl1 
(39.4D5) 
M IgG2b 1:100 Light Fixation (e.g. 20min for a 
E10.5 body) 
DSHB 
RC2 M IgGM  1:5 Any DSHB 
S100β M IgG1 1:400 Any Sigma-Aldrich 
Sox10 GP 1:4000 Standard Gift from M. 
Wegner 
 
 
2.9.3. β–Galactosidase staining  
2.9.3.1. Tissue fixation and preparation 
Mouse embryos were dissected out, rinsed in 1 x PBS, and then fixed in X-Gal fixative (1 % 
formaldehyde, 0.2 % glutaraldehyde, 2 mM MgCl2, 5 mM EGTA in 1 x PBS) by various length 
of time.  For example, E11 embryos were fixed during 1 h, E12.5 and E13.5 for 2 to 3 h, and 
half P8 brain for around 3h.  Embryos more than 14.5 days old were cut into two or three 
pieces to equivalent size of E11-13.5 embryos and fixed accordingly.  After fixation, 
embryos were incubated in 20 % sucrose until they sunk and subsequently embedded in 
Tissue Tek O.C.T. compound (SAKURA).  
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2.9.3.2. Detection on cryostat tissue sections 
Frozen sections were cut 20-30µm thick on a Bright OTF 500 cryostat.  Sections from a 
negative control were processed simultaneously with the experimental ones to check for any 
endogenous β-Gal activity.  Sections were collected on SuperFrost Plus slides (VWR 
International) and dried for one hour at least.  If the sections were not going to be used 
immediately they were stored at -80°C.  The sections were covered with 400 µm of X-Gal 
fixative (1% (v/v) formaldehyde, 0.2% (v/v) Glutaraldehyde, 2mM MgCI2, 5mM EGTA, IX PBS) 
in a humidified chamber, and then incubated for 20’ at room temperature (X-Gal fixative 
stock solution could be used for a week if stored at 4°C and protected from light).  The 
slides were then washed three times for ten minutes each with wash buffer (0.1 M 
Phosphate buffer pH 7.3, 2 mM MgCl2, 0.1 % Sodium deoxycholate, 0.02 % NP4O).  After 
washes, slides were incubated in freshly prepared LacZ staining buffer inside coplin jars at 
30°C overnight and protected from light.  This incubation was sometimes longer than 
overnight if the staining was still weak, it never acquired background.  The LacZ staining 
buffer stock (1 ml of 50 mg/mI X-Gal [5-bromo-4-chloro-3-indolyl-B-D galactosidase, 
Molecular Probes (Invitrogen) 2007 dissolved in dimetylformamide], 82 mg K3Fc (CN6) 
(Sigma), 105 mg K4Fe (CN6) 3H20 (Sigma), diluted in ~ 49 ml wash buffer) was prepared by 
mixing all the components, without the need to filter.  After staining, the slides were 
washed thoroughly in 1 x PBS, post-fix in X-Gal fixative by 10 mm at room temperature, 
washed again with 1 x PBS three times by 5 minutes each, dehydrate through alcohols and 
xylene (30 % ETOH by 15”, 60 % ETOH by 15”, 80 % ETOH by 30”, 95 % ETON by 1’, 100 % 
ETOH by 1’, Xylene by 1’ [x2]), and then mounted in DPX mountant (Fluka). The β- Gal 
staining on sections started to diffuse after two or three months. 
 
2.9.4. Retrograde labelling from sympathetic ganglia 
Sympathetic MNs in Nkx2.2 CreERT2 : Rosa26 YFP mice were retrogradely labelled with 1,1 
dioctodecyl-3,3,3’,3’-tetramethylindocardocyanine (DiI, Invitrogen).  Eviscerated neonates 
were fixed by immersion overnight in 4% (w/v) PFA at 4°C.  A tiny crystal of DiI was placed 
inside a single sympathetic chain ganglion at thoracic level T3-T6 and the preparation was 
incubated in PBS containing 0.04% (w/v) sodium azide for 4 days at 37°C.  Floating 
vibratome sections (400 µm) were immuno-labelled for YFP (rabbit anti-GFP; AbCam, 
1:6,000) as described above, at 4°C without Triton X 100. 
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2.9.5. Electron microscopy 
For pre-embedding immuno-electron microscopy, newborn Nkx2.2 CreERT2 : Rosa26 YFP 
mice that had received tamoxifen at E12.5 and E13.5 were anesthetized and perfused 
transcardially with phosphate-buffered saline (PBS) followed by 4% (w/v) 
paraformaldehyde/ 0.1% (v/v) glutaraldehyde in 0.1 M PBS.  After dissection, spinal cords 
were immersed in 4% paraformaldehyde/ 0.1% glutaraldehyde in 0.1 M PBS overnight at 4°C.   
90 µm-thick vibratome sections of spinal cord at thoracic level T10-T13 were pre-incubated 
with 10% (v/v) sheep serum in PBS containing 0.02% (w/v) saponin for 2 hours at 20–25 °C, 
then incubated with shaking overnight at 4°C with rabbit anti-GFP IgG (1:6000, Abcam) 
followed by biotin-conjugated anti-rabbit IgG (1:200, Jackson Immuno Research Labs) 
overnight at 4°C with agitation.  Slices were then subjected to avidin/ biotin enhanced 
immuno-peroxidase (ABC Kit, Vector PK-6100) using 3,3’-diaminobenzidine (Sigma) and 
nickel ammonium sulphate (Alrich) as contrast agents.  Stained sections were post-treated 
with1% (w/v) osmium tetroxide in 0.1 M phosphate buffer pH7.3 at 4oC for 1 hour, 
dehydrated in a graded ethanol-water series, cleared in propylene oxide, infiltrated with 
Araldite resin and finally flat-embedded between Melinex sheets.  Semi-serial ultra thin 
sections of the whole vibro slice were cut at 70-80 nm using a diamond knife on a Reichert 
Ultracut E microtome.  Sections were collected on 300 mesh grids and stained with uranyl 
acetate and lead citrate.  Electron micrographs were taken in a Joel 1010 transmission 
electron microscope and recorded using a Gatan Orius CCD camera. 
 
 
2.10.Tamoxifen induction 
Cre-ERT2 activation was routinely induced by the oral administration of tamoxifen since it 
was found oral gavage was the most suitable technique of administration of tamoxifen (see 
Chapter 3).  Tamoxifen (TM, Sigma, T5648) was dissolved in pure corn oil at a max 
concentration of 40mg/ml using a sonicator (Decon model FS100B).  A step of sonication at 
30°C for 45min was usually enough to get tamoxifen into solution.  If more concentrated 
tamoxifen solution were needed (for example up to 100mg/ml), then tamoxifen (TM) was 
dissolved in a corn oil solution containing 10% (v/v) ethanol.  Very concentrated TM solutions 
were also sonicated at 30°C for 45min (sometimes for even less time).  A further step of 
sonication at 37°C for 10- 15 min was sometimes needed, in particular for the 100mg/ml TM 
solution, to get TM completely into solution.  At 100mg/ml the TM solution was not that so 
stable and it was used immediately.  Another reason for adding ethanol is that it is known to 
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improve induction levels.  Care was taken not to exceed 10µl of ethanol per dose due to the 
effects of ethanol on vertebrate embryogenesis (further discussed in Zhou et al. 2003; Sari 
et al. 2004; Yelin et al. 2005; Parnell et al. 2006; Yelin et al. 2007). 
The tamoxifen stock was administered at different concentration to the pregnant female on 
one or more occasions.  No more than 100µl of total volume (hence, 10µl of ethanol) was 
given to each female per dose (pregnant females were weighed prior to administration of 
TM and the concentration of the stock solution was adjusted to the desired dose 
accordingly).  Tamoxifen usually prevented normal parturition (please, see section 3.2.7) so, 
for postnatal analyses, litters were delivered surgically and fostered. 
 
2.11.Data analysis 
2.11.1. Microscopy 
Light microscopy images were captured digitally in a Zeiss Axioplan microscope with a 
Hamamatsu digital camera on a Dell computer by using the SimplePCI imaging software.   
Confocal images were acquired under one of three confocal systems: a TCS SPI confocal 
microscope (Leica Microsystems), a UltraView ERS microscope (Perkin Elmer), or a TCS SPE 
confocal microscope (Leica Microsystems). 
Confocal Z-stacks of stained sections were recorded at 0.5-1 µm increments whereas 
confocal Z-stacks of whole-mount at 3-6 µm increments.  
XZ and YZ views were reconstructed using Volocity software (Perkin Elmer) or Leica LAS AF 
Lite Software.  
Composite images were assembled using Adobe Photoshop CS 8.0 software and/or Microsoft 
ICE (Image Composite Editor).  
 
2.11.2. Quantification 
Protein colocalisation (multiple fluorochromes) was assessed in the confocal microscope.  At 
least three animals/embryos were used for each genotype/TM-induction.  A minimum of 
three 4 µm-thick Z-stack sections for each specific condition were immunolabeled to count 
triple or double-positive cells.   
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Counts were done manually and were expressed as average ± SEM. T-test was used for 
statistical analysis in this thesis (Microsoft Office Excel 2003).  
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Chapter 3  -   Generation and 
characterization of Nkx2.2-
CreER
T2
 transgenic mice  
 
3.1. Introduction to 
Nkx2.2  
The Nkx2.2 gene (Nk-2 transcription 
factor related, locus 2 [Drosophila] 
gene) was first isolated as a homeobox-
containing gene with a pattern of 
expression restricted to longitudinal 
columns of cells along the entire developing CNS axis (Price et al. 1992; Shimamura et al. 
1995).  Nkx2.2 is a member of the mouse Nkx-2 family whose homeobox domains are most 
homologous to that of the Drosophila Nk-2 gene.  Members of the Nk family share two 
regions of homology outside the homeobox domain (Harvey 1996): 1) a region of 10 amino 
acids (aa) located near the N terminus – the TN (tin) domain (Rudnick et al. 1994) and 2) 
17aa found downstream of the homeobox domain – the Nk2 specific domain (NK2-SD also 
called the NK2 domain) (Price et al. 1992).  The NK2-SD domain has an important role in 
transcription factor functions (Watada et al. 2000).  Interestingly, the Nkx2.2 homeobox 
domain contains two nuclear localization signals (NLS) which act cooperatively in mediating 
complete nuclear transport of Nkx2.2 (Hessabi et al. 2000).  The mouse Nkx2.2 gene has 

 Sidney Harris 
Sciencecartoonsplus.com 
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three transcript variants** and is encoded by two or three exons, depending on transcript, 
spanning a region of maximum 11.09 Kb on mouse chromosome 2.  Identification and 
characterization of an Nkx2.2 enhancer revealed a region sufficient to account for the 
normal ventral Nkx2.2 expression in the neuroepithelium.  This region is directly regulated 
by Wnt-Tcf repressor activity and positive Shh-Gli signalling and implicates graded Shh and 
Wnt signalling in defining the p3 domain (Lei et al. 2006; Vokes et al. 2007).   
Mice homozygous for Nkx2.2 mutation exhibit different phenotypes (see below for a detailed 
description). Because of functional redundancy between Nkx2.2 and its family gene Nkx2.9 , 
mice carrying only one Nkx2.2 allele are indistinguishable from wild-type animals (Sussel et 
al. 1998; Briscoe et al. 1999).  Accordingly, Nkx2.2+/- : Nkx2.9-/- compound-mutant mice, 
lacking the compensatory activity of Nkx2.9, have impaired normal locomotor behaviour and 
show moderate increase in motorneurons from the medial motor column, at the expenses of 
reduction, albeit not complete, of mature Sim1+ V3 interneurons (Holz et al. 2010).  
Nkx2.2 is expressed in the CNS but its pattern of expression changes dramatically throughout 
development.  At first, Nkx2.2 is detected in the most ventral region of the neural tube on 
either side of the central canal (Shimamura et al. 1995).  This region later becomes the p3-
domain (Briscoe et al. 2000), in which Nkx2.2 activity, together with Nkx2.9,play the 
defining role (Briscoe et al. 1999; Holz et al. 2010)††.  Apart from playing a role within the p3 
domain, Nkx2.2 has also been implicated in the formation of the floor plate (Lek et al. 
2010).  In the developing spinal cord, Nkx2.2-expressing p3 progenitors give rise to Sim1-
expressing V3 INs in the ventral cord, whereas in the hindbrain they give rise to visceral MNs 
(vMNs) followed by 5HT-expressing serotonergic neurons (Ericson et al. 1997b; Briscoe et al. 
1999; Pattyn et al. 2003a). Nkx2.2 initially perdures in V3 INs (Briscoe et al. 1999; Zhang et 
al. 2008), but is then rapidly down-regulated in migratory V3 INs as well as post-mitotic 
visceral MNs and serotonergic neurons (Pattyn et al. 2000; Cheng et al. 2003; Pattyn et al. 
2003a).  While V3 IN generation is dependent on the selective expression of Nkx2.2 (Briscoe 
et al. 1999; Briscoe et al. 2000), Nkx2.2 activity is sufficient, but not necessary (Briscoe et al. 
1999), to trigger vMN generation via activation of Phox2b (Pattyn et al. 2000; Pattyn et al. 
                                              
 
 
** More recently a fourth transcript variant has been identified 
(http://www.ensembl.org/Mus_musculus/Transcript/Summary?db=core;g=ENSMUSG00000027434
;r=2:147003284-147019979;t=ENSMUST00000067075; accessed on June 2011). This new variant, 
however, was not considered in Figure 3.7. 
†† Either gene alone is sufficient to restrict Olig2 expression to the pMN domain, but not when 
both genes are knocked out and/or down-regulated (see Figure 1.2 Panel B). 
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2003b). On the other hand, Nkx2.2 is necessary but not sufficient for production of 
serotonergic neurons (Briscoe et al. 1999; Pattyn et al. 2003a), since it acts cooperatively 
with different co-factors, depending on the level of the hindbrain being considered (Cheng 
et al. 2003; Craven et al. 2004).  Additionally, SLIT1, a gene expressed in ventral radial glia 
and white matter astrocyte precursors, was found to require Nkx2.2 activity for its 
expression (Hochstim et al. 2008; Genethliou et al. 2009).   
Nkx2.2 is expressed in cells of the oligodendrocyte lineage too.  The levels of expression of 
Nkx2.2 vary in oligodendrocyte lineage cells during development and in adulthood and its 
intensity controls their proper developmental – too much or too little of Nkx2.2 can affect 
OL differentiation (Kitada et al. 2006; Liu et al. 2007).  Embryonically, dorsal expansion of 
Nkx2.2 into the Olig2+ pMN domain is associated with the initiation of gliogenesis (Zhou et al. 
2001) as the interaction between Olig2 and Nkx2.2 proteins inhibits V3 IN development and 
promotes an OL fate (Sun et al. 2001a); nevertheless, transfection of Nkx2.2 alone has been 
shown to be insufficient to impose an OL character (Zhou et al. 2001).  Accordingly, Nkx2.2 
was found to form a physical complex with Olig2 in mammalian cells and yeast two-hybrid 
assay (Sun et al. 2003).  Nkx2.2 can also couple with other bHLH proteins, other than Olig2, 
to drive OL production.  It has been suggested that Mash1 can cooperate with Nkx2.2 to 
specify OLPs and direct differentiation to mature OLs (Sugimori et al. 2007; Sugimori et al. 
2008).  Immature pre-myelinating OLs still express Nkx2.2.  For this reason mutation of 
Nkx2.2 causes a delay and a dramatic decrease in the number of PLP+ pre-myelinating OLs 
and, subsquently, MBP+ mature myelinating OLs (Qi et al. 2001).  Besides activating PLP 
expression (Fu et al. 2002), Nkx2.2 prevents the precocious expression of MBP in pre-
myelinating OLs (Wei et al. 2005), allowing MBP expression only in mature OLs after Nkx2.2 
expression is down-regulated (Xu et al. 2000).  All in all, Nkx2.2 plays a crucial role during 
OL proliferation and differentiation but not in mature myelinating OLs. 
The dynamic changes of Nkx2.2 expression during development are recapitulated in 
remyelinating episodes (Fancy et al. 2004; Watanabe et al. 2004).  Two recent reports show 
a transient-regulation of Nkx2.2 expression in dividing OLPs and immature OLs, but down-
regulation in mature remyelinating OLs.  Interestingly enough, and in contrast to 
development, the regulation of Nkx2.2 was shown to be independent of endogenous Shh 
(Fancy et al. 2004). 
Moreover, Nkx2.2 expression has been detected in the ventral forebrain (Price et al. 1992), 
thalamus (Vue et al. 2007), hypothalamus (Kurrasch et al. 2007) and retina (Fu et al. 2001) 
too.  Nkx2.2 is also expressed outside the CNS.  Its expression has been identified in heart, 
lung, thyroid and pancreas (Lints et al. 1993; Rudnick et al. 1994; Kimura et al. 1996).  In 
the pancreas, Nkx2.2 plays a vital role in the final differentiation of pancreatic beta-cells, 
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the exclusive source of insulin (Cissell et al. 2003, Sussel et al. 1998, Wang et al. 2004).  In 
Nkx2.2 null mice, beta-cells are markedly reduced, which leads to diabetes shortly after 
birth and eventually death (Sussel et al. 1998). 
Besides its role during patterning of the neural tube (see section 1.3.1.1), transcriptional 
repressor activity of Nkx2.2 was also found to regulate general activator proteins, such as 
Sp1 and E2F, capable of driving transcription of proneural bHLH protein Hb9, a protein 
specifically expressed in MNs (Lee et al. 2004).  These results provide further support for the 
derepression model of gene regulation in the neural tube (see section 1.3.1.1).  Nkx2.2 can 
also act as a transcriptional activator to promote target gene expression (Watada et al. 
2000).  In particular, the insulin gene was shown to be directly activated by Nkx2.2 in 
differentiated pancreatic beta cells (Cissell et al. 2003). 
 
 
3.2. PAC transgenesis 
3.2.1. Identification of a suitable probe for screening a genomic PAC 
library 
In order to find a cDNA fragment specific to the Nkx2.2 gene that could allow us to screen a 
genomic PAC library for clones containing Nkx2.2, small pieces of DNA were isolated from a 
full length Nkx2.2 cDNA and used as probes on mouse genomic Southern blots.  The 
fragment that hybridized to single bands corresponding to the Nkx2.2 locus was then used to 
screen a Mouse genomic P1 Artificial Chromosome (PAC) library.  The selected probe was a 
620bp Not I/Xho I fragment that spanned the entire Exon I (see Figure 3.1). 
 
3.2.2. Isolation and characterization of Nkx2.2 PACs 
PACs are P1-derived artificial chromosomes that were developed for cloning large genomic 
fragments into Escherichia coil (E. coli). Despite their large size, PACs can be propagated 
and manipulated in bacteria.  PACs have their own inherent advantages when it comes to 
using them for mouse transgenic studies.  Because PACs can contain large DNA fragments, 
up to 200-300Kb, they are unlikely to be silenced, i. e. they are less likely to be subject to 
positional effects.  PAC DNA can easy be purified and modified directly in E. coli by 
recombineering technologies (see section 3.4). 
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3.2.2.1. PAC library screening 
A mouse genomic PAC library (RPCI21) was obtained from the UK HGMP Resource Centre.  
This had been constructed with fragments of female 129/SvevTACfBr mouse spleen genomic 
DNA ligated into the pPAC4 vector (see vector pPAC4 map, in 
http://www.chori.org/bacpac/ppac4.htm).  The library contains 128,000 clones, in 336 
microtitre plates, that grew in LB broth with kanamycin (25 µg/ml) and 7.5% glycerol.  The 
resulting culture was plated out and then gridded in a 4x4 array on 22.2x22.2 cm Hybond N 
nylon membranes (Amersham) using a Genetix Qbot robot.  Each clone was spotted twice to 
give 36,864 spots on each membrane.  7 filters, each divided into 6 panels, which, in turn, 
contain 24x16 of the 4x4 array, cover the whole library.  Clones spotted on the filters had 
been processed by SDS treatment, denaturation and neutralisation, dried and UV 
crosslinked.  To screen for the presence of Nkx2.2 PACs, the membranes were hybridised 
overnight with the above mentioned labelled radioactive probe.  The subsequent pattern of 
spots observed on the autoradiography films enabled us to identify the Nkx2.2 PAC clones.  
Four Nkx2.2 PAC clones were identified from the whole PAC library (see Figure 3.2).  To 
each of the clones was assigned an identification number (see Table 3.1). 
 
Table 3.1  -  Naming PACs. 
Description ID 
512 - D5 Mouse PAC (RPCI 21) clone 1 
544 - M7 Mouse PAC (RPCI 21) clone 2 
637 - P21 Mouse PAC (RPCI 21) clone 3 
638 - P21 Mouse PAC (RPCI 21) clone 4 
 
 
3.2.2.2. Checking authenticity of PAC clones 
PAC DNA was isolated as described in materials and methods (mini-prep protocol).  To 
confirm the identity of the clones, the PACs were digested with BamHI and XhoI (as with the 
genomic digestion mentioned above) and analyzed by Southern blotting using the 620bp 
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NotI/XhoI Nkx2.2 cDNA fragment as a probe (see Figure 3.1).  Hybridization of the probe to 
a 3 kb or a 2.2 kb band (respectively for BamHI and XhoI) confirmed the identity of the 
clones.  Large quantities of each PAC DNA were prepared. 
 
3.2.2.3. Molecular characterization of Nkx2.2 PACs 
To identify the size of the genomic DNA inserts the purified PAC DNA was digested with the 
following infrequent restriction endonucleases: NotI, which is able to release the insert, and 
SalI enzyme.  Digested PAC DNA was analysed by pulse field gel electrophoresis (PFGE).  
From PFGE, the four clones (PAC ID:1, ID:2, ID:3 and ID:4) were estimated to contain 
genomic fragments of approximately 200 Kb, 150 kb,. 170 kb and 170 Kb respectively (see 
Figure 3.3).   
 
3.2.2.4. Mapping the ends of the genomic inserts by inverse PCR 
The extremities of the purified PACs were further characterized by inverse PCR using 
primers and conditions provided by N. Kessaris. This was carried out to determine which 
regions of the mouse genome each PAC contains and its orientation. 
The inverse PCR strategy can be summed up in the following four steps: 
Step 1. PAC DNA was digested using a variety of restriction enzymes that were supposed to 
cut inside the regions of the vector immediately flanking the genomic insert (the 5’ and 3’ 
end vector-insert junction) and at unknown locations within the genomic insert.  It was 
necessary to use a variety of restriction enzymes since it is unknown which restriction sites 
do exist in the ends of the genomic insert. 
Step 2. The digested PAC DNA was diluted and self-ligated using T4 DNA ligase.  
Circularization serves to reorient the vector arm templates in a manner that permits the 
vector arm primers to anneal in the appropriate orientation in the next step of PCR 
amplification. 
Step 3. Sets of 5’ and 3’ end vector arm primers were used to amplify the 5’ and 3’ end 
vector-insert junction fragments, respectively. To confirm the authenticity of the resulting 
PCR products, nested PCR was carried out with two sets of 5’ and 3’ end vector arm 
primers. 
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Step 4. The amplified products were purified by gel electrophoresis, subcloned into 
appropriate plasmid, and sequenced. The DNA sequencing results were blasted to Nkx2.2 
gene sequence (in www.ensembl.org) thus allowing us to locate the identity of the genomic 
insert in the mouse Nkx2.2 gene. 
It should be noted that the 5’ end arm of the pPAC4 vector is arbitrary and does not 
necessarily correspond to the 5’ end of the genomic insert. An example of an inverse PCR 
strategy is given in Figure 3.4. 
 
PAC clone ID:1 : PFGE and inverse PCR data showed that clone ID:1 contain a genomic DNA 
fragment that was 206 Kb in length. In fact clone ID:1 contained 100 Kb upstream of Nkx2.2 
and 106 Kb downstream, positioning Nkx2.2 roughly in the middle.  This clone ID:1 was 
identified as the most suitable clone for our study as it was the most likely to contain all the 
regulatory elements for correct expression of the Nkx2.2 homeogene (see Figure 3.5).  
Although not shown here, the original PAC ID:1 clone obtained from HGMP contained a large 
deletion of approximately 100 Kb, missing out Nkx2.2 altogether but otherwise mapping 
precisely in the Nkx2.2 genomic region by inverse PCR. This suggested that the PAC clone 
had undergone recombination resulting in this deletion.  The same PAC clone was ordered 
again from HGMP and this time the correct 206 Kb genomic clone was obtained without 
recombination. 
Nkx2.2 PAC ID:1 also contained the related gene Nkx2.4. In order to avoid overexpression of 
this gene in our mouse transgenics, Nkx2.4 had to be removed (see section 3.3.3) 
 
PAC clone ID:2 : This PAC clone contains 60 Kb upstream and 96 Kb downstream of Nkx2.2.  
Because of its smaller size and short region upstream (60 Kb) of Nkx2.2 I decided not to use 
this PAC in further work (see Figure 3.5). 
 
PAC clone ID:3 and ID:4 : Inverse PCR for these PACs anchored one of their ends 160 Kb 
away from Nkx2.2.  The other end of the PAC did not match any known sequences in the 
mouse genome suggesting that they fall within as yet non-sequenced region.  However, 
PFGE showed that these two PACs were identical and contained only approximately 10 Kb 
downstream of Nkx2.2 making them unsuitable for Nkx2.2 transgenics (see Figure 3.5). 
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3.2.3. Construction of targeting vectors 
3.2.3.1. Basic targeting vector designs 
In the present study I needed to construct two targeting vectors.  The fundamental 
elements of them are the homology to the target DNA, a positive selection and two unique 
restriction sites one on either side of the two homologies for isolating of the targeting 
cassette without vector sequences.  The two targeting vectors were named Nkx2.2-CreERT2 
and Nkx2.4.  The former was used to replace part of the Nkx2.2 coding sequence with 
tamoxifen-inducible Cre recombinase (Cre-ERT2) and the latter was used to delete the 
Nkx2.4 gene from the PAC. 
 
3.2.3.2. The Nkx2.2 targeting vector 
The Nkx2.2-CreERT2 targeting vector was designed to drive homologous recombination and 
replace part of Nkx2.2 sequences with Cre-ERT2.  In addition to Cre recombinase and two 
regions of homology to the target DNA, which is where recombination will occur, the 
targeting vector also contains a positive selection marker.  In this case, the selection marker 
used was chloramphenicol (Cm) flanked by FRT sites.  This marker is used to select correctly 
targeted clones and is removed prior to microinjection into mouse embryos.  The process of 
removing the chloramphenicol marker is similar to the Cre/loxP system.  The strain of 
bacteria EL250, used for PAC manipulation contains an arabinose inducible flpe gene.  The 
expression of FIpe (a genetically enhanced, site-specific FIp recombinase) can be induced by 
arabinose to remove the selection marker Cm that is flanked by the site-specific recognition 
sites of the recombinase, the FRT sites (Buchholz et al. 1998) (see Figure 3.6). 
 
Cloning strategy for construction of the Nkx2.2 targeting vector (see Figure 3.7 and 
Table 2.1): 
Step 1.  5’ homology (357bp) was obtained by PCR amplification using Nkx2.2 PAC clone 
ID:1, as template, and the set of primers (Nkx2.2 5’AscF1, Nkx2.2 5’ NcoR1).  In this step 
BstAPI restriction site was added to the 3’ end of the 5’ homology.  5’ homology was cloned 
into pCRII-TOPO and sequenced; 
Step 2.  This involved the amplification of the 5’ end of Cre-ERT2 (400bp) using pCre-ERT2 as 
template (kindly provided by Pierre Chambom) and the set of primers (CreERT2BstAPIF1, 
CreBamR1).  In this step BstAPI restriction site and the 23bp upstream of Nkx2.2 ATG was 
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added to the 5’ end of the 5’ end of Cre-ERT2.  The 400bp fragment was then cloned into 
pCRII-TOPO and sequenced; 
Step 3.  The 5’ homology and the 5’ end of Cre-ERT2 fragments were inserted in 
pBluescriptIISK PacI AscI (pBluescriptIISK with a modified MCS to introduce PacI and AscI. 
kindly provided by N. Kessaris) in a three way ligation.  For this, the 320bp BstAPI/AscI 
fragment, isolated from the plasmid that resulted from Step 1, and the 388bp BstAPI/BamHI 
fragment, isolated from plasmid that resulted from Step 2, were cloned into the BamHI/AscI 
sites of pBluescriptIISK PacI AscI at the same time; 
Step 4.  This step involved cloning the whole Cre-ERT2 cassete into pBluescriptIISK (kindly 
performed by Françoise Jamen).  For this, 2Kb EcoRI fragment was isolated from plasmid 
pCre-ERT2 and inserted in BamHI fragment of pBluescriptIISK by a blunt ended ligation; 
Step 5.  In this step BamHI/NotI Cre-ERT2 fragment from Step 4 was inserted in plasmid from 
Step 3 as BamHI/NotI.  At this stage I have already placed 5’ homology in the 5’ end of the 
Cre-ER
T2 cassette; 
Step 6.  3’ homology (470bp) was obtained by PCR amplification using Nkx2.2 PAC clone 
ID:2, as template, and the set of primers (Nkx2.25’AscF1, Nkx2.25’NcoR1).  In this step, NotI 
and PacI were added to the 5’ and 3’ end, respectively.  3’ homology was cloned into pCRII-
TOPO and sequenced, having the sequencing result been blasted to the mouse Nkx2.2 gene 
to check the accuracy of the amplified fragment; 
Step 7.  This step involved the insertion of 3’ homology into plasmid from Step 5 as 
NotI/PacI;  The isolation of the 3’ homology fragment was carried out by PacI digest 
followed by NotI digest. 
Step 8.  Finally, the positive selection marker chloramphenicol was isolated from pPI22 
(kindly provided by Palma Iannarelli) as a NotI fragment and subsequently cloned into the 
plasmid from Step 7 previously digested with NotI.  Additionally, the construct 5’ homology – 
Cre-ERT2 - FRT - Cm - FRT - 3’ homology was further digested with MluI and its restriction 
site removed by blunt ended ligation.  The construct 5’ homology – Cre-ERT2 - FRT - Cm - 
FRT - 3’ homology is now complete. 
 
3.2.3.3. The Nkx2.4 targeting vector 
The reason for removing Nkx2.4 coding sequence was to avoid possible adverse effects of 
introducing an extra copy of the Nkx2.4 gene into the mouse genome.  In Xenopus it has 
Raquel Taveira-Marques Tracing NSCs in the ventral NT Results – Part I 
 
 100/200 
been shown that Nkx2.4 expression is strictly segregated to the ventral half of the neural 
tube at all stages and that the expression of Nkx2.4 overlaps that of Nkx2.1 in the ventral 
diencephalon (Small et al. 2000).  Overexpression of Nkx2.4 could conceivably affect 
embryonic development and hence interfere with the normal expression of the Nkx2.2 gene 
(see Figure 3.8).  
 
The targeting vector was designed to recombine at the Nkx2.4 locus and replace it with 
chloramphenicol resistance.  The Nkx2.4 targeting vector was also designed in such a way as 
to insert a MIuI restriction site for linearization of the selected PAC clone. 
 
Cloning strategy for generating the Nkx2.4 targeting vector (see Figure 3.9 and Table 
2.1): 
Step 1.  5’ homology (516bp) was obtained by PCR amplification using Nkx2.2 PAC clone 
ID:1, as template, and the set of primers (Nkx2.45’PacF1, Nkx2.45’MIuR1).  In this step PacI 
and MluI restriction sites were added to the ends.  5’ homology was cloned into pCRII-TOPO 
and sequenced; 
Step 2.  This involved the amplification of the 3’ homology (681 bp) using Nkx2.2 PAC clone 
ID:1, as template, and the set of primers (Nkx2.43’HindF1, Nkx2.43’AscR1).  In this step 
HindIII and AscI restriction site were added to the ends.  3’ homology was then cloned into 
pCRII-TOPO and sequenced; 
Step 3.  Finally, the 5’ homology, the 3’ homology and the positive selection marker 
chloramphenicol were inserted in pBluescriptIISK PacI AscI (pBluescriptIISK with a modified 
MCS to introduce PacI and AscI) in a four way ligation.  For this, the 516bp EcoRI/PacI 
fragment, isolated from the plasmid that resulted from Step 1, and the 681 bp AscI 
fragment, isolated from plasmid that resulted from Step 2, and chloramphenicol cassette 
isolated from pPI22 fragments (kindly provided by Palma Iannarelli) were cloned into the 
PacI/AscI sites of pBluescriptIISK PacI AscI at the same time; the construct 5’ homology – Cm 
- 3’ homology is now complete. 
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3.2.4. PAC modification by homologous recombination in bacteria 
 
Brief introduction 
Highly efficient phage-based E. coli homologous recombination systems that enable 
modification and subcloning of PAC DNA without requiring restriction enzymes or DNA ligase, 
have been recently developed.  This so-called recombinogenic engineering or 
recombineering, uses phage recombination functions to induce homologous recombination 
using homologies of 50bp (or less).  The two most known phage-encoded recombination 
systems are Rac encoded RecET system and λ-encoded Red system (Copeland et al. 2001).  
In turn, there are two ways that Red recombination can be induced: through a plasmid 
system or through a defective prophage.  The latter was the one I used.  
In the defective λ-prophage-based system, gam, bet and exo, the three genes required for 
Red recombination, are expressed from λ-prophage which is integrated into the E. coli 
chromosome, and their expression is under the tight control of the temperature sensitive λ-
cI857 repressor.  At 32°C, when the repressor is active, the expression of these genes is 
undetectable.  However, when cells are subjected to 42°C for 15 min, the repressor is 
inactivated and the genes are co-ordinately expressed from the λ-pL promoter at very high 
levels, making it possible to achieve greater than 104 recombinants per 108 electroporated 
cells. 
The recombinogenic bacteria strain EL250 that I used in our recombination system is a 
modified DH10B strain (Gibco) containing the defective λ-prophage (Yu et al. 2000).  This 
specialised E. coli strain was further engineered to include arabinose-inducible flpe gene, 
which catalyses the excision of an frt site-flanked sequence (in this study, the selectable 
marker chloramphenicol) in the presence of arabinose (Lee et al. 2001). 
 
3.2.4.1. Removal of loxG site from pPAC4 backbone 
The pPAC4 vector backbone contains a loxG site.  Like loxP, loxG is a site-specific 
recognition sequence for Cre recombinase.  So, it is possible that Cre-mediated 
recombination could occur between two loxP and two loxG sites.  To avoid this I removed 
loxG from the pPAC4 vector backbone in Nkx2.2 PAC clone ID:1.  In addition, an SV40 
promoter driving the expression of blastocidin-σ-methylase and an SV40pA were all removed 
from the vector backbone to minimise adverse effects introduced by this strong promoter.  
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Figure 3.10 shows where the ampicilin gene was inserted in the pPAC4 vector backbone.  
The targeting vector was kindly provided by N. Kessaris. 
In order to confirm the removal of loxG, Southern analysis of the modified PAC DNA digested 
with PstI using as a probe the XhoI/BglII fragment from the plasmid shown in Figure 3.10.  A 
difference around 7.5 Kb should be seen between modified and unmodified Nkx2.2 PAC 
clone (see Figure 3.11). 
 
3.2.4.2. Removal of Nkx2.4 gene from recombinant PAC vector 
The original plan for PAC modification was to first remove the loxG site and insert an 
ampicillin selection cassette.  This would be followed by insertion of Cre-ERT2, using for 
selection chloramphenicol flanked by FRT sites.  This would allow us to remove the selection 
cassette using FIpe and subsequently delete Nkx2.4 from the PAC using chloramphenicol 
again for selection.   
Following insertion of Cre-ERT2 into the Nkx2.2 locus various attempts were made to remove 
Nkx2.4, but all were unsuccessful, resulting in deletion of sequences from the recombinant 
PAC clone (see Figure 3.12). 
It appeared that the presence of Cre-ERT2 fragment allowed the DNA to fold in such a way 
that permitted two homologous regions (as small as 50bp) distant from each other to 
recombine unexpectedly and delete a fragment from the full sequence of the recombinant 
PAC. 
In an effort to overcome this unexpected recombination the plan was changed.  Instead of 
first inserting Nkx2.2 and then the Nkx2.4 targeting vector, I did the other way round.  The 
removal of Nkx2.4 was carried out first by homologous recombination using Nkx2.4 targeting 
vector and Nkx2.2 PAC clone ID:1.  In order to confirm the removal of the gene, Southern 
analysis of PAC DNA, isolated from the modified Nkx2.2 PAC clone digested with HindIII, was 
carried out using as a probe the 5’ homology of Nkx2.4 gene (see Figure 3.12). 
A difference around 2.5 Kb should be seen between modified and unmodified Nkx2.2 PAC 
clone (Figure 3.12, left).  Furthermore, to confirm the existence or not of deletions mini-
preps were digested with SalI and NotI enzymes and run on PFGE (data not shown). 
At this point of the study, I have a recombinant form of Nkx2.2 PAC clone ID:1 from which 
loxG and Nkx2.4 gene were removed.  Because our recombinant PAC clone was already 
resistant to chloramphenicol and the selection cassette used in Nkx2.2- CreERT2 targeting 
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vector also carried  chloramphenicol resistance, correctly recombined clones containing 
CreER
T2 had to be identified without selection.  For this, colony lifts and hybridization with 
a probe specific to the CreERT2 gene were used in 2 rounds of enrichment (see Figure 3.13). 
Recombinant PAC clone integrity was confirmed by pulsed field gel electropholesis (PFGE).  
Afterwards, chloramphenicol selection was removed by inducing the expression of Flpe using 
arabinose, as described in materials and methods. 
 
3.2.5. Injection of the recombinant PAC clone into mouse fertilised 
eggs by pronuclear injection 
The recombinant PAC clone was linearised with MIuI, purified (see materials and methods 
for protocol) and injected using a dilution of 1 in 20 into mouse fertilised eggs by pronuclear 
injection as described in materials and methods.  In total 9 pregnancies were obtained by 
pronuclear injection of Nkx2.2-CreERT2 recombinant PAC clone, which resulted in 53 animals 
being born.  
The resulting offspring were then analysed by PCR using the set of primers (CreBamHI, 
Nkx2.25’AscF1; offspring were also genotyped using primers from Table 2.2) and by 
Southern blotting using as probe 3’ homology of Nkx2.2.  In total four pups were positive for 
the transgene.  The founders were named 4/1 , 5/4 , 7/5 , and 10/2 and were used to 
generate four independent transgenic lines.  
As it is possible to see in Figure 3.14, the probe used for Southern blot picks up two bands.  
This is due to the fact that the fertilized eggs used in microinjection are derived from two 
mouse strains that exhibit a polymorphism at this locus.  Additionally, it is shown by Figure 
3.14 that only one copy of the transgene integrated into the genome of founder 7/5, as the 
intensity of the transgenic band is as strong as the intensity of either of the two 
corresponding endogenous bands of the Nkx2.2 gene.  Similarly, the other three lines were 
also found to carry a single copy of the transgene. 
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3.3. Transgene expression analysis 
3.3.1. Characterizing the expression of the CreER
T2
 transgene in the 
embryonic spinal cord between E10.5 and E15.5 
The expression of CreERT2 transgene in the four transgenic lines was first assessed by RNA in 
situ hybridization.  Transgene expression is often dependent on its site of integration in the 
genome.  The transgene can happen to integrate into a chromosomally active region of the 
genome, resulting in the expression of the transgene.  Alternatively the transgene can 
integrate into a chromosomally silent region which could lead to the inactivation of the 
transgene.  Consequently, the characterization of the CreERT2 expression pattern was 
carried out in all four transgenic founders and has shown that only one of these four lines – 
transgenic line 4/1 - expressed the transgene at appropriate levels and in the correct 
pattern at E10.5 (see Figure 3.15 - A and data not shown).  I have selected line 4/1 for 
further study.  
Some additional characterization of CreERT2 embryonic expression was further carried out at 
E10.5, E12.5, E13.5 and E15.5 to compare it with that of Nkx2.2 and Olig2 protein as well as 
with the expression of Sim1, a specific marker for V3 interneurons which are known to 
originate from the p3 domain (Fan et al. 1996; Sommer et al. 1996; Briscoe et al. 1999).  At 
E10, expression of transgene was restricted to the VZ of p3 domain which is marked by the 
the expression of Nkx2.2 (see Figure 3.15 A).  At this age Nkx2.2 and Olig2 expression 
domains were non-overlapping with a sharp boundary.  Similarly, the dorsal limit of the 
transgene was observed to abut the Olig2 expression domain, the so-called pMN domain.  On 
E10.5 CreERT2 mRNA and protein was still present in the VZ but was also detected in cells 
that had migrated from the VZ and settled in the ventral cord close to the midline (see 
Figure 3.15 E and data not shown).  These cells were confirmed to be V3 interneurons by 
their co-expression with marker Sim1 (see Figure 3.15 E).  Surprisingly, at more caudal 
regions of the spinal cord, where Hoxc9 expression defines thoracic spinal cord (Dasen et al. 
2003), a small number of cells were found to express CreERT2 only (see Figure 3.15 B arrow 
heads).  The number of CreERT2-positive/Nkx2.2-negative cells increased from E10.5 to 
E12.5 and were more preeminent at the thoracic level of the spinal cord (see Figure 3.15 A, 
B, and E).   
Until E12.5, more and more CreERT2-positive cells had migrated dorsally and settled in the 
intermedio-lateral cord, while a few others had settled in a medial position near the central 
canal of the upper thoracic spinal cord (see Figure 3.16 B; around 2/3 [90 cells out of 141 
per cord] of CreERT2-positive cells that had left the VZ migrated dorsally whereas the other 
Raquel Taveira-Marques Tracing NSCs in the ventral NT Results – Part I 
 
 105/200 
1/3 remained ventral to p3 domain [51 cells out of 141 per cord]).  At lower thoracic levels 
(caudal to T8), CreERT2-positive cells were also observed in the dorsal cord (see Figure 3.16 
C).  Neither of the dorsally-migrating cell populations expressed Nkx2.2 (see Figure 3.16 A-
D).  The persistence of the CreERT2 transgene in migratory cells, and its failure to down-
regulate at the same time as endogenous Nkx2.2, might reflect a greater stability of Cre 
transcripts and/or de-regulated transcription of the PAC transgene.  Nevertheless, it is 
suggested that CreERT2 expression might actually be useful as a short-term p3 lineage 
marker.  Supporting this idea, I found that at E15.5, the cluster of CreERT2-positive cells in 
the dorsal cord was positioned at the same level as a dorsal population of Sim1-positive 
cells, which were absent in Nkx2.2 KO (see Figure 3.16 E, Figure 4.15 and data not shown).  
At E13.5, some Sim1-positive cells were found to migrate dorsally at upper cervical cord, 
resembling migratory CreERT2-positive cells at the same level, which suggests that CreERT2 
persists in p3-derived migratory neurons (see Figure 3.15 D).  To further investigate whether 
CreERT2 could be used as a lineage tracer of the p3 domain, I then looked for supporting 
evidence for CreERT2 perdurance in the different differentiated cell populations known to be 
generated in the p3-domain of the hindbrain (Pattyn et al. 2003a; Guthrie 2007).  
 
3.3.2. Enduring transgene expression in p3 derived neurons of the 
developing hindbrain after Nkx2.2 down-regulation 
Given the fact that CreERT2 continues to be expressed in cells outside the domain of Nkx2.2 
expression in the spinal cord, it was important to ascertain whether the transgene behaved 
likewise in the hindbrain (HB) where p3 progeny have been extensively studied and 
characterised (Briscoe et al. 1999; Pattyn et al. 2003a; Pattyn et al. 2003b).  p3 progenitors 
from the HB are known to give rise to branchiomotor and visceral motor neurons and to later 
serotonergic interneurons expressing Phox2b and 5HT (among other markers) (Briscoe et al. 
1999; Pattyn et al. 2000; reviewed in Chandrasekhar 2004; Guthrie 2007).   
Similar to spinal cord, CreERT2 transcript and protein were analysed in HB at E11.5 and E13.5 
and its expression pattern was compared with that of Nkx2.2, Phox2b and 5HT (see Figure 
3.17).  CreERT2 transcript expression was first analysed at E11.5 by whole-mount in situ 
hybridization.  It was noted that its expression extended along the midline within the 
ventricular zone having also been observed in regions adjacent to the VZ (e.g. in 
rhombomere (r) 4, see Figure 3.17 A) or in postmitoic cells which had migrated laterally, 
settling within r2-r3 in a unique location known to be occupied by the trigeminal (V) neurons 
(BM neurons; Song et al. 2006 ; see also Figure 3.17 A).  CreERT2 expression outside the VZ 
resembled that of Tbx20, a marker upregulated in post-mitotic BM/VM neurons but absent in 
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their progenitors and sMNs (Song et al. 2006).  To further assess CreERT2 expression, 
transverse sections at E11.5 were cut and stained for Nkx2.2 and Cre proteins.  While 
mimicking Nkx2.2 expression in the VZ (close-ups in Figure 3.17 B), CreERT2 expression was 
detected outside the VZ in post-mitotic cells that from their specific locations could be 
identified as the branchial facial (VII) BM neurons (white arrow heads in Fingure 3.18 B).  
Branchial facial (VII) BM neurons are generated within r4 and then migrate tangentially 
along the anteroposterior axis of the hindbrain into r6 before settling in the dorsolateral 
region of r6 (Song et al. 2006).  Concurrently, Cre was observed to co-express with Phox2b, a 
marker involved in BM and VM neurons differentiation (Pattyn et al. 2000), in r6 (see Figure 
3.17 C, r6).  In fact, almost Phox2b positive cells, if not all, were also seen to co-localise 
with Cre (see Figure 3.17 C).  Some cells, however, were only Cre-positive and lay in close 
proximity to the VZ.  These cells could be stained for 5HT confirming their identity as 
serotonergic neurons (see Figure 3.17 D).  All in all, these data show that there is 
perdurance of Cre expression in post-mitotic cells that are known to derive from p3 
progenitors of the hindbrain and therefore that Cre expression can be used as a neuronal 
lineage tracer in the hindbrain.  It remains to be proved whether CreERT2 behaves similarly 
in the spinal cord.  
Visceral motor nerons can also be found along the spinal cord.  Parasympathetic MNs are 
located in the sacral spinal cord while sympathetic motor neurons (SPNs) are found mainly in 
the thoracic spinal cord (Loewy 1990).  This raises the question of whether the post-mitotic 
CreERT2 positive cells that settled in the intermedio-lateral cord of the spinal cord could be 
visceral motor neurons too.  They were absent in the lower cervical region of the spinal cord 
but present at thoracic levels suggesting that they might be SPNs.  To test this hypothesis, I 
carried out immunohistochemistry for Cre and nNOS/Isl1 at E12.5.  I also performed 
stainings for HB9/Isl1 to differentiate SPNs from somatic MNs (Figure 3.18 B, see also Table 
1.1).  Indeed, nearly all Cre-positive cells co-stained for nNOS (Figure 3.18 A) whereas only 
a sub-population of them co-labelled with Isl1 (Figure 3.18 A, arrow heads).  This might be 
because those Cre-positive cells were themselves in different stages of 
maturation/differentiation rather than being different sub-types of SPNs (Isl1 has been 
shown to be essential to the overall assignment of visceral spinal motor neuron identity) 
(Pfaff et al. 1996).  A few SPNs could be seen to express HB9 too (Figure 3.18 B, arrows), 
which was not surprising since HB9 has been implicated in the differentiation of visceral 
MNs, mainly determining subclass identity of SPNs - SPNs located in the intermediolateral 
nucleus versus central autonomic nucleus (Arber et al. 1999).  This seems to be a peculiarly 
of visceral MN of the spinal cord, though, as cranial visceral MNs do not express HB9 (Briscoe 
et al. 1999).  Moreover, HB9 has been shown to be expressed in visceral MNs at some point of 
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their development because visceral MNs are all labelled in Hb9-GFP mouse during adulthood 
(Wilson et al. 2005). 
All in all, these data imply that p3 progenitors generate not only V3 interneurons but also 
SPNs and a class of unidentified dorsal neurons (quite possibly Sim1 positive).  This was 
unexpected because SPNs have been presumed to share the same progenitors as sMNs – 
originating in pMN, not p3 (Briscoe et al. 1999; Thaler et al. 2004).  However the possibility 
remains that SPNs might activate Nkx2.2-CreERT2 ectopically after they leave the VZ, and 
are not genuinally derived from p3 Nkx2.2-expressing progenitors in the VZ.  To tackle this 
potential complication a panoply of mutants mice were studied, something I will discuss in 
Chapter 4. 
 
3.3.3. Characterization of transgene expression during gliogenesis 
Olig2 expression in the rodent ventral neural tube initiates in a region adjacent to the 
developing floor plate (Takebayashi et al. 2000; Jeong et al. 2005; Dessaud et al. 2007; Ribes 
et al. 2010).  Subsequently, Nkx2.2 is upregulated and, by repressing Olig2, establishes its 
unique domain of expression that ultimately becomes ventral and non-overlapping to the 
that of Olig2.  By E10.5, Nkx2.2 and Olig2 can be seen forming mutually exclusive and 
adjacent domains (see Figure 3.19 A) - Nkx2.2 domain being sandwiched between the floor 
plate and Olig2.  At this age Nkx2.2 and Olig2 domains – the p3 and pMN progenitor domains, 
respectively – become  neurogenic.   
Sim1-positive V3 INs derive from p3-progenitors around E10 ‡‡ and their generation continues 
for at least two days.  Being known to be a transcription factor crucial to V3 INs 
specification (Briscoe et al. 1999), Nkx2.2 remains strictly regulated within the p3 domain 
during these stages of development.  However, around E12.5 Nkx2.2 is upregulated inside 
the Olig2 domain and a new region of overlap between Nkx2.2 and Olig2 is formed (see 
Figure 3.19 B).  This region has been named p*, to differentiate it from the p3 and pMN 
domains (Zhou et al. 2001).  Both regions p* and pMN are known to give rise to 
oligodendrocyte precursors (OLPs), which then migrate away from the VZ to populate the 
entire spinal cord (Zhou et al. 2001; Fu et al. 2002).  From E12.5, it was observed that Nkx2.2 
                                              
 
 
‡‡ At 28 somites (E10), Sim1 expression has just started and can be seen weakly expressed in a 
few cells flanking the most ventral region of the spinal cord.  By 38 somites, Sim1 expression is 
strong and abundant within the V3 IN population (data not shown). 
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co-labels with Sox10 and PDGFRα within the Olig2+ neuroepithelial domain, although there 
are Sox10+ cells that are Nkx2.2-negative but Olig2-positive (asterisk in Figure 3.19 D; see 
also Figure 3.19 C).  At least 60% of the cells that express Sox10 co-express Nkx2.2 within 
the Olig2+ neuroepithelial domain.  As OLPs migrate away from the VZ, Nkx2.2 appears to be 
translocated from the nucleus to the cytoplasm (arrow heads in Figure 3.19 E).  Nkx2.2 is 
downregulated eventually during migration, whereas OLPs express Olig2 throughout their 
development (Richardson et al. 2006; Richardson et al. 2011).  Nevertheless, expression of 
Nkx2.2 returns once again to differentiating oligodendrocytes.  At this stage, Nkx2.2 plays 
an important role in oligodendrocyte maturation which takes place mainly after birth in the 
sub-pial white matter (Qi et al. 2001).   
 
Expression of the Nkx2.2 CreERT2 transgene in the neuroepithelium was found not to overlap 
with the Olig2 expression domain after E12 (see Figure 3.15 B and C).  The transgene also 
was not up-regulated with Nkx2.2 in differentiating oligodendrocytes (Qi et al. 2001 and data 
not shown).  While this prevents us from using it for studies of oligodendrogenesis within the 
p*/pMN domain, Nkx2.2-CreERT2 mice were still useful to answer the question of whether 
some, if any, oligodendrocytes are ever produced by p3 progenitors.  This is a point to be 
dealt with in the following chapter, Chapter 4. 
 
 
3.4. Optimization studies for CreER
T2
 activation 
In order to label Nkx2.2-expressing cells it is necessary to cross Nkx2.2-CreERT2 mice to a 
Cre dependent reporter and to activate CreERT2 by TM administration.  Different methods of 
TM administration were employed in pilot studies in an effort to determine the most 
efficient and least toxic way to activate Cre during embryogenesis (note that TM is known to 
have antiestrogenic properties therefore it can interfere with pregnancy; see text-box 
below).  The efficiency of TM is dependent on the route of administration.  There are 
currently three methods for administration of TM in pregnant females: intraperitoneal 
injection, oral administration through food and oral administration by gavage.  I found that 
oral gavage was the most suitable technique of administration of TM.  Highly dependent on 
the reporter mouse strain used and influenced by the weight and the age of the pregnant 
female and the precise time when transgene activation was needed, the optimum TM dose 
was found to be the highest dose that could be tolerated without inducing spontaneous 
abortion.  For longer-term fate map analyses, it was necessary to use a lower dose of TM.  
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Comparative studies of TM induction with different reporter lines have shown that Rosa26-
LacZ and Rosa26-YFP reporter mice were more suitable Cre reporter lines than Rosa26-GFP 
and Z-EG, the two latter having a very low recombination efficiency in my hands (see Figure 
3.20).  Also late weaned and/or previously pregnant, ~2-3-month-old females weighing more 
than ~ 24g frequently seem to hold the pregnancy to term better when compared to younger 
females (see Figure 3.21).  Presumably absortion of TM by body fat might reduce the side 
effects of TM for the pregnancy by preventing it from binding with the oestrogen receptors 
in the endometrium, uterine tissue and mammary gland, structures highly important during 
pregnancy (Robinson et al. 1991; Wade et al. 1993; Sairam et al. 2002; Buchanan et al. 
2007, and also see text-box below).  In an attempt to apply some statistical analyses to the 
data of Figure 3.21, non-parametric measures, namely Logistic regression and Spearman's 
rank correlation coefficient, were carried out using SPSS software.  Spearman's rank 
correlation coefficient (sr) can be used to measure the statistical dependence between a 
binary variable and a continuous variable.  I coded the occurrence of pregnancy as a binary 
variable (0 is abort and 1 is pregnant) and considered the female’s age (in months), her 
weight on the day of TM administration (in grams), TM dosage (in mg per Kg of female’s 
body weight), and the time of TM injection (varying between 6.5 and 10.5) as continuous 
variables.  As seen in Table 3.2, there is no significant correlation between pregnancy and 
continuous variables age, weight and TM dosage.  However, the time of injection appears to 
moderately influence the propability that the female will abort, sr = 0.401, p = 0.0001. 
 
Table 3.2  -  Spearman's rank correlation coefficients between a binary variable (pregnancy) 
and continuous variables (age and weight of pregnant female, dose and time of tamoxifen 
administration).   
Spearman's rank correlation coefficients values vary from -1 to +1. 
Parameter Age Weight TM Dosage Time of Injection 
Correlation coefficient (sr) 
with pregnancy 
0.086 0.075 0.148 0.401 
p value 0.465 0.559 0.153 0.0001 
Sample size (n) 74 63 95 95 
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Similar conclusions were also drawn when using Logistic regression analysis.  Table 3.3 and 
Table 3.4 summarise the results.  Logistic regression evaluates the probability of a 
categorical dependent variable, in this case the probability of pregnancy after E13.5 (0 is 
abort and 1 is pregnant), on the basis of continuous independent variables (age and weight 
of pregnant female, dose and time of tamoxifen administration).  The study was done in 2 
steps.  Because age and weight are correlated to some extent (sr = 0.4 , p = 0.015) I entered 
age and weight in the first step of the logistic regression to account for any variance due to 
these two variables.  These were observed to be statistically non-significant (p = 0.603).  
However, adding time and dose of tamoxifen injection into de model revealed to 
significantly improve the outcome (p = 0.015).  The fitness of the model is however poor 
(Chi-square = 12.276) possibly due to some missing data. 
 
Table 3.3  -  Summary statistics of Logistic regression 
 Chi-square df P 
Model at Step 1                                                
(age + weight) 
1.013 2 0.603 
Model at Step 2                                                    
(age + weight + time of injection + TM dosage) 
12.276 4 0.015 
 
 
Table 3.4  -  Unique contribution of individual variables at step 2 
Individual Variables B df p 
Age -0.171 1 0.896 
Weight 0.001 1 0.998 
TM dosage 0.05 1 0.094 
Time of injection 0.599 1 0.565 
Constant -12.362 1 0.304 
 
 
I found that even at the optimum dose of TM, pregnant females did not enter labour 
normally at the appropriate time, so for postnatal analyses, pups were surgically removed 
from their mothers and reared by a foster mother (protocol described in Nagy et al. 2001).  
Initially, females were left to give birth naturally and if birth didn’t happened by E19.5 
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litters were delivered by Caesarean section and fostered. Subsequent litters subjected to 
the same protocol conditions were delivered at E18.5. As some embryos might die during 
gestation due to TM effect, both mother and father were homozygous for the transgene(s) in 
order to increase the chances of getting more material to analyse.  Additionally, protein-
enriched food was given to the pregnant females (>19% protein extruded rodent diet 2019, 
Harlan Teklad) to help them to hold the pregnancy better.  
 
Text-box  -  The effects of tamoxifen on pregnancy 
The pharmacological aspects of TM are complex and biologically context-dependent Furr et 
al. 1984.  TM has anti-estrogenic properties because it binds to the oestrogen receptor (ER).  
The binding prevents the receptors from recycling thereby reducing the number of receptor 
molecules available for subsequent 17-ß-estradiol activity.  However, the drug as well as its 
metabolised form, 4-hydroxytamoxifen, are themselves also biologically active compounds.  
Both drugs can behave either as pure agonists, partial agonists, or as antagonists depending 
on both tissue and specie.  For example, TM opposes oestrogen action in the breast and 
mouse mammary glands whereas it manifests estrogenic activity in the mouse uterine 
tissues and skeleton.  The pharmacological behaviour of TM also depends on the dose 
administered.  In the rat uterus TM is an agonist at low concentrations and antagonist at 
higher concentrations, hence its partial agonist effect.  Moreover, biological activity of TM 
differs among genes, depending on the mechanism of gene regulation TM may appear either 
as agonist or antagonist.  The diverse biological activity of TM among tissues or cells or 
genes of a specie and between species, led scientists to classified it as a selective oestrogen 
receptor modulator (SERM). 
The differential biological activity of TM stems from the fact that oestrogen receptors are 
ligand-regulated transcriptional factors and that cells possess the ability to distinguish 
among different ER–ligand complexes.  The binding of the ligand induces activating changes 
in the transcriptional inactive ER that allow ER to interact with specific oestrogen response 
elements within the regulatory region of a target gene.  The conformational changes of ER 
are dependent on the ligand, and the ability of ligand-bound ERs to regulate target gene 
transcription is determined by the cell- and tissue-specific expression of both coactivator 
and corepressor proteins involved in the ER signalling cascade.  In addition, the discovery of 
more than one receptor, specifically ERα and ERβ, together with the discovery of two 
distinct transcriptional activating functions (AF1 and AF2) within the ERα, which are 
affected differently by TM, help to further explain the diverse nature and the magnitude of 
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the estrogenic properties of TM (McDonnell et al. 2002).  Interestingly enough, the effects of 
TM are also dependent on the presence or absence of other hormones, like oestrogen (E) or 
progesterone (Kohlerova et al. 2004). 
As a result of the anti-estrogenic properties of TM, the high concentrations of TM that 
sometimes are required to activate Cre-ERT2 are quite close to interfere with pregnancy, 
often resulting in abortion or failure of birth.  Abortion is often a consequence of the 
agonist effect of TM in the mouse reproductive tissues.  Indeed, and consistent with 
previous findings (Sadek et al. 1996), increasing TM levels increases the risk of foetuses 
aborting and reduces the sizes of litters.  It is likely that the high levels of TM and its 
agonist effect on mouse reproductive tissues might resemble the high quantities of E that 
are known to cause foetal death or reduce foetal growth by blocking decidualisation 
(Milligan et al. 1997).  Abortion can also be a consequence of the effect of TM on 
suppressing progesterone receptor (PR) synthesis levels.  Total or partial inhibition of PR has 
been observed in hypothalamus, mammary glands and uterus of TM-dosed mice (Muldoon 
1987; McKenna et al. 1992). In addition, TM or E has been reported as an effective 
competitor for progesterone binding sites in the mouse brain (Bukusoglu et al. 1996). So, it 
is not surprising that the blockage of PR, and hence progesterone signalling cascade, has 
been shown to induce abortion or resorption of foetuses (Milligan et al. 1997).  Even as 
abortion does not happen until birth, failure of birth might happen on induced pregnant 
females.  Such incident might again be due to the antagonist properties of TM in the mouse 
uterus and brain.  It has been shown in rat that tamoxifen interference with normal 
oestrogen activity can disrupt the onset of labour (Downing et al. 1981).  Moreover, it has 
been shown that TM acts on various hormones, a group of proteins also termed “contraction-
associated proteins”, which are involved in the mechanism of parturition.  For example, 
production of prostaglandins, responsible for stimulating contractions of the myometrium, is 
stimulated by E near birth and can be inhibited by TM.  The effect of TM can be reversed by 
administering natural or synthetic prostaglendins (Furr et al. 1984 and therein).  Fos levels, 
which only show significantly higher transcript levels during labour, decrease considerably 
after TM treatment (Wu et al. 2007).  A third example is oxytocin, which also plays a role 
during parturition, given the influence of oxytocin on uterine contractions.  Even using 
supramaximal concentrations of oxytocin, this hormone can not override TM inhibitory 
effect on contractile responses of the myometrium (Lipton et al. 1984).  On the whole, TM 
can create inbalances in the hormonal levels of pregnant females that can alter the normal 
course of the pregnancy.  
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It is therefore difficult to predict the outcome of TM treatment on the induced pregnant 
females because the spectrum of biological actions of TM ranges from full agonist to 
complete antagonist to oestrogen action.  It seems that the ultimate effect of TM action 
depends considerably more on the time of injection and, to a lesser degree, on the TM dose, 
and hence a pool of females no less than 3 in number was dosed when testing each 
induction protocol.  As previously reported, induction by TM did show a dose-dependent 
response on the level of induction obtained (Hayashi et al. 2002) (see Figure 3.22).  
However, that usually happens at the expenses of adverse effects for the pregnancy.  
Nonetheless, it was often possible to find a situation where successful pregnancy could 
coexist with good Cre induction.  Reproducible recombination with few or no side effects for 
pregnancy was frequently achieved using 200mg/Kg body weight (bw) of TM in a variety of 
our reporter transgenics, meaning that such concentration of TM represents a good starting 
point when optimising Cre induction in new transgenic lines.  It is worth mentioning that for 
some of our transgenics, 200mg/Kg bw gave nearly complete induction whereas in other 
transgenic lines the same concentration was barely enough to induce any Cre 
recombination.  
The possibility of Cre recombinase activity in the absence of TM induction was also 
considered.  Unlike other reports (Imayoshi et al. 2006), my Nkx2.2-CreERT2 line exhibited 
no background recombinase activity (data not shown), recombination being completely 
dependent on TM administration. 
Several abnormalities have been linked to Cre genotoxicity in the mouse both in vitro and in 
vivo.  In vitro studies involving the use of cultured cells lacking exogenous loxP sites have 
reported “illegetimate” recombination events resulting in chromosomal rearrangements, 
aneuploidy, decreased growth and cytopathic effects.  Reports of Cre-site infidelity in 
transgenic mice have also been recently published.  For example, a study by Schmidt et al. 
links male sterility to chronic high-level expression of Cre in the spermatids of transgenic 
animals.  Also, Cre toxicity effects can compromise normal tissue development as described 
by Forni et al. (2006).  In that study, a form of hydrocephalus is attributed to a toxic 
threshold of nuclear Cre expression in neurogenic cells of Nestin-NLS-Cre mice.  The 
development of hydrocephaly was observed to be dependent on TM treatment when using 
Nestin-CreER
T2 transgenic line and this was aggravated at higher TM doses, presumably 
because high TM induced more efficient nuclear accumulation of CreERT2 (Schmidt et al. 
2000; Forni et al. 2006). 
However, in my studies such aberrations due to Cre genotoxicity seemed not to be 
important.  The fact that my transgenic line only carries one copy of the transgene (or two 
copies in the homozygotes) might explain the lack of Cre toxicity.  Homozygous mice for Cre 
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recombinase induced at embryonic ages live as long as one year of age without showing any 
aberrant phenotype.  Also, any embryos that showed morphologic defects or striking 
abnormalities were rejected from the present studies.  The results reported in this thesis 
using Nkx2.2-CreERT2 transgenic line were in any case always compared with/validated by 
control experiments. 
 
 
3.5. Discussion 
3.5.1. Assessing Nkx2.2-CreER
T2
 transgene expression 
To fate map the progeny of Nkx2.2-expressing p3 progenitors I generated an Nkx2.2-CreERT2 
PAC transgenic line by pronuclear injection.  Although the expression of Nkx2.2 is initially 
confined to the p3 domain, soon after E12.5 the domains of Nkx2.2 and Olig2 (which 
demarcates the pMN domain) switch from being mutually exclusive to overlapping (Zhou et 
al. 2001).  Moreover, later in development Nkx2.2 has also been reported to be expressed in 
differentiating oligodendrocytes (Qi et al. 2001).  I therefore made use of the tamoxifen-
inducible form of Cre recombinase (CreERT2) (Indra et al. 1999) to dissociate the different 
phases of Nkx2.2 expression by timed administration of tamoxifen.  The restricted 
expression pattern of Nkx2.2 in the neuroepithelium was faithfully recapitulated by CreERT2 
transgene in founder mouse lines up to E12.5.  However, the transgene failed to mimic the 
dorsal expansion of Nkx2.2 expression into the Olig2 domain during the gliogenic phase (at 
E12.5 and thereafter) and it was not observed being upregulated either in OLPs or in 
differentiating OLs.  Instead, the transgene expression was carried over in post-mitotic 
neuronal cells that appear to emanate from the p3 domain.  The fact that CreERT2 
expressing cells of the hindbrain co-labelled with neuronal markers such 5HT and Phox2b, 
specifically expressed in serotonergic neurons and branchial/visceral motor neuons, 
respectively, which are known to derive from p3 progenitors of the hindbrain, supports the 
hypothesis that Cre could be used as a neuronal lineage tracer of the p3 domain in the 
hindbrain and, by extension, in the spinal cord too.  If so we have to conclude that p3 
progenitors generate SPNs, the visceral motor neurons of the thoracic spinal cord, because 
they co-express Cre as well as their specific marker nNOS.  This is unexpected because SPNs 
have long been thought to share the same origin as sMNs – the pMN domain.  Other 
unidentified cells, possibly Sim1-positive interneurons and/or other interneurons, could also 
come from p3 progenitors as Cre-expressing cells are seen migrating away in a pattern that 
does not resemple SPNs (e.g. the expression pattern differs from the one of Chat staining).  
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Nonetheless, it remains possible that the Nkx2.2- CreERT2 transgene might be activated 
ectopically in those post-mitotic neuronal cells after they migrate away from p3 domain.  
Further studies are needed to iron out this potential complication (see chapter 4 for further 
discussion). 
How can we explain the aberrant and unexpected behaviour of the Nkx2.2-CreERT2 
transgene?  It is known that the insertion site of the transgene can influence the dynamics of 
expression (Clark et al. 1994).  It is also possible that regulatory elements that control 
Nkx2.2 might not be present in the transgene so as to ensure an accurate expression 
throughout development.  Actually, a study of functional screening for Shh regulatory 
elements uncovered that each of the 6 enhancers that play different roles during 
development are distributed as far apart as 400 kb (Jeong et al. 2006).  It is then possible 
that the chosen PAC, which spans merely 200kb, might not contain all the regulatory 
elements needed to mimic expression of Nkx2.2 exactly.  In addition, one cannot exclude 
the possibility that even though only ~50bp of genomic DNA is replaced by the CreERT2 insert 
that could itself result in a detrimental effect on the transcriptional regulation of the 
transgene. 
 
3.5.2. Tamoxifen recombination efficiency studies 
Successful activation of Cre was found to be dependant on the levels of Cre expression, Cre-
conditional reporter used, TM concentration, weight of pregnant female and stage of 
induction.  Different methods for administration of TM were employed and oral gavage was 
chosen as the most suitable and most reliable.  I have found with Nkx2.2-CreERT2 line that 
R26R-YFP (Srinivas et al. 2001) consistently gives higher recombination rates when compared 
with other Cre-conditional reporters.  Young et al. (2010) put forward a plausible 
explanation that could explain the utterly disparate Cre-recombination activity levels 
observed between, for example, R26R-YFP (very high) and R26R-GFP reporter line (Mao et al. 
2001) (virtually no recombination).  The fact that R26R-GFP contains 3 lox sites instead of 2 
as in R26R-YFP together with transient activation of CreERT2 only upon TM administration 
could hamper efficient activation of reporter gene (Young et al. 2010).  Nevertheless, the 
R26R-GFP reporter has often been reported to successfully recombine in constitutive Cre 
lines (e.g. Fogarty et al. 2005), so the activity of CreERT2 is probably reduced compared to 
the Cre protein.  
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Figure 3.1  -  Southern analysis of mouse genomic DNA using a NotI-XhoI fragment from 
mouse Nkx2.2 cDNA as a probe.  Above: Southern blot of mouse genomic DNA digested 
with ApaI, BamHI, XhoI or SacI and hybridized with the mouse Nkx2.2 cDNA fragment (620bp 
NotI/XhoI fragment).  The membrane was exposed to a Hiperfilm™ MP at -70°C, overnight.  
Size markers are shown on the left.  Below: Diagram of the mouse Nkx2.2 cDNA showing the 
position of the probe and the localization of the open reading frame (ORF), the position of 
the homeodomain (HD), and the positions of the exon I and exon II.  The NotI site lies in the 
vector backbone sequence just upstream of the cDNA insert.  The scale bar is 100bp. 
HD 
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Figure 3.2  -  One of the six panels of a membrane mouse PAC hybridised with mouse 
Nkx2.2 cDNA fragment (620bp NotI / XhoI fragment from pNkx2.2).  The membrane shows 
a positive signal (in duplicate) which corresponds to a Nkx2.2 PAC clone. The membrane was 
exposed to a Hyperfilm™ MP at -70°C, overnight. 
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Figure 3.3  -  Pulsed field gel electrophoresis of PAC DNA from the 4 selected Nkx2.2 
PAC clones digested with NotI and SalI enzymes.  The band corresponding to the backbone 
of the pPAC4 vector (16.7 Kb) is indicated by the blue arrow.  Size markers are shown on the 
left side of each gel photo.  See text for more details. 
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Figure 3.4  -  Inverse PCR strategy.  Above: schematic representation of the location of 
restriction sites of selected enzymes to carry out inverse PCR procedure (the sequence of 
the primers is shown in Table 2.1).  Below: an example of inverse PCR. 
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Figure 3.5  -  Structures of the selected Nkx2.2 PAC clones.  The 620bp NotI/XhoI probe 
from pNkx2.2 is represented by a dark blue bar (not to scale) and Nkx2.4 gene is 
represented by a light blue bar (not to scale).  Note that SalI enzyme cuts the PAC backbone 
only once.  The scale bar is 25Kb.  Arrows indicate direction of transcription. 
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Figure 3.6  -  The genetic strategy used to generate Nkx2.2-CreERT2 mouse line.  (A) Map 
of the genomic region of the unmodified PAC insert and the positions of Nkx2.2 and Nkx2.4 
genes.  (B) The endogenous Nkx2.2 locus (including its three transcript variants) and the 
relative location of the targeting vector containing the CreER
T2
 gene and a bacterial 
cloramphenicol resistance cassette (Cm
r
) flanked by FRT sites (arrowheads).  The ATG of the 
Nkx2.2 gene coincides with the ATG of the Nkx2.2-CreER
T2
 gene.  Exon structure is 
represented by boxes – black regions denote the open reading frame.  (C) The Cm
r
 cassette 
was removed before microinjection of the modified PAC (exemplified for “Transcript 2”).  
Note that the FRT site is not to scale. 
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Figure 3.7  -  Construction of Nkx2.2 targeting vector.  See section 3.2.3.2 for a 
description. 
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Figure 3.7 (cont.)  -  Construction of Nkx2.2 targeting vector.  See section 3.2.3.2 for a 
description.  The frt sites are represented in pink in the PI22 plasmid. 
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Figure 3.8  -  The Nkx2.4 targeting vector.  Alignment with Nkx2.4 gene from which there 
is only one transcript identified to date (see text for details). 
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Figure 3.9  -  Construction of Nkx2.4 targeting vector.  A 4-way ligation was carried out to 
combine the 536bp Nkx2.4 5’ homology, the 688bp Nkx2.4 3’ homology, the 1289bp Cm
r
 
cassette from PI22, and a modified pBluescript vector named pBluescriptSK PacAsc to 
produce Nkx2.4 targeting vector.  The ligation was digested with NotI before plating in the 
presence of chloramphenicol to reduce contamination from the plasmid backbones.  The frt 
sites are represented in pink in the PI22 plasmid. 
Isolate 
536bp  
EcoRI /PacI 
fragment 
(sequential 
digest with 
PacI 
followed by 
EcoRI) 
Ligate 
AscI/PacI 
digest 
Isolate 1289bp 
HindIII/EcoRI 
fragment 
Isolate 
688bp 
AscI/HindIII 
fragment 
 
Raquel Taveira-Marques Tracing NSCs in the ventral NT Figure 3.10 
 
 126/200
Figure 3.10  -  Schematic representation of pPAC4 vector map (top panel), and strategy 
cloning of ampicillin gene into pPAC4 vector backbone (bottom panel).  See text for 
details. 
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Figure 3.11  -  Checking removal of loxG.  Southern analysis of PstI digested PAC DNA from 
modified Nkx2.2 PAC clone ID:1 using XhoI/EcoRI fragment containing ampicilin gene (4 
mini-preps plus the negative control are shown).  Size markers are shown on the left.  See 
section 3.2.4.1 for a description. 
with 
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Figure 3.12  -  Removal of Nkx2.4 gene by homologous recombination.  On left: Southern 
analysis of HindIII digested PAC DNA from modified Nkx2.2 PAC clone ID:1 using 5’ homology 
of Nkx2.4 gene as a probe (3 mini-preps plus the negative control are shown).  On right: 
Pulse field gel electrophoresis of PAC DNA from unmodified Nkx2.2 PAC clone ID:1 (wt PAC) 
and from recombinant Nkx2.2 PAC clone ID:1 after removal of IoxG and Nkx2.4 (rec PAC, 
only one PAC preparation is shown).  PAC DNA was previously digested with NotI and SalI 
enzymes.  Size markers (white squares) or the expected fragment sizes (arrows) are shown 
on the left of each gel photo. 
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Figure 3.13  -  Insertion of Nkx2.2-CreERT2 targeting vector by homologous 
recombination and removal of chloramphenicol cassette.  Left: Primary and secondary 
screens of small libraries of Nkx2.2 PAC clone ID:1 without loxG and Nkx2.4 gene and with or 
without Nkx2.2-CreER
T2
 targeting vector inserted were performed using a specific probe to 
CreER
T2
 gene.  Right: Southern analysis was carried out to confirm the removal of Cm
r
 
cassette.  XhoI PAC DNA digests were probed with 3’ homology of Nkx2.2 gene (3 mini-preps 
plus the negative control are shown).  The expected fragment sizes are shown on the left. 
with 
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Figure 3.14  -  Genotyping of a candidate for Nkx2.2-CreERT2 transgenic line.  Southern 
analysis of SacI digested tail DNA from 5 pups using 3’ homology of Nkx2.2 gene.  Genomic 
DNA from (B6 x CBA)F1 mouse strain (C1 ) and genomic DNA from B6 mouse strain (C2) were 
used as negative controls.  Nkx2.2 PAC clone ID:1 DNA was used as a positive control (C+).  A 
founder is marked with an asterisk.   
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Figure 3.15  -  Defining the limits and pattern of CreERT2 expression.  (A-C) Expression of 
the endogenous Nkx2.2, Olig2, and the CreER
T2
 transgene revealed by 
immunohistochemistry.  Transverse sections of the cervical spinal cord at E10 (A) and upper 
thoracic spinal cord at E12.5 (B, C).  Cre transgene does not mimic Nkx2.2 expression 
pattern regarding its overlap with Olig2 at E12.5 (C; the dorsal limit of Nkx2.2 expression 
domain is marked with an asterisk).  (D-E) CreER
T2 
transcript expression in a pattern 
resembling that of migratory Sim1-positive cells (D) and V3 interneurons located in the 
ventral horn (E). In situ hybridization probes and antibodies used are as indicated.  
Tamoxifen was administered ~5hours before harvesting to assure translocation of CreER
T2
 
protein into the nucleus without YFP reporter activation.  See text for more details.  Scale 
bars in A, C & E, 50µm and in B, 100µm. 
Raquel Taveira-Marques Tracing NSCs in the ventral NT Figure 3.16 
 
 132/200 
 
Figure 3.16  -  Characterisation of CreERT2 transcript expression at E12.5 and E15.5.  
Differences between CreER
T2
 and Nkx2.2 expression were assessed by in situ hybridisation at 
various levels of the spinal cord (A-D; see text for more details).  A dorsal cell population is 
present at lower thoracic spinal cord but absent at other levels of the spinal cord.  This 
same dorsal cell population seem settling at the equivalent position of dorsal Sim1-positive 
cells (brackets in E).  Scale bars in A-D, 100µm. 
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Figure 3.17  -  CreERT2 expression in the hindbrain.  CreERT2 expression was assessed in 
flat-mounted hindbrains at E11.5 by in situ hybridization (A) and at E13.5 by 
immunohistochemistry (C).  Transverse sections of E11.5 (B) and of E13.5 hindbrains (D) 
were analysed for Cre protein expression at rhombomere (r) 4 and r3 (B and D, 
respectively).  mRNA probes and antibodies used are as indicated.  Sections were 
counterstained with Hoechst 33258 (Hst).  Scale bars in A &C, 250µm and in B & D, 100µm. 
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Figure 3.18  -  Marking SPNs, but not sMNs, by Cre labelling.  Consecutive and transverse 
sections of E12.5 spinal cord at upper thoracic level.  Antibodies used are as indicated.  See 
text for more details.  Scale bars in A &B, 50µm. 
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Figure 3.19  -  Dynamic expression of Nkx2.2 and Olig2 in the ventral spinal cord.  
Nkx2.2 and Olig2 expression domains change from mutually exclusive (A) to overlapping 
domains (B-D).  Specific OLP markers, Sox10 and PDGFRα, were detected within this 
overlapping domain at E12.5 (C and D).  Translocation of Nkx2.2 from nucleus to the 
cytoplasm can be observed as OLPs detach from the VZ (arrow heads in D, and most notably 
in Nkx2.2/Olig2 close-up).  Asterisk in D demarcates the dorsal limit of Nkx2.2 expression; 
albeit weaker in signal intensity, Nkx2.2 dorsal region of expression is up-regulated within 
the PDGFRα expression domain.  See text for more details.  Scale bars in A-D, 50µm. 
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Figure 3.20  -  Recombination efficiencies in various Cre-reporter lines.  (A-B) Reporter 
gene activation in Rosa26-YFP (A) and Rosa26-LacZ (B) mice.  Transverse sections of ventral 
spinal cord immunolabelled for YFP (A) or developed for β-galactosidase enzyme activity (B) 
at embryonic day 14.5 (E14.5), after administration of 200mg/Kg (A) or 280mg/Kg (B) of TM 
at E8.5.  (C-D) Reporter gene activation in Rosa26-GFP mice.  Immunofluorescence 
detection of GFP (arrows) in a few cells of the ventral spinal cord at E14.5 after 
administration of 200mg/Kg bw (C) or 400mg/Kg (D) of TM at E8 (transverse section). 
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Figure 3.21  -  TM administration-induced spontaneous abortion while influenced by 
dosage and time of injection and female’s age and weight.  Some critical TM dosages used 
in the experiments were plotted on a graph.  Every dot represents a single TM 
administration to a pregnant female with the age/weight at the time of TM injection 
specified in the y-axis.  Some females aborted beyond E13.5 after TM administration (A, C), 
while others were able to hold long term pregnancies (B, D; harvest after E13.5).  TM is 
likely to have a more detrimental effect on early stages of development or/and possibly on 
younger and lighter females too.  TM dosages were decided by taking the negative effects of 
TM on pregnancy in account, but aiming at reducing the length of time in each experiment.  
The fact that older females are less prone to breed was also taken into consideration. 
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Figure 3.22  -  The level of recombination following TM administration is dose-
dependent.  Transverse sections of ventral spinal cord stained histochemically for β-
galactosidase enzyme activity with X-Gal at specific embryonic day (E) after administration 
of the indicated dose of TM at E8.  At E10.5 there is barely detectable recombination with 
200mg/Kg TM compared to 400mg/Kg bw (body weight, bw). 
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Chapter 4  -   Fate mapping analysis 
 
 
4.1. Glia contribution from the p3 domain 
 
4.1.1. A proportion of radial glial cells derive from the p3 domain 
To fate map p3 progenitors, Nkx2.2-CreERT2 and Rosa26-YFP mice were crossed.  I 
administered a single dose of tamoxifen at specific embryonic days and immunolabelled for 
YFP at progressively later times.  For example, when tamoxifen was delivered E7.5 and 
animals analysed at E11.5, this is referred to as E7.5 → E11.5.  Initial studies were 
concentrated on the lower cervical spinal cord (C5 – C8).  Radial glia were the first cell type 
to express YFP and their long slender processes were invariably located close to the ventral 
midline (Figure 4.1).  YFP-labelled cells were densely packed in the most ventral region of 
the spinal cord.  Figure 4.1 shows the presence of YFP in radial glial fibres in E7.3 → E11.5 
mice.  These fibres can be seen to co-label with radial glial cell marker RC2 and to project 
radially to the pial surface, as described by Camillo Golgi in 1885 (for review see Bentivoglio 
et al. 1999).  Even at E14.5, YFP-labelled radial glial fibres were still visible (data not 
shown; instead see Figure 3.23).  In E7.3 → E11.5 cords a few cells had migrated out and lay 
just outside the VZ, remaining ventrally and close to their point of origin.  They could 
possibly be Sim1 - expressing V3 INs that are known to accumulate in the ventral horn 
(Briscoe et al. 1999); however, I could not ascertain it because neither neuronal marker 
NeuN is expressed at this age nor co-labelling of Sim1 with YFP is technically achievable for 
the time being. 
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4.1.2. Production of oligodendrocytes and astrocytes from the p3-
domain  
At lower cervical spinal cord, I observed that all p3-derived cells of E6.8 → P12.5 Nkx2.2-
CreER
T2 : Rosa26-YFP cords were invariably located close to the ventral midline in a 
“wedge” distribution which persisted until adult stages, suggesting that the majority of p3-
derived cells migrate radially from the VZ (Figure 4.1 B-F and data not shown).  To identify 
the various cell types produced from Nkx2.2-expressing progenitors, I have carried out 
double-immunolabelling for YFP together with different cell lineage markers.  Neurons were 
identified with neuronal marker NeuN (Mullen et al. 1992), astrocytes by the expression of 
GFAP (Debus et al. 1983) or S100β (Matus et al. 1975), oligodendrocytes for the presence of 
CC1 (Bhat et al. 1996) and Sox10 (Kuhlbrodt et al. 1998) or Olig2 (Lu et al. 2000), the latter 
markers also expressed by OLPs.  Many of the YFP-positive cells found within the wedge-
shaped area flanking the ventral midline co-labelled for glial markers (Figure 4.1 B-F).  The 
vast majority of all those cells were seen to colocalise with astrocytic markers GFAP and 
S100β.  Colocalisation of YFP and GFAP was observed in the ventral funiculus and in the 
ventral commissural axon tracts and in cells with fibres radially orientated (Figure 4.1 C).  
Their position together with their morphology identifies them as GFAP-positive fibrous 
astrocytes.  Moreover, the arrangement of the p3-derived fibrous astrocytes arrangement 
resembles that of radial glial processes present from earlier times, suggesting they might be 
produced via direct trans-differentiation of radial glia (Voigt 1989).  Colocalisation of YFP 
and S100β were mainly seen in the ventral horn gray matter (Figure 4.1 D).  These cells 
possess a unique morphology characterised by a relatively small S100β+/YFP+ cell body 
surrounded by a dense network of YFP-only positive processes, identifying them as 
protoplasmic actrocytes.  p3-derived protoplasmic astrocytes in gray matter were invariably 
associated with NeuN positive neurons, of which some were also YFP-positive.  The few 
NeuN-positive cells co-labelling for YFP were found to occupy laminae VII and VIII (Figure 4.1 
B), which allows them to be identified as ventral V3 INs (Briscoe et al. 1999; Zhang et al. 
2008).  Finally, a small proportion of YFP+ cells co-expressed the oligodendrocyte lineage 
marker Sox10, within which some were co-labelled for oligodendrocyte precursor (OLP) 
marker PDGFRα (data not shown; Pringle et al. 1992) and others co-expressed CC1, a marker 
of differentiated oligodendrocytes (Figure 4.1 F).   
 
Most importantly, the domain of YFP activation is located ventrally but outside the pMN 
domain (see Figure 3.16 C), a domain demarcated by Olig2 expression and which is thought 
to be the primary source of oligodendrocytes in the spinal cord (Lu et al. 2002; Takebayashi 
et al. 2002; Zhou et al. 2002; Tripathi et al. 2011).  The generation of oligodendrocytes from 
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Nkx2.2-positive progenitors has been reported in chick (Soula et al. 2001; Gotoh et al. 2011).  
Even if remote, there is the possibility that the YFP-labelled olidendrocytes in Nkx2.2-
CreER
T2 : Rosa26-YFP cords could come from progenitor cells that after being produced in 
the p3 domain migrate into the Olig2-expressing progenitor domain at a time when Nkx2.2 is 
known to expand into the pMN domain.  To be sure that oligodendrocytes labelled in Nkx2.2-
CreER
T2 : Rosa26-YFP cords are p3-derived I analysed E6.8 → E12.5 cords for colocalisation 
of YFP with Olig2 within the VZ.  Figure 4.2 shows that YFP-positive progenitors stay 
restricted to the p3 domain and they do not co-express Olig2.  Since I showed that the 
expression of the transgene does not expand dorsally (into the p* domain) as the 
endogenous Nkx2.2 expression does (see section 3.3.3 and Figure 3.16 C), I conclude that 
Nkx2.2 is up-regulated in cells of the pMN domain and progenitors from p3-domain do 
produce a few oligodendrocytes in mice. 
 
To further confirm that the generation of oligodendrocytes originate from the p3 domain 
and to investigate their distribution at earlier and later developmental stages, the 
expression of YFP and oligodendroglial markers, Olig2 or Sox10, were examined in E10.5 → 
E12.5 (Figure 4.3), E10.5 → E14.5 (Figure 4.4), E10.5 → E16.5 (Figure 4.5), E10.5 → P1.5 
(Figure 4.6), and E10.5 → P12.5 (Figure 4.7) Nkx2.2-CreERT2 : Rosa26-YFP spinal cords.  The 
production of p3-derived oligodendrocytes seems to begin as early as E12.5 (Figure 4.3) 
increasing gradually in number (Figure 4.4 – 4.5).  Postnatally, cells co-expressing YFP and 
Sox10 were concentrated mainly in the ventral funiculus (Figure 4.7).  However, YFP-
positive oligodendrocyte cells were also found scattered in other areas of the cord, such as 
the dorsal horn and funiculus (Figure 4.6 and 4.7), intermediate zone (Figure 4.7) and 
lateral funiculus (Figure 4.8).  At least some of them had attained a more mature phenotype 
as demonstrated by their labelling with CC1 (Figure 4.6).  Although a matter of speculation, 
it is worth observing that p3-derived oligodendrocytes tended to position themselves along 
the neuronal processes of p3-derived neurons (Figure 4.8). 
 
Restricted astrocytic distribution of YFP-positive cells in the ventral cord was still observed 
in E15.5 → P1 Nkx2.2-CreERT2 : Rosa26-YFP cords (Figure 4.9 A).  In E17.5 → P2 cords YFP+ 
astrocytes could still be seen in the ventral gray and white matter.  Some other YFP+ cells 
were noted in the ependymal layer (see below).  Taken together, these data indicate that 
generation of astrocytes and ependymal cells still takes place after E17.5 (Figure 4.9 B).   
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4.2. Remnants of embryonic p3 domain in the adult 
ependymal layer 
Previous works suggest that the ependymal cells around the central canal of the 
postnatal/adult spinal cord are derived from ventral Nkx6.1-expressing neuroepithelial 
domain of the embryo.  This is not only because ependymal cells express Nkx6.1 but also 
because fate mapping studies of progenitor domains more dorsal than the Nkx6.1-expressing 
domain show that they do not contribute to the ependymal layer (Fu et al. 2003; Fogarty et 
al. 2005; Fogarty 2006).  Consistent with this, YFP+ cells were found to be invariably located 
in the ventral half of the epithelial cell layer surrounding the postnatal central canal in 
postnatal Nkx2.2-CreERT2 : Rosa26-YFP spinal cords (Figure 4.10).  These postnatal 
ependymal cells could be fate mapped as late as E17.5 (that is after tamoxifen 
administration at E17.5) (Figure 4.9).  Making use of a knock-in mouse generated within the 
Richardson lab, which express Cre under the control of Olig2 promoter (D.H. Rowitch / N 
Kessaris, unpublished), I could show that ependymal cells are also derived from the pMN 
domain.  These ependymal cells were also found in the central and ventral parts of the 
postnatal ependymal layer, implying that dorsal ependymal cells are derived from the p2 
domain [since the Dbx1 domain (p1, p0, dp6 and dp5) does not contribute (Fogarty et al. 
2005)] (Figure 4.10).  The most ventral cells of the postnatal ependymal layer are not 
labelled in Olig2-Cre : Rosa26-YFP mice§§, and they possibly come from floor plate 
progenitors (Figure 4.10). 
 
 
4.3. Defining the neuronal lineages of the p3 domain 
The unexpected possibility of perdurance of CreERT2 in neurons derived from p3 progenitors 
fits in with the co-labelling of Cre with 5HT and Phox2b observed in the hindbrain (Figure 
3.18 and section 3.3.2).  To test whether CreERT2 expression could be a result of ectopic 
activation in post-mitotic neuronal cells after they had left the VZ, I have analysed YFP 
expression in thoracic spinal cords in early-induced Nkx2.2-CreERT2 : Rosa26-YFP cords.   
                                              
 
 
§§ In Olig2-Cre : Rosa26-YFP mice, both p3 and pMN progenitor domains are fate mapped 
(Dessaud et al. 2007; also see section 4.3.5) 
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The defined time of onset of Nkx2.2 protein expression at around E8.5 (Jeong et al. 2005) 
permitted me to estimate that of CreERT2 protein, which can only take place at or after 
E8.5.  The estimated serum lifetime of tamoxifen in vivo does not exceed 2 days (Robinson 
et al. 1991; Danielian et al. 1998; Buchanan et al. 2007).  I therefore examined the p3 
derived neuronal cells by administering tamoxifen before E6.5, early enough to avoid Cre-
recombination in cells other than p3 progenitors in the VZ, and searched for the expression 
of YFP and neuronal markers (nNOS and NeuN) in E5.5/6.5 → E13.5 Nkx2.2-CreERT2 : 
Rosa26-YFP spinal cords (Figure 4.11).  YFP-positive cells were observed to mimic the Cre 
expression pattern, although only a subset of p3 precursors was labelled because of 
inefficient recombination (Figure 4.11 A).  Some of the YFP-positive processes could be seen 
crossing the ventral midline (Figure 4.11 A arrow).  These processes belong to V3 INs that 
settle ventrally close to the floor plate (also labelled for YFP) and are known to be 
commissural neurons (Zhang et al. 2008).  Other YFP-labelled cells were located laterally 
and medially in the intermediate cord and co-expressed nNOS (Figure 4.11 A) and NeuN (not 
shown).  These cells could not be found in cervical spinal cord (not shown) and had spindle-
shaped soma often nested in the intermediolateral nucleus (IML), providing evidence of their 
SPN identity (Cabot 1990; Joshi et al. 1995).  SPNs can be retrogradly labelled with Di-I 
crystals applied to sympathetic chain ganglia.  Figure 4.11 B shows retrograde labelling from 
nerve terminals in the sympathetic chain ganglia of P0.5 Nkx2.2-CreERT2 : Rosa26-YFP mice 
TM-induced at ~E10.5***.  YFP- and Di-I positive cell can be seen in the IML nucleus and in 
other cells in the intermediate medial spinal cord (arrow heads in Figure 4.11 B), 
demonstrating that some YFP-positive cells are true SPNs. 
In E6.8 → P12.5 Nkx2.2-CreERT2 : Rosa26-YFP spinal cords, at lower thoracic level (around 
T8), some YFP-positive cells were identified as being neurons through their expression of 
neuronal marker NeuN (Figure 4.12 arrows).  The fact that these cells were located in the 
deep dorsal horn demonstrates that the dorsal CreERT2 expressing cells (Figure 3.17) do 
come from the p3 domain, then migrate to the dorsal horn and can persist postnatally.  As I 
mentioned earlier, dorsal CreERT2 expressing cells probably correspond to a group of 
interneurons that settle dorsally and express Sim1 during their development (Figure 3.17).  
It is an interesting idea that these interneurons might participate in local spinal circuits with 
SPNs (“sympathetic interneurons”). 
 
                                              
 
 
*** Repetitive administration of TM at later stages was carried out to allow long term pregnancy 
while providing a good level of recombination. 
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4.3.1. Tracing dorsal INs but not SPNs in Ngn3-Cre : Rosa26-YFP mice 
Ngn3 transcripts were expressed in p3 from E10.5 to E12.5, and more weakly in p1 to dp5 
(Figure 4.13 and 4.14).  Ngn3 is known to label Sim1-expressing V3 INs (Briscoe et al. 1999), 
hence the appearance of YFP-positive cells in the ventro-medial cord in Ngn3-Cre : Rosa26-
YFP cords.  A small number of dorsal neurons was also YFP-labelled in Ngn3-Cre : Rosa26-
YFP and they possibly are the same dorsally positioned group of YFP+ cells in Nkx2.2-CreERT2 
: Rosa26-YFP spinal cords described above (Figure 4.13).  On the contrary, Ngn3-Cre : 
Rosa26-YFP mice did not reveal YFP-positive SPNs at any age, suggesting that SPNs are 
specified before the onset of Ngn3 expression, that is before E10.5 (Figure 4.14).  Here, it is 
worth mentioning, that the dorsal expression domain of Ngn3 in the neuroepithelium is 
unlikely to be the source of the above-mentioned dorsally positioned neurons because the 
latter are not fate-mapped in Dbx1-Cre : Rosa26-YFP  mice (Fogarty et al. 2005; data not 
shown). 
 
4.3.2. Lack of dorsal p3-derived neurons in Nkx2.2 null mice 
If the dorsal CreERT2 expressing cells found at lower thoracic levels of the cord (T8 and more 
caudal) were indeed p3 derived cells and putatively Sim1-expressing neurons, one might 
expect they would not be present in Nkx2.2 null mice.  Confirming this expectation I found 
that the dorsal CreERT2 expressing cells as well as Sim1+ V3 INs, known to derive from 
Nkx2.2-positive progenitors (Briscoe et al. 1999), were missing in Nkx2.2 mutants (Figure 
4.15).  Incidentally, p3-progenitors (strong labelling in ventral midline) together with SPNs 
and some unidentified ventral CreERT2-expressing cells were still present in mice lacking 
Nkx2.2.  The existence of p3-progenitors suggests that other unidentified factors act to 
specify and maintain the p3 domain.  
 
4.3.3. SPN production does not require Nkx2 activity 
It is shown that Nkx2.2-expressing precursors generate Sim1-positive V3 interneurons in the 
spinal cord, and serotonergic interneurons and visceral motor neurons in the hindbrain 
(Ericson et al. 1997b; Briscoe et al. 1999). Nkx2.2 activity is required not only for the 
formation of Sim1-positive V3 interneurons in the spinal cord but also for the production of 
p3-derived serotonergic interneurons in the hindbrain (Briscoe et al. 1999).  Meanwhile, 
Nkx2.2 null mice do not lack p3-derived visceral motor neurons (vMNs) of the hindbrain and 
it was suggested that this reflects a redundancy in activity of the closely related Nkx2.9 
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(Briscoe et al. 1999).  Since Nkx2.9 is expressed both in the p3 domain of the spinal cord and 
in the hindbrain (Pabst et al. 1998), I tested the possibility that Nkx2.9 compensates for the 
loss of Nkx2.2 activity in Nkx2.2 null cords.  However, I found that SPNs form in mice that 
lack either Nkx2.2 or Nkx2.9 or both, judging by the expression of nNOS at E13.5 (Figure 
4.16). 
 
4.3.4. SPN development depends on sonic hedgehog signalling in 
Nkx2.2-progenitors 
SHH activity is necessary for normal formation of most ventral progenitor domains in neural 
tube.  Alteration of SHH signalling through disruption of Smo (encoding the SHH signalling 
receptor Smoothened) results in changes to the properties and/or fates of the ventral 
progenitors.  In an attempt to specifically impair specification of Nkx2.2-expressing 
progenitors, Nkx2.2-CreERT2 mice were crossed with Smoflox/flox mice to ablate SHH signalling 
within p3 domain.  E6.5/7.5 → E13.5 Nkx2.2-CreERT2 : Smoflox/flox cords were then examined 
for the expression of nNOS and HB9, which mark SPNs and sMNs, respectively.  I found that 
the number of PGNs decreased by 52% +/- 6% (mean +/- s.e.; n=3), without significant 
variation in the number of sMNs (Figure 4.17), reinforcing the idea that SPNs and sMNs have 
separate developmental origins.   
In Shh null mice, the most ventral progenitor domains (p3, pMN and p2) are lost and instead 
the ventral-most region adjacent to the floor plate acquires p1-domain characteristics and 
up-regulates Dbx1 (which is normally expressed in progenitor domains occupying either sides 
of the dorsoventral midline; Pierani et al. 1999).  To confirm whether the observed reduction 
in SPN numbers corresponded to a loss of Shh activity in the p3 domain, I analysed E6.5/7.5 
→ E11 Nkx2.2-CreERT2 : Smoflox/flox cords for the expression of Dbx1.  I identified a few cells 
expressing Dbx1 ectopically in the most ventral region of the spinal cord where p3-domain 
was supposed to form, implying that Shh was missing in those Dbx1-labelled progenitor cells 
(Figure 4.18). 
 
4.3.5. Olig2 loss of function impairs generation of both SPNs and 
sMNs 
Current understanding of the developmental origin of SPNs is that they are formed from the 
same pool of Olig2-expressing progenitors as somatic motor neurons (Lu et al. 2002; 
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Takebayashi et al. 2002; Zhou et al. 2002).  To confirm that SPN generation requires Olig2, I 
analysed Olig2 mutant cords for the presence of SPNs and found that both SPNs and sMNs 
were missing (Figure 4.19), as previously described (Lu et al. 2002; Takebayashi et al. 2002; 
Zhou et al. 2002).  Figure 4.19 also shows some nNOS-positive cells scattered throughout the 
ventral cord of Olig2 null mice that were missing in control littermates.  Although they 
express nNOS, these cells are unlikely to be misplaced SPNs since Isl1- as well as Hb9-
positive cells are not present in Olig2 null cords (Zhou et al. 2002; Lu et al. 2002)†††. 
Nonetheless, expression of nNOS is not retricted to autonomic motor neurons because 
ventral neurons in laminae VII, VIII, IX have also been shown to express nNOS (Reuss et al. 
2001).  On a more speculative note, those nNOS-positive cells scattered in the ventral cord 
of Olig2 null mice could arise from progenitor domains affected by the loss of the Olig2-
expressing pMN domain.  In Olig1/2 null mice, for example, pMN domain is converted into a 
“p2-like” domain with concomitant increase in Chx10-expressing V2 INs (Lu et al. 2002; Zhou 
et al. 2002), while other nearby domains, such p1 and p3 domains, are unaffected. 
 
Therefore, paradoxically, SPNs seem to derive from Nkx2.2-expressing progenitors yet also 
require OLIG2 for their development.  A possible explanation for this lies in the fact that 
Nkx2.2-positive cells are known to express Olig2 at very early developmental stages (Jeong 
et al. 2005; Dessaud et al. 2007), so it is possible that SPNs derive from progenitors that 
transiently express both Nkx2.2 and Olig2.  Another possible explanation might be that the 
requirement for Olig2 in SPN generation is not cell-autonomous – i.e. some interaction 
between the Olig2-expressing cells and Nkx2.2-expressing progenitors might be required for 
SPN production. 
 
To determine wether SPNs descend from Olig2-expressing progenitors, Olig2–Cre : Rosa26-
YFP spinal cords were examined for the expression of YFP and SPN markers, such nNOS.  
YFP-labelled cells (presumed SPNs) were then seen in the IML, co-expressing nNOS, and in 
the ventral horn where sMNs are known to settle (Figure 4.20), confirming that SPNs as well 
as sMNs derive from Olig2-expressing progenitors.  Therefore, my results suggest segregated 
origins for autonomic versus somatic motor neurons, in that SPNs are generated by 
progenitors with a history of both Nkx2.2 and Olig2 expression, whereas sMNs originate from 
progenitors that only express Olig2.  In the hindbrain, where sMNs and vMNs are known to be 
derived from separate progenitors domains (pMN and p3 respectively) (Osumi et al. 1997; 
                                              
 
 
††† Isl1 and Hb9 have been reported to be crucial genes to the development of SPNs (Pfaff et al. 
1996; Arber et al. 1999). 
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Ericson et al. 1997b), it also seems that p3 progenitors express Olig2 transiently during early 
development because I was able to observe YFP-positive p3-derived neurons (Phox2b and 
5HT-expressing neurons) in Olig2–Cre : Rosa26-YFP mice (Figure 4.20).  
 
 
4.4. Discussion 
 
4.4.1. Summary of the results 
Using Cre-loxP technology I have fate-mapped the Nkx2.2-expressing p3 domain of the 
embryonic neural tube and shown that it generates neurons, oligodendrocytes, astrocytes 
and ependymal cells.  A population of radial glial cells are also p3-derived and are 
presumably the first to be generated, followed by neurons and glia.  Different populations 
of p3-derived neurons were identified in the spinal cord: 1) Sim1-expressing V3 INs, 2) an 
unidentified dorsally-located Sim1-positive neuronal population, and 3) the pre-ganglionic 
motor neurons of the sympathetic nervous system (SPNs).  The majority of p3-derived glia 
were invariably found within a wedge-shaped area close to their site of origin, although a 
few oligodendrocytes were seen scattered throughout the spinal cord.  p3-derived 
astrocytes included two subtypes - fibrous and protoplasmic astrocytes.  p3-derived fibrous 
astrocytes were GFAP-positive and settled in the ventral funiculus whereas most 
protoplasmic astrocytes expressed S100β and very little or no GFAP, and occupied the 
ventral gray matter.  These cells have small cell bodies surrounded by a dense mass of fine 
branching processes.  Finally, ependymal cells originating in the p3 domain were 
occasionally detected and found embedded in the neuroepithelial cell layer that surrounds 
the postnatal central canal. 
 
4.4.2. Segregated origins for somatic and autonomic motor neurons 
The inducible Cre recombinase is a valuable tool for fate-mapping experiments inasmuch as 
it enables us to label progenitor cells and all its progeny in a spatio-temporally controlled 
manner.  However, the technique involves the use of tamoxifen (TM) for activating Cre-
recombinase which raises some problems.  It has been reported that the serum lifetime of 
TM is approximately 24hours (Danielian et al. 1998); however, higher doses can last longer in 
mother’s serum (Robinson et al. 1991).  To test whether recombination of the Rosa26-YFP 
reporter in SPNs could be a result of ectopic activation of CreERT2 in SPNs or in their 
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migratory restricted-precursors, I administered TM early enough to not get labelled those 
migratory restricted-precursors (CreERT2–positive cells).  For that I assumed that TM would 
not last more than 2 days, based on the available published data.  In this context, it would 
be important to ascertain that the administered TM dose in those early fate-mapping 
experiments does not indeed exceed 2 days in mother’s serum.  
Additional supporting evidence for a p3-derived origin of SPNs relies on partial ablation of 
SHH signalling in p3 progenitors, through conditional deletion of the Smo receptor in Nkx2.2-
CreER
T2
 : Smo
flox/flox mice.  Depletion of SPNs without altering sMNs numbers and/or 
distribution.  The specific deletion of Smo in p3 progenitors was then confirmed by the 
ventral ectopic activation of Dbx1, which is known to be up-regulated in the absence of SHH 
signalling at more dorsal regions of the spinal cord (Pierani et al. 1999).  Despite the very 
small number of Dbx1-positive cells observed within the p3 domain, the number of nNOS-
positive SPNs was significantly decreased by ~50%.  This discrepancy could be explained by 
the lapse of time needed to activate the targeted disruption of SHH signalling in p3 
progenitors.  DBX1 is known to be expressed only in the neuroepithelium and downregulated 
immediately after cells migrate away from the VZ (Pierani et al. 2001).  If total disruption of 
SHH signalling occurs in the neuroepithilum, then that results in up-regulation of Dbx1 
expression in p3-progenitors.  But, the same does not accur if complete ablation of Shh 
signalling happens in cells already migrated away from the VZ, which are no longer 
competent to express Dbx1.  Another potential pitfall could derive from the perdurance of 
Smo expression in migratory cells leaving the VZ.  This is not expected however to happen 
having in mind similar studies in forebrain.  It has been reported that SHH signalling does 
not have any effect on migration/maturation of interneuron populations of the brain but 
only during their specification in timed-deletion of Smo experiments (Fuccillo et al. 2004; 
Xu et al. 2010).  A similar experimental stategy could be used to assess that deletion of Smo 
is restricted to p3-progenitors – which would include administer TM at later times of 
development (for example E8.5/9.5) and analyse for the presence of SPNs (expected to 
appear in normal numbers and distribution) at E13.5. 
Despite deriving from Nkx2.2-expressing precursors, production of SPNs appears not to 
require NKX2.2 function since they are present in Nkx2.2 null cords.  They seem not to 
require NKX2.9 for their development either, as suggested previously for visceral MN 
development of the hindbrain (Briscoe et al. 1999), and they develop apparently normally 
even in the absence of both NKX2.2 and NKX2.9 (Figure 4.16).  Presumably other factors are 
needed for SPN specification from p3-progenitors.  For example, it is reported that in the 
hindbrain PHOX2b plays a key role in vMN differentiation (Pattyn et al. 2000).  It is worth 
mentioning that a p3 Pax6-independent domain still persists in the absence of Nkx2.2 and/or 
Nkx2.9, hence the lack of expansion of Pax6 expression domain in those mutants 
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(Genethliou et al. 2009; Holz et al. 2010).  Since somatic MNs are known to derive from the 
Pax6/Olig2-expressing domain it implies that the presence of SPNs could be correlated with 
the lack of expression of Pax6 in the p3 domain. 
I also found that SPNs come from progenitors with a history of both Nkx2.2 and Olig2 
because I was able to label them in Nkx2.2-Cre-ERT2 : Rosa26-YFP  and  Olig2-Cre : Rosa26-
YFP cords.  Since sMNs are known to derive from Olig2-expressing progenitors, that implies 
that separate pools of progenitors produce SPNs and sMNs.  The expression of Olig2 in p3 
progenitors is in agreement with previous studies demonstrating that OLIG2 is expressed in 
the most ventral regions of the neural tube at very early stages of development, overlapping 
with the Nkx2.2 expression domain between ~E8.5 and ~E9.5, before retreating from the 
most ventral region to form the pMN domain (Takebayashi et al. 2000; Jeong et al. 2005; 
Dessaud et al. 2007).  Taken together, my results support separate origins for somatic and 
visceral motor neurons – the latter deriving from progenitors in the region of overlap 
between Nkx2.2 and Olig2 existing prior to ~E9.5, and the former from progenitors that 
never express Nkx2.2.  My results also imply that a first level of subtype specification in MN 
development already occurs in the neuroepithelium, leaving room for further diversification 
of MNs as cells migrate away from VZ. 
 
4.4.3. Glial cells generated within p3-domain 
In mice, p3-derived progenitors give rise to oligodendrocytes, as in chick (Gotoh et al. 2011), 
as well as two types of astrocytes – fibrous astrocytes in white matter, as previously 
reported (Hochstim et al. 2008) and protoplasmic astrocytes in gray matter.  p3-derived 
astrocytes migrate in a strictly radial fashion and settle only in the ventral spinal cord.  p3-
derived oligodendrocytes represent a very small fraction of the total spinal cord 
oligodendrocyte population (estimated to be ~3%) and they remain largely confined to the 
ventral funiculus; however, a sparse population of p3-derived oligodendrocytes can be 
observed postnatally.  Both astrocytes and most of the oligodendrocytes settle close to their 
site of origin, the region to which their radial glia precursors originally project to, 
suggesting they are produced by transformation of radial glia as reported for Dbx1- and 
Msx3-derived glia (Fogarty et al. 2005; Fogarty 2006).  Taken together the data obtained 
from Dbx1-, Msx3- and Nkx2.2- Cre lines, one can anticipate the following common features 
for the production of astrocytes: 1) both fibrous and protoplasmic astrocytes derive from 
common precursors (specially demonstrated with Nkx2.2-CreERT2 line; this Thesis) 2) they 
are all very much restricted in their migratory properties, settling close to or radially 
opposed to their respective progenitor domain and 3) there are multiple origins for 
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astrocytes along the neuroepithelium.  A more exhaustive fate-mapping study throughout 
the various neuroepithelial domains of the spinal cord has been addressed elsewhere (Tsai 
et al. in preparation).  The fact that astrocytes can arise from different progenitor domains 
opens the possibility of functionally distinct astrocytes being derived from different 
progenitor domains, as it is observed in interneuron development (Lewis 2006; Goulding 
2009), but further studies will be needed to answer that and other questions.   
Oligodendrocytes also can come from different regions of the neuroepithelium with 
different progenitor domains contributing in varying degree to the total number of spinal 
cord oligodendrocytes.  The majority of oligodendrocytes (~80%) in the spinal cord come 
from the pMN domain (Richardson et al. 2006; Tripathi et al. 2011), whereas Dbx1- or p3-
derived oligodendrocytes account for a comparatively small contribution (Fogarty et al. 
2005; Tripathi et al. 2011; this Thesis).  Although generated from various progenitor 
domains, oligodendrocytes derived from different sources have similar electrical properties 
(Tripathi et al. 2011), suggesting that they could substitute for each other if required.  
Fittingly, OLPs derived from different regions of the forebrain were shown to be functionally 
redundant, for example ventrally-derived OLPs were able to compensate for the loss of 
dorsally-derived OLPs (Kessaris et al. 2006).  A similar situation has been recently described 
in the dorsal funiculus of the spinal cord where the original ventrally-derived 
oligodendrocytes are replaced by dorsally derived oligodendrocytes later in development 
(Tripathi et al. 2011).  Some differences among species have been noted as well.  Whereas in 
chick the majority of oligodendrocytes come predominantly or exclusively from the 
overlapping region of NKX2.2 and OLIG2 (Soula et al. 2001; Richardson et al. 2006), in rodents 
they arise from all parts of the Olig2-expressing pMN-progenitor domain.  However, the 
primary source of oligodendrocytes in the rodent spinal cord might actually be the Olig2-, 
Nkx2.2-expressing p*-domain since substantial overlap with Sox10/ PDGFRa-expressing 
region is observed at E12.5 (Figure 3.20).  Unfortunately, this cannot be teased out using my 
Nkx2.2-CreER
T2 line since the transgene is not expressed in the p* domain as the endogenous 
gene is (Figure 3.16). 
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Figure 4.1  -  p3 generates radial glial cells, neurons and glia.  (A) A sub-population of 
radial glial cells (RC2-expressing cells) co-labels with YFP identifying them as p3-derived.  
Their processes project to the pial surface close to ventral midline.  (B-F) Sub-populations of 
neurons (Neu
+
), astrocytes (GFAP
+
 or S100b
+
) and oligodendrocytes (Sox10
+
 or CC1
+
) are also 
YFP-labelled, hence p3-derived.  See text for more details.  Scale bars in A, 50µm and in B, 
100µm. 
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Figure 4.2  -  Nkx2.2-expressing p3-derived cells do not migrate to the pMN domain 
during expansion of Nkx2.2 into the Olig2 domain.  Transversal sections of Nkx2.2-
CreERT2 : Rosa26-YFP cord immunolabelled for YFP and Olig2.  No YFP-positive cells can be 
seen labelling with Olig2, which implies that YFP-positive cells do come from Nkx2.2-
expressing p3 progenitors. Mother was induced at E6.5 and E6.8 and analysed at E12.5. 
Scale bar is 50µm. 
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Figure 4.3  -  Rare appearance of p3-derived OLPs at E12.5.  Double labelling of YFP and 
Olig2 on transverse section at cervical levels of E12.5 spinal cord shows colocalisation in 
migratory oligodendrocyte precursors (arrow), albeit rare to find. 
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Figure 4.4  -  A few more OLPs derive from p3 progenitors at E14.5.  Transversal sections 
of cervical spinal cord of E10.5 → E14.5 Nkx2.2-CreER
T2
 : Rosa26-YFP mice immunolabelled 
for Sox10 and YFP. 
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Figure 4.5  -  p3-derived oligodendrocytes appear more often at later stages of 
embryogenesis.  Double labelling of YFP and Sox10 (for example, see arrows and arrow 
heads) on transverse section at cervical levels of E16.5 spinal cord shows colocalisation in 
p3-derived oligodendrocyte located in the ventral funiculus possibly generated by trans-
differentiation of radial glia. (see text for more details). 
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Figure 4.6  -  p3-derived OLPs can differentiate into mature oligodendrocytes.  
Transversal section of E6.5 → P1.5 Nkx2.2-CreER
T2
 : Rosa26-YFP cervical spinal cord 
immunolabelled for YFP (green) and CC1 (red), a monoclonal antibody that recognises 
adenomatosis polyposis coli (APC) which is up-regulated in myelinating oligodendrocytes.  
Arrows show co-labelling of YFP (green) with CC1 (red). 
YFP / CC1 
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Figure 4.7  -  Wide distribution (but low number) of p3-derived oligodendrocytes 
throughout the spinal cord.  Transversal sections of cervical spinal cord of E10.5 → P12.5 
Nkx2.2-CreER
T2
 : Rosa26-YFP mice immunolabelled for Sox10 and YFP. 
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Figure 4.8  -  Some p3-derived oligodendrocytes tend to position themselves along the 
neuronal processes of p3-derived neurons.  Transversal sections of upper thoracic spinal 
cord of E14.5 → P13.5 Nkx2.2-CreER
T2
 : Rosa26-YFP mice immunolabelled for NeuN and YFP. 
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Figure 4.9  -  Restricted distribution of p3-derived astrocytes to the ventral spinal cord 
during late embryogenesis.  Transversal sections of cervical spinal cord of E15.5 → P1 (A) 
or E17.5 → P2 (A) Nkx2.2-CreER
T2
 : Rosa26-YFP mice.  Antibodies used are as indicated.  
Sections were counterstained with Hoechst 33258 (blue staining). 
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Figure 4.10  -  Ependymal cells of the spinal cord derive from ventral progenitors only.  
Above: Transversal sections of cervical E6.8 → P12.5 Nkx2.2-CreER
T2
 : Rosa26-YFP cords.  
Below: Transversal sections Olig2-Cre x YFP at P10 (thoracic spinal cord).  Antibodies used 
are as indicated.  Sections were counterstained with Hoechst 33258 (Hst, blue). 
YFP/Olig2/Hst 
YFP/GFAP/Hst 
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Figure 4.11  -  Characterisation of YFP-labelled SPNs.  Above: Transversal section of 
E5.5/6.5 → E13.5 Nkx2.2-CreER
T2
 : Rosa26-YFP thoracic spinal cord.  Below: Retrograde 
labelling of SPNs in E10.5/11.5/12.5 → P0.5 Nkx2.2-CreER
T2
 : Rosa26-YFP thoracic spinal 
cord.  Antibodies used are as indicated. See text for more details. 
YFP / Di-I 
A 
B 
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YFP / NeuN 
YFP 
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Figure 4.12  -  YFP+, NeuN+ neurons in deep dorsal horn are p3 derived.  E6.8 → P12.5 
Nkx2.2-CreER
T2
 : Rosa26-YFP spinal cords, at lower thoracic level (around T8) 
immunolabelled for NeuN and YFP.  Arrows point towards YFP
+
, NeuN
+
 neurons. 
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Figure 4.13  -  Dorsal interneurons are labelled in Ngn3-Cre : Rosa26-YFP mice.  Above: 
Expression of endogenous Ngn3 at E12.5 revealed by in situ hybridization, further 
immunolabelled for Olig2.  Below: Transversal section of E16.5 lower thoracic spinal cord of 
Ngn3-Cre : Rosa26-YFP.  Antibodies used are as indicated.  Scale bar in A, 200µm.  Images 
kindly provided by Hui-Hsin Tsai (Rowitch lab, UCSF). 
E16.5 
E12.5 
Olig2 ngn3 
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Figure 4.14  -  SPNS are not fate-mapped in Ngn3-Cre : Rosa26-YFP mice.  Above: 
Expression of endogenous Ngn3 at different embryonic stages, revealed by in situ 
hybridization.  Below: Transversal sections of E13.5 thortacic spinal cord of Ngn3-Cre : 
Rosa26-YFP mice immunolabelled for nNOS and YFP.  Images kindly provided by Hui-Hsin 
Tsai (Rowitch lab, UCSF). 
YFP nNOS 
E’ E’’ 
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Figure 4.15  -  Dorsal CreERT2-expressing neurons as well as Sim1-positive V3 INs are 
missing in Nkx2.2 mutants.  CreERT2 transgene transcript at E15.5, revealed by in situ 
hybridisation.  Transversal sections of Nkx2.2 null mice (-/-) and respective wild type 
littermate (+/+) at lower thoracic levels of the cord (around T8, above, and more caudal, 
below).  Arrows indicate SPNs and square brackets, dorsal CreER
T2
-expressing neurons. 
+/+ -/- 
+/+ -/- 
CreER
T2
 
 
CreER
T2
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Figure 4.16  -  Presence of SPNs in mice lacking either Nkx2.2 or Nkx2.9 or both genes.  
Transversal sections of thoracic spinal cord immunolabelled for nNOS at E13.5.  SPNs 
(arrows) are generated in Nkx2.2, Nkx2.9 and Nkx2 double knock-out mice in normal 
numbers and distribution as the ones in the wild type (Wt) littermates.  Cell nuclei were 
poststained with Hoechst 33258 (Hst, blue). 
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Figure 4.17  -  Loss of SPNs, but not sMNs, due to the disruption of p3-progenitor 
specification.  Tamoxifen was administered to pregnant mother twice at E6.5 and E7.5 and 
embryos analyzed at E13.5.  Immunolabelling of consecutive sections of Nkx2.2-CreER
T2
 : 
Smo
flox/flox
 thoracic spinal cord for nNOS and HB9 to visualise SPNs and sMNs, respectively.  
Disruption of SHH signalling specifically in p3-progenitors only affects SPNs production, but 
not that of sMNs, suggesting that SPNs and sMNs come from separate progenitor pools. 
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Figure 4.18  -  Targeted loss of Shh signalling in p3 domain leads to ectopic activation of 
Dbx1 in the ventral spinal cord.  Expression of Dbx1 in E6.5/7.5 → E11 Nkx2.2-CreERT2 : 
Smo
flox/flox
 cords revealed by in situ hybridisation. 
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Figure 4.19 -  Apparent absence of SPNs in Olig2 null spinal cords.  Immunoflourescence 
detection of nNOS in Olig2 null spinal cords and respective control littermate.  Two 
transverse sections of thoracic spinal cord are shown for each genotype.  nNOS
+
 cells are 
seen in Olig2
-/-
 cords but they are not clustered in the intermediate cord where SPNs are 
normally found (arrows).  The identity of these scattered nNOS
+
 cells is not known. 
Olig2 -/- Wt littermate 
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Figure 4.20  -  Tracing visceral motor neurons in Olig2-Cre mice.  Above: Transversal 
section of E12.5 thoracic spinal cord of Olig2–Cre : Rosa26-YFP.  Below: Hindbrain of Olig2–
Cre : Rosa26-YFP at the level of rhombomere 5 (r5) at E12.5.  Antibodies used are indicated. 
Sections were counterstained with Hoechst 33258 (Hst, blue). 
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Chapter 5  -   Conclusion 
 
5.1. Summary of 
results 
The experimental strategy adopted 
in this Thesis involves the use of 
Cre-mediated recombination in 
transgenic mice to follow the cell-
fates of precursors expressing 
Nkx2.2 in the p3 domain of the 
spinal cord neuroepithelium.  
Although the initial expression of 
Nkx2.2 is initially confined to the 
p3 domain, soon after E12.5 the 
domains of Nkx2.2 and Olig2 (which 
demarcates the pMN domain) 
switch from being mutually 
exclusive to overlapping (Zhou et al. 2001).  In order to label cells emanating from the p3 
domain and not from pMN, I have used a tamoxifen-inducible form of Cre-recombinase (Cre-
ER
T2) which requires ligand (tamoxifen, TM) binding for activation.  To insert the coding 
region of Cre-ERT2 into the Nkx2.2 locus I used PAC vector and homologous recombination in 
bacteria.  Mouse PAC clones that carry genomic DNA inserts containing Nkx2.2 flanked by 
large genomic regions likely to include all the regulatory elements required for normal 
expression of Nkx2.2 were identified.  Suitable PAC inserts were then genetically engineered 
to ensure that Cre-ERT2 expression under the control of the Nkx2.2 gene behaved in the 
same pattern as the endogenous gene.  The resultant modified PAC was subsequently used 
for oocyte injections and generation of transgenic mice.  Mice expressing Cre-ERT2 under the 

 Sidney Harris 
Sciencecartoonsplus.com 
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control of Nkx2.2 (Nkx2.2-Cre-ERT2 mice) were then bred with reporter mouse strains 
containing an inactive reporter gene under the control of an ubiquitous promoter.  The 
reporter gene was constitutively activated by Cre-mediated recombination upon TM 
administration, which allowed me to permanently label all the progenitor cells that express 
Nkx2.2 and all their progeny once Cre-ERT2 was activated.  TM administration was found to 
yield suitable levels of recombination when mature Rosa26-YFP reporter mice were used and 
TM was administered by gavage at the highest dose not conducive to significant levels of 
lethality.   
Fate-mapping experiments using Nkx2.2-Cre-ERT2 : Rosa26-YFP mice enabled me to 
demonstrate that Nkx2.2-expressing p3 neuroepithelial cells of the spinal cord give rise to 
three distinct neuronal populations - Sim1-expressing V3 interneurons, pre-ganglionic motor 
neurons of the sympathetic nervous system (SPNs, visceral motor neurons of the thoracic 
spinal cord) and dorsally-located Sim1-expressing interneurons.  Nkx2.2-expressing p3-
progenitors also produce two spatially restricted subtypes of astrocytes (fibrous and 
protoplasmic), a small number of oligodendrocytes and ventrally-positioned ependymal 
cells.  The majority of p3-derived glia (all astrocytes and a subset of p3-derived 
oligodendrocytes) migrate in a strictly radial manner and their final settling positions are 
confined to the most ventral regions of the spinal cord.  Because of p3-derived glia settle 
within the region that their radial glia precursors originally project to, one can speculate 
that most p3-derived glia originate from p3-derived radial glia by direct trans-
differentiation, as shown directly for oligodendrocytes that originate in the more dorsal 
Dbx1- or Mxs3- domains (Fogarty et al. 2005; Fogarty 2006; Richardson et al. 2006).  Some 
scattered p3-derived oligodendrocytes were also found spread throughout the spinal cord.  
They cannot be derived directly from p3-derived radial glial, but could come from 
intermediate precursors that are derived initially from p3-derived radial glia and which 
proliferate and migrate over relatively long distances.  It is known that ~80% of mature 
oligodendrocytes which populate the entire adult spinal cord arise from highly proliferative 
and migratory restricted progenitors – the so-called OLPs –that derive from the pMN domain 
(Richardson et al. 2006; Tripathi et al. 2011).   
I found that Cre-ERT2 continues to be expressed (perdures) in SPNs and in p3-derived 
ventrally and dorsally-located Sim1-expressing interneurons after Nkx2.2 is extinguished.  
One can be fairly confident that Cre-ERT2 behaves as a short-term p3 lineage tracer, because 
dorsally-located Sim1 / CreERT2-expressing interneurons, as well as ventrally-located V3 INs, 
are lost in Nkx2.2 null mice.  Moreover, conditional loss of SHH signalling in Nkx2.2-
expressing p3-precursors causes disruption to SPN production, and to that of CreERT2-
expressing cells at the same location, without affecting sMNs.  I also found that SPNs come 
from progenitors with a history of both Nkx2.2 and Olig2 because I was able to label them in 
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Nkx2.2-Cre-ER
T2 
: Rosa26-YFP  and  Olig2-Cre : Rosa26-YFP cords.  Since sMNs are known to 
derive from Olig2-expressing progenitors only, it implies that separate pools of progenitors 
produce SPNs and sMNs.  Therefore, my results support a model in which motor neuron 
subtype specification already takes place in progenitor cells before they migrate away from 
the VZ.  In the developing hindbrain, it is accepted that visceral and somatic MNs are 
derived from separate progenitor pools – the former from p3 progenitors and the latter from 
pMN ones.  Additionally, I show that visceral MNs in the hindbrain originate from progenitors 
with a history of both Nkx2.2 and Olig2, like their counterparts in thoracic spinal cord, 
whereas sMNs arise from progenitors that never express Nkx2.2.  This is the same as I 
observed in the spinal cord, allowing me to propose that the same general program of MN 
specification is orchestrated all along the neuraxis. 
 
5.2. Future developments/applications 
The fact that visceral and somatic motor neurons develop from separate progenitor pools 
raises the possibility that the transcriptional programs underpinning their specification 
might differ substantially.  It also establishes the idea that the mechanisms involved during 
visceral motor neuron development operating in the brainstem versus spinal cord could have 
more common features than we previously believed.  The prospect of being able to find 
unique factors that specify visceral motor neuron development, distinct from those linked to 
somatic motor neuron development, would allow us, for example, to specifically produce 
visceral motor neurons in vitro for cell transplantation or even to regulate their 
development in vivo.   
It is noteworthy that p3 progenitors generate both motor neurons and interneurons, two key 
elements of motor circuits.  Moreover, different types of p3-derived neurons express some 
of the same neuronal markers during their development – for example, both dorsal and 
ventral p3-derived interneurons express Sim1 during embryogenesis (Figure 3.16 and 3.17) 
and likewise SPNs and dorsally-located Sim1-expressing p3-derived INs can be marked with 
neurotransmitter nNOS in the postnatal cord (not shown).  This raises the possibility that 
these different neuronal populations might interact with each other in the formation of a 
local sympathetic circuit.  In preliminary experiments to visualise YFP immunolabelling in 
the transmission electron microscopy by diaminobenzidine histochemistry (Figure 5.1), I 
identified synapses on postnatal SPNs at which both pre- and post-synaptic structures were 
YFP-positive.  These results suggest that different classes of p3-derived neurons might be 
electrically coupled.  The idea that cells derived from the same progenitors have 
preferentially synapse with their sister cells already has a precedent (Yu et al. 2009).  The 
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Nkx2.2-CreER
T2 mice described in this Thesis are a valuable tool with which to study the 
neuronal circuitry of the spinal autonomic nervous system. 
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Figure 5.1  -  Synaptic connectivity of p3-derived neurons might contribute to intra-
spinal autonomic circuits.  (please, see text for more details)  Scale bars in B & C, 500nm, 
and in inset of C, 100nm. 
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